










The handle http://hdl.handle.net/1887/20272  holds various files of this Leiden University 
dissertation. 
 
Author: Kanwal, Zakia 





Regulatory mechanisms of innate immune 
















































































Regulatory mechanisms of innate immune 







ter verkijging van 
de graad van Doctor aan de Universiteit Leiden, 
op gezag van Rector Magnificus prof. mr. P.F. van der Heijden,  
volgens besluit van het College voor Promoties 
te verdedigen op woensdag 12 december 2012 
















Promotor:  Prof. dr. H.P. Spaink 
Co-Promotor:  Dr. A.H. Meijer 
Overige leden : Prof. dr. C.J. ten Cate 
   Prof. dr. J. den Hertog 
   Prof. dr. G. Griffiths (University of Oslo) 






































































To honor my parents 
 






































































Chapter 1  General introduction  9 
 
Chapter 2  Deficiency in hematopoietic phosphatase Ptpn6/Shp1  
hyperactivates the innate immune system and impairs control  
of bacterial  infections in zebrafish embryos 43 
 
Chapter 3  RNA-Seq profiling of leukocyte populations and  
mycobacterium-infected cells from wild type and ptpn6- 
deficient zebrafish larvae 79 
  
Chapter 4  MicroRNA-146 function in the innate immune response of  
zebrafish embryos to bacterial infection 109 
 
Chapter 5  Summary and discussion 133 
 
Samenvatting  143 
 






































Regulation of the innate immune response 
Protection against harmful agents is a fundamental process in all living beings. These 
harmful agents include microorganisms, which are the cause of a wide variety of 
infectious diseases. To combat infections, the body must first detect the presence of 
microorganisms as non-self materials. The body initially does this by recognizing 
molecules unique to groups of related microorganisms. These unique microbial 
molecules are called pathogen-associated molecular patterns or PAMPs (Mogensen, 
2009). The recognition of PAMPs activates the immune system, which is traditionally 
divided into two main branches: innate immunity and adaptive immunity (Janeway and 
Medzhitov, 2002). Cells of the innate immune system, such as macrophages and 
neutrophils, contain specific receptors, which are responsible for the recognition of 
PAMPs (Mogensen, 2009; Beutler, 2009). PAMP recognition will activate various anti-
microbial defense mechanisms in these cells. This includes the attraction of other 
immune cells to the site of infection, which results in a local inflammation that helps to 
clear the infection. In addition, activated innate immune cells will alert cells of the 
adaptive immune system, including helper T-cells, cytotoxic T-cells and antibody-
producing B-cells. In cooperation with cells of the innate immune system, these 
adaptive immune cells will mount a highly specific immune response against the 
infectious agent. Furthermore, once the infection is cleared, the adaptive immune 
system provides an immunological memory such that the body can respond more 
effectively should a re-encounter with the same infectious agent occur.  
Together, the innate and adaptive immune system form a highly effective barrier 
against infectious agents. Unfortunately, the immune defenses, especially inflammation, 
are also harmful to our own body (Beutler, 2009). It is therefore essential that the 
immune system is tightly regulated to ensure that inflammatory responses are resolved 
timely. In this thesis the zebrafish is used as an animal model to study mechanisms 
involved in the regulation of the innate immune response. This introductory chapter 
gives an overview of the current knowledge of the innate immune system of vertebrates 
and discusses how various negative control mechanisms are thought to keep the 
immune response in check. 
 
The innate immune system 
Innate immunity is the immunity one is born with and is the first level of defense which 
subsequently triggers more antigen-specific responses by the adaptive immune system 
(Janeway and Medzhitove, 2002). Innate immunity comes into action immediately after 
exposure to microbes. The cell types contributing to the innate immune response 
include phagocytic cells (neutrophils, monocytes, and macrophages), cells that release 
inflammatory mediators (basophils, mast cells, and eosinophils), cells that present 
antigens to the adaptive immune system (dendritic cells), and natural killer cells (NK 
cells). The innate immune system also has a humoral component, including serum 




microbes, innate immune cells activate several anti-microbial mechanisms and secrete 
small peptides, called cytokines, as communication signals. While the innate immune 
system was once believed to be non-specific in nature, the discovery of the Toll-like 
receptors (TLRs) completely changed the view on innate immunity. The TLRs were 
recognized as a family of pattern recognition receptors (PRRs) evolved to detect PAMPs 
(Akira et al., 2001; Beutler, 2009; Mogensen, 2009). The discovery that triggering of 
TLRs forms an essential bridge between the innate and adaptive immune system led to 
a greatly renewed interest in the innate branch of the immune system (Poltorak et al., 
1998; Beutler, 2009, Steinman, 2006). In 2011 these discoveries were awarded with the 
Nobel Prize in Medicine. 
The innate immune system triggers the activation of the adaptive immune 
system by production of proinflammatory cytokines and by providing stimulatory 
signals via major histocompatibility complex (MHC) molecules and costimulatory 
molecules such as CD40, CD80, and CD86; together, it facilitates a full activation of the 
immune system for an efficient response to pathogens (Janeway and Medzhitov, 2002; 
Steinman, 2006). 
In addition to TLRs, other main families of PRRs that detect molecules of 
microbial origin have also been discovered. The function of the ‘outward-looking’ TLRs 
that act as cell-surface receptors to recognize bacteria, is complemented by the ‘inward 
looking’ nucleotide oligomerization domain (NOD)-like receptors (NLRs) that recognize 
bacterial molecules in the cytoplasm (Franchi et al., 2012). Similarly, TLRs on 
endosomal membranes, functioning in viral recognition, work in concert with the 
cytoplasmic retinoic acid-inducible gene I (RIG-I)-like helicases (RLHs) (Kawai and 
Akira, 2008; Loo and Gale, 2011). These three families of PRRs will be discussed in 
detail below. They have critical roles in host control of infection processes, but these 
receptors and their downstream signalling components have also been associated with 
inflammatory diseases (Beutler, 2009). 
  
TLRs 
PAMPS recognized by TLRs comprise lipids, glycolipids, lipoproteins, proteins and 
nucleic acids from a large number of microbial taxa including bacteria, viruses, 
parasites and fungi (Mogensen, 2009). The TLR-dependent recognition of PAMPS 
occurs in different cellular compartments, among which the plasma membrane, 
endosomes, lysosomes and endolysosomes (Akira et al., 2006). TLRs were first 
recognized as pattern recognition receptors when one of them, TLR4, was identified as 
the long-sought receptor that responds to bacterial lipopolysaccharide (LPS), a 
component of the outer membrane of Gram-negative bacteria that can cause septic 
shock (Poltorak et al., 1998). Gene targeting and knock-out studies have subsequently 
demonstrated that each TLR has a distinct function in terms of PAMP recognition and 
immune responses (Akira et al., 2006; Beutler, 2009; Mogensen, 2009). For example, 
TLR2, which generally forms heterodimers with TLR1 and TLR6, is involved in the 
recognition of PAMPs such as bacterial lipoprotein, lipoteichoic acid, peptidoglycan, and 
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yeast zymosan. As another example, TLR5 recognizes flagellin, the principal component 
of bacterial flagella. Besides recognizing molecules of microbial origin, there are some 
TLRs, such as TLR4, which also recognize host molecules that are released by damaged 
tissue (Osterloh and Breloer, 2007; Miyake, 2007; Piccini and Midwood, 2010) 
  On the cytoplasmic side, TLRs have a characteristic protein domain called the 
Toll ⁄ interleukin-1 (IL-1) receptor (TIR) domain (Akira et al., 2006). The TIR domain 
accounts for the major portion of the cytoplasmic domain and serves two purposes. 
First, it contains an oligomerization site, facilitating dimeric interactions between the 
TLR subunits. Second, it contains a site that recruits cytoplasmic adaptor proteins that 
also contain TIR domains. MYD88 was the first discovered member of the TLR adaptor 
family, after which four other TIR domain–containing adaptors were identified: TIRAP 
(MAL), TRIF, TRAM, and SARM (O’Neill and Bowie, 2007). Individual TLRs selectively 
recruit distinct adaptor molecules, thereby resulting in more specific immunological 
responses to the infecting microbes (Akira et al., 2006). For example, TLR3 and TLR4 
generate both type I interferon and inflammatory cytokine responses, whereas cell 
surface TLR1-TLR2, TLR2-TLR6 and TLR5 induce mainly inflammatory cytokines. 
MYD88 is used by all TLRs except TLR3, and activates transcription factors such as NF-
κB and mitogen-activated protein kinases (MAPKs) to induce inflammatory cytokines. 
In contrast, TRIF is used by TLR3 and TLR4 and induces alternative pathways that lead 
to activation of the transcription factors IRF3 and NF-κB  and the consequent induction 
of type I interferon and inflammatory cytokines. TRAM and TIRAP function as sorting 
adaptors that recruit TRIF to TLR4 and MyD88 to TLR2 and TLR4, respectively. SARM1 
is the only adaptor protein for which a negative regulatory role in TLR signaling has 
been proposed, as discussed further below (Carty et al., 2006). Following the 
recruitment of adaptors, a signaling complex consisting of IRAK1 and IRAK4 kinases is 
formed that subsequently activates TRAF6 and downstream MAPK and NF-κB  signaling 
pathways (Gay et al., 2011) (Fig. 1). 
 
NLRs  
The importance of NLR family members in immunity was first suggested by the fact that 
one of them, a trans-activator of MHC gene transcription, class II transactivator (CIITA), 
was mutated in patients with bare lymphocyte syndrome (Steimle et al., 1993). The 
human NLR family contains more than 20 members, most of which recognize PAMPs as 
well as danger signals (Franchi et al., 2012). Among the NLRs, NOD1 and NOD2 
recognize the degradation products of bacterial cell wall components, and 
NLRP3(NALP3) responds to various stimuli by forming the inflammasome complex, 
which promotes the release of active IL-1β and IL-18 by caspase-1-dependent cleavage 
of the precursor forms (Franchi et al 2009, 2012; Martinon et al., 2009). Dysregulation 
of NOD2 signaling is involved in the pathogenesis of a variety of inflammatory 
disorders, such as Crohn's disease (Billmann-Born, 2011; Rosenstiel and Schreiber, 
2009). NOD2 has also been implicated in the development of autoimmune diseases, 
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Figure 1. Negative regulation of the TLR pathway. Different negative regulators of the TLR 




The RLR family has three members namely, RIG-I, Mda5 and LGP2. They are RNA 
helicases that detect viral RNA species and signal through the adaptor molecule IPS-1, 
thus inducing antiviral responses (Yoneyama and Fujita, 2009; Kawai and Akira, 2008). 
The RLR-mediated signalling cascade culminates in the induction of transcription 
factors like interferon regulatory factors  (IRFs) and NFκB and subsequent expression 
of interferon-stimulated genes. Like NLRs, RLRs act cooperatively with TLR signalling in 
the innate response and to modulate the adaptive immune response. Aberrant RLR 
signaling or dysregulation of RLR expression has also been implicated in the 
development of autoimmune diseases (Loo and Gale, 2011).  
 
Detection of danger signals by the innate immune system 
In addition to PAMP recognition by PRRs, other possible means of pathogen recognition 
include the modification of host proteins by microbial enzymes, the detection of 
‘missing self’ due to downregulation of major histocompatibility complex (MHC) class I 
molecules, and the recognition of ‘danger’ by sensing ‘change caused by infection’ 
(Beutler, 2009). By analogy with PAMPs, these danger signals are commonly referred to 
as danger-associated molecular patterns (DAMPs) (Gallucci and Matzinger, 2001; 
Bianchi, 2007). Examples of danger signals include extracellular ATP released by 
damaged cells, crystals, and bacterial toxins. Especially the inflammasome-associated 
NLRs have central roles in the response to DAMPs, but the importance of DAMP-
mediated activation of TLRs is increasingly recognized (Franci et al., 2012; Piccinini and 
Midwood, 2010). An aberrant response of TLRs, NLRs or other PRRs to such 
endogenous danger signals is thought to contribute to inflammatory and autoimmune 
diseases. 
 
Innate immunity and control of autophagy  
It has recently become clear that systems for protein degradation are essential for tight 
control of the inflammatory response. TLR and NLR pathways have been shown to 
control the autophagy system, which functions to deliver cellular waste materials (e.g. 
damaged organelles, long-lived proteins, and insoluble protein aggregates) and 
invading microbes into autolysosomes and is suggested to be involved in the regulation 
of inflammation (Deretic, 2012). Demonstrating the importance of autophagy for 
control of the inflammatory response, mutations in the gene encoding the autophagy-
related molecule Atg16L1 have been linked to Crohn’s disease (Hampe et al., 2007). 
Macrophages derived from Atg16L1-deficient mice showed more activation of caspase-
1 and production of IL-1β and IL-18 in response to LPS (Saitoh et al., 2008). Moreover, 
intestinal Paneth cells derived from Atg16L1-deficient mice showed higher expression 
of genes involved in responses to intestinal injury (Cadwell et al., 2008). These results 





Negative regulation of the immune system 
Sufficient production of inflammatory mediators is essential to clear infections; 
however, activation of the innate immune system against infections can be a double 
edged sword for the host. Pro-inflammatory cytokines mediate a positive feedback loop 
on the innate immune system, and unchecked production of cytokines is hazardous to 
the host and may cause severe outcomes such as hyperthermia, organ failure, and even 
death in extreme cases. (Kobayashi and Flavell, 2004). The inflammatory response must 
therefore be very tightly regulated. The innate immune system is run by a large set of 
effector molecules, some of which regulate it positively by integration of signals, while 
others function in the resolution phase to maintain homeostasis. The latter are typically 
considered as the negative regulators of the system. Negative regulators play critical 
roles in all pathways of innate and adaptive immunity to keep the systems in balance. 
 
Negative regulation of TLR signaling 
Unrestrained TLR signaling can have major deleterious effects on host cells as excessive 
inflammation may lead to tissue damage and inflammatory disorders. The ability of 
microbial TLR ligands to trigger various inflammatory diseases has been intensively 
discussed. Some examples of diseases that may depend on a TLR-mediated microbial 
trigger include arthritis (Joosten et al 2003; Deng et al., 1999), multiple sclerosis 
(Waldner et al., 2004; Kerfoot et al., 2004; Ichikawa et al., 2002), myocarditis (Eriksson 
et al., 2003), diabetes (Lang et al., 2005), atherosclerosis (Yumoto et al., 2005), colitis 
(Cario, 2010), and Crohn’s disease (Man et al., 2011). In the healthy situation, TLR 
signaling can be suppressed at multiple levels by various negative regulators, which 
include inhibitory variants of TLR adaptor proteins or downstream kinases, ubiquitin 
ligases and deubiquitinases, transcriptional regulators, phosphatases, and microRNAs 
(Kobayashi and Flavell, 2004; Liew et al., 2005; O,Neill 2008; Wang et al., 2009; 
Contreras and Rao, 2012) Below, we discuss some key negative regulators of TLR 
signaling whose dysfunctioning have been shown to lead to over-activation of the host 
immune response (Fig. 1).  
 
SIGIRR (Single Ig IL-1-related receptor): SIGIRR/TIR8 is a member of the TIR 
domain-containing family of receptors and functions as an inhibitor of interleukin-1 
receptor (IL-1R) and Toll-like receptor (TLR) signaling. It has been suggested to 
function as a blocking receptor by interacting with IL-1R, TLR4, MYD88, IRAK1, and 
TRAF6, thereby inhibiting IL-1R and TLR-4 signaling (Qin et al., 2005). The ability to 
dampen signaling from IL-1R family members and TLRs makes SIGGIR a key regulator 
of inflammation, cancer-related inflammation, and autoimmunity (Xiao et al., 2007; 
Garlanda et al., 2009). 
 
MYD88s and TAG: MYD88s is a splice variant of MYD88 (Janssens et al., 2002). It lacks 
the ability to bind IRAK-1. Overexpression of MYD88s reduces the phosphorylation of 
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IRAK-1 and reduces NF-κB activation upon IL-1 and LPS treatment (Janssens et al., 
2002; Burns et al., 2003). A splice variant of TRAM, named TAG (TRAM adaptor with 
GOLD domain), has also been reported (Palsson-McDermott et al., 2009), TAG can 
displace the adaptor TRIF from TRAM and thus can act as a specific inhibitor of the 
MYD88-independent pathway activated by TLR4.  
 
SARM1: In contrast to the other four TLR adaptor molecules MYD88, MAL, TRIF and 
TRAM, the fifth adaptor, SARM1, was identified as a negative regulator of innate 
immunity. SARM1 was found to inhibit the function of TRIF, which acts downstream of 
TLR3 and TLR4 (Carty et al., 2006). SARM1 was also shown to play a role in neuronal 
morphogenesis, where it interacts with and receives signal from Syndecan2 and 
controls dendritic arborization of neurons through the MKK4–JNK pathway (Chen et al., 
2011). 
 
TOLLIP (Toll interacting protein): TOLLIP represents a ubiquitin-binding protein 
that interacts with several signaling components in the TLR and IL-1R signaling 
cascades (Burns et al., 2000; Capeluto, 2011). By modulating signaling and membrane 
trafficking processes through its interaction with proteins, like IRAK1, or with 
phosphoinositides, TOLLIP acts as a critical negative regulator of the immune system 
(Ankem et al., 2011; Capeluto, 2011).  
 
IRAK3:  IRAK3 (IRAK-M) acts as a negative regulator of TLR signaling by inhibiting the 
dissociation of IRAK1 and IRAK4 kinases from the TLR signaling complex. IRAK3-
deficient mice showed increased inflammatory responses to bacterial infection and 
reduced endotoxin tolerance (Kobayashi et al., 2002). Expression of IRAK3 is induced 
upon TLR stimulation and IRAK3-deficient cells showed increased production of 
proinflammatory cytokines upon TLR and IL-1R stimulation. Mutations in IRAK3 have 
been associated with a susceptibility to asthma (Balaci et al., 2007; Pino-Yanes et al., 
2012). Furthermore, IRAK3 has been found to suppress TLR7-mediated autoimmunity 
in a mouse model of systemic lupus erythematosus (Lech et al., 2011) and was found to 
be of critical importance in down-regulating induction and progression of dextran 
sodium sulfate (DSS)-induced colitis (Berglund et al., 2010). 
 
TANK: TANK was originally identified as a TRAF-binding protein that has both 
stimulatory and inhibitory functions (Cheng and Baltimore, 1996). In addition, TANK 
binding to TBK1 and IKKi has been linked to the activation of both NF-κB  and IRF3 
(Pomerantz and Baltimore, 1999; Guo and Cheng, 2007; Clark et al., 2011). Recently, it 
became apparent that TANK is not essential for interferon induction and instead is a 
potent negative regulator for TLR-mediated induction of proinflammatory cytokines, 
suppressing constitutive TLR signaling in response to commensal microorganisms 
(Kawagoe et al., 2009). TANK-deficient mice spontaneously develop autoimmune 
glomerular nephritis, which is suppressed by treatment with antibiotics or deficiency in 




interferons, TANK-deficient macrophages and B cells show more NF-κB activation and 
IL-6 production in response to TLR ligands. TANK-deficient cells also show enhanced 
TRAF6 ubiquitination. Therefore, TANK acts as a negative regulator of TRAF6 
ubiquitination in both macrophages and B cells. 
 
Zinc finger proteins:  A20 (TNFAIP3) is a zinc finger protein produced during TLR 
stimulation that has two enzymatic activities, acting as an E3 ubiquitin ligase and a 
deubiquitinase. In vitro analysis has shown that A20 restricts NF-κB  activation by 
modulating RIP1 and TRAF6 (Jacque and Ley, 2009; Kawai and Akira, 2010). A20 has 
also been shown to block the IKK complex upstream of NF-κB  (Skaug et al., 2011). A20-
deficient mice die prematurely due to severe inflammation and cachexia and are more 
responsive to LPS and TNF (Lee et al., 2000). Polymorphisms within the A20 genomic 
locus have been associated with multiple inflammatory and autoimmune disorders, 
including systemic lupus erythaematosis, rheumatoid arthritis, Crohn's disease and 
psoriasis (Vereecke et al., 2011). Another zinc finger protein that is induced by TLR 
agonists is the RING-finger type tripartite-motif protein TRIM30α. This protein was 
found to interact with the TAB2-TAB3-TAK1 adaptor-kinase complex required for NF-
κB activation. TRIM30 α promoted the degradation of TAB2 and TAB3, and inhibited 
NF-kB activation induced by TLR signaling (Shi et al., 2008). TRIM30α has also been 
implicated in the negative regulation of inflammasome signaling (Hu et al., 2010). 
Zc3h12a has a CCCH-type zinc-finger domain and is also induced upon TLR signaling 
(Matsushita et al., 2009). Zc3h12a targets the 3′ untranslated regions of IL-6 mRNA and 
IL-12p40 mRNA for degradation via its RNase activity. Zc3h12a-deficient macrophages 
consistently produce remarkably large amounts of IL-6 and IL-12p40 but normal 
amounts of TNF in response to TLR agonists (Matsushita et al., 2009). Zfp36 
(Tristeraprolin) is another zinc-finger protein which prevents the development of 
autoimmune arthritis (Taylor et al., 1996). Zfp36 has been shown to bind AU-rich 
elements in the 3′ untranslated region of TNF mRNA and remove the poly(A) tail by 
deadenylation, which leads to degradation (Carrick et al., 2004). Therefore, the Zc3h12a 
and Zfp36 zinc finger proteins control mRNA stability through different mechanisms. 
 
ATF3: ATF3 is a transcriptional repressor of the ATF/CREB family that is induced 
during infection and inflammation alongside with the induction of many transcriptional 
activators (Whitmore et al., 2007; Medzhitov and Horng, 2009; Thompson et al., 2009). 
Bone marrow derived ATF3-deficient macrophages showed high production of 
cytokines including IL-12p40, IL-6 and TNF upon LPS stimulation. ATF3 has been 
proposed to inhibit IL-6 and IL-12b transcription by altering chromatin structure, 
thereby restricting access to transcription factors (Gilchrist, 2006). Because ATF3 is 
itself induced by LPS, it seems to regulate TLR4-stimulated inflammatory responses as 
part of a negative-feedback loop. ATF was shown to protect mice against LPS-induced 
endotoxic shock (Gilchrist, 2006), and to ameliorate allergen-induced airway 
inflammation and hyperresponsiveness in a mouse model of human asthma (Gilchrist, 
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2008). It was also demonstrated that ATF3 protects against atherosclerosis by 
controlling macrophage lipid metabolic and inflammatory pathways (Gold, 2012).  
 
PDLIM2: The PDZ-LIM domain protein PDLIM2 was recently shown to play an 
important role in the termination of NF-κB activation. PDLIM2 functions as a nuclear 
ubiquitin E3 ligase promoting polyubiquitination of the p65 subunit of NF-κB. 
Polyubiquitinated p65 was subsequently sequestered by PDLIM2 into discrete 
intranuclear compartments where proteasome-mediated degradation occurred 
(Tanaka et al., 2007). PDLIM2 deficiency increased nuclear p65 and proinflammatory 
cytokine production in response to innate stimuli (Tanaka et al., 2007). PDLIM2 was 
also found to promote the polyubiquitination and proteasomal degradation of STAT3, 
thereby disrupting STAT3-mediated gene activation (Tanaka et al., 2011). STAT3 
function is critical for the differentiation of T helper 17 (TH17) cells, which are thought 
to contribute to the pathology of autoimmune and inflammatory diseases, in particular 
granulomatous inflammation. By targeting of STAT3, PDLIM2 inhibited TH17 cell 
development and granulomatous responses. Deficiency in PDLIM2 exacerbated 
granuloma formation. Based on these results PDLIM2 provides a potential therapeutic 
target for the treatment of autoimmune diseases (Taneka et al., 2011).  
 
SOCS proteins: Suppressor of cytokine signaling (SOCS) proteins function as negative 
regulators of cytokine signaling (JAK-STAT) pathways but are also induced by TLR 
stimuli and involved in regulation of TLR signaling (Heeg and Dalpke, 2003). For 
instance, SOCS1-deficient cells were shown to be hyperresponsive to TLR stimulation 
(Fujimoto and Naka, 2010). Defects in SOCS protein function contribute to a variety of 
inflammatory disorders and are also viewed as attractive therapeutic targets in 
autoimmune diseases (Yoshimura, 2004; Ramgolam and Markovic-Plese, 2011).   
 
SH2 domain containing phosphatases: Like the SOCS proteins, several Src homology 
(SH2) domain-containing phosphatases also act on multiple signaling pathways 
involved in the responses to cytokines and microbial triggers. The lipid phosphatase 
SHIP1 (SH2 domain-containing inositol-5-phosphatase 1) negatively regulates the 
activation of immune cells primarily via the phosphoinositide 3-kinase (PI-3K) pathway 
(March and Ravichandran, 2002). However, SHIP1 has also been shown to regulate 
TLR4-mediated LPS responses by a phosphatase activity and PI-3K-independent 
mechanism (An et al., 2005). Recently, the zebrafish homolog of SHIP1 was shown to 
control neutrophil inflammation by limiting the motility of neutrophils and their 
recruitment to sites of injury (Lam et al, 2012). 
Other important SH2 domain-containing regulators of TLR and cytokine 
responses are the protein tyrosine phosphatases (PTPs), SHP1 and SHP2. These are 
enzymes that remove phosphate groups from phosphorylated tyrosine residues on 
proteins. All PTPs carry a highly conserved active site motif C(X)5R (PTP) signature 
motif, share a common catalytic activity, and possess a similar core structure. Together 




signaling molecules, such as the MAP kinases, and perform important roles in the 
regulation of cell proliferation and maturation. The human genome carries a total of 
107 genes encoding PTPs of which the majority is experimentally verified for the 
function of the catalytic domain (Alonso et al., 2004). Biochemical and genetic studies 
demonstrated that PTPs are involved in both positive and negative signaling pathways 
(Van Vactor et al., 1998). Deregulation of several PTPs leads to a number of pathogenic 
effects in human diseases (Li and Dixon, 2007). PTPs have been shown to regulate many 
aspects of TLR and cytokine receptor signaling during innate and adaptive immunity. 
They are divided into evolutionary distinct classes on the basis of primary structure of 
the catalytic domain. PTPs can also be classified based on their cellular localization as 
receptor like PTPs which are transmembrane receptors and non-receptor intracellular 
PTPs. SHP1 and SHP2 are members of the non-receptor cytosolic PTPs which carry one 
phosphatase domain at the C-terminus and two tandem SH2 domains at the N-
terminus. The SH2 domains act as protein phospho-tyrosine binding domains, and 
mediate the interaction of PTPs with their substrates. These substrates include cytokine 
receptors, e.g., erythropoietin or c-kit (Yi et al 1995; Yi and Ihle, 1993), but also 
intracellular signaling molecules, e.g. tyrosine kinases of the JAK family (Klingmuller et 
al., 1995).  
Both SHP1 and SHP2 have been reported to be involved in the negative 
regulation of TLR signaling and cytokine receptor signaling (An et al., 2008; An et al., 
2006; Croker et al., 2008). More specifically, SHP2 (also known as PTP non-receptor 
type 11 (PTPN11)) inhibits TRIF-dependent TLR3- and TLR4-mediated signaling, 
thereby suppressing type 1 IFN and proinflammatory cytokine production. In vitro 
studies suggested that this cytokine suppression by SHP2 is carried out by preventing 
TANK binding kinase (TBK1) from phosphorylating its substrates upon its interaction 
with SHP2 after TLR3 activation (An et al 2006). Additionally, SHP2 is known to have 
several functions as a positive regulator in immunity (Gadina et al., 1998; Salmond et 
al., 2005). Negative regulatory mechanisms of SHP1 (also known as PTP non-receptor 
type 6 (PTPN6)) also play important roles in controlling immune signaling pathways. 
While SHP2 is ubiquitously expressed, SHP1 is predominantly expressed in 
hematopoietic cells (Yi et al., 1992), and functions as an important regulator of multiple 
signaling pathways in immune cells. SHP1 has been shown to interact with, and 
dephosphorylate a wide spectrum of phospho-proteins involved in hematopoietic cell 
signaling. Loss of function mutations in the SHP1 gene at the motheaten (me/me) locus 
in mice revealed the role of SHP1 in negative regulatory pathways of cell signaling in 
immune cells. Motheaten mice suffer from multiple hematopoietic abnormalities and 
die at an early age (Shultz et al., 1993; Zhang et al., 2000). Lack of SHP1 leads to a 
decrease in the number of astrocytes and microglia in the brains of motheaten mice 
(Wishcamper et al., 2001) and was shown to mediate the cytokine activity in astrocytes 
through negative regulation of the JAK/STAT pathway and by regulating IFN-inducible 
gene expression (Massa and Wu, 1996; Massa and Wu, 1998). SHP1 deficiency has been 
linked with many inflammatory and autoimmune diseases in humans. Levels of SHP1 
protein and mRNA were found to be significantly lower in the peripheral blood 
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mononuclear cells (PBMCs) of Multiple Sclerosis patients compared to control 
individuals (Christophi et al., 2008). Neutrophil- and IL-1-dependent inflammatory 
disease in SHP1 (Y208N/Y208N) mice was shown to be due to the loss of negative 
regulation of TLR and IL-1R signaling (Croker et al., 2011). SHP1 also acts as a negative 
regulator of the signaling pathways involved in the development of chronic 
inflammatory asthma and lung infections. Defective SHP1 function in asthma 
contributed to the enhanced inflammatory gene expression during Mycoplasma 
pneumoniae infections (Wang et al., 2012). Selective deletion of SHP1 in B cells was 
sufficient to cause autoimmune diseases, showing its critical regulation in adaptive 
immune processes (Pao et al., 2007). 
SHP1 was also shown to act as a tumor suppressor gene in many lymphoma, 
leukemia, and other cancers owing to its antagonistic behaviors to the growth 
promoting and oncogenic capacities of tyrosine kinases (Wu et al., 2007). In agreement, 
decreased levels of SHP1 have been observed in many leukemia and lymphoma cell 
lines. On the other hand, SHP-1 was found to be over-expressed in prostrate, ovarian, 
and breast cancer cell lines (Wu et al., 2007). These finding indicate that dysregulation 
of SHP1 function can lead to abnormal cell growth and cause a number of pathologies. 
While it reduces the TLR-mediated inflammmatory cytokine induction by inhibiting NF-
κB  and MAP kinases activation, it can promote type 1 IFN production simultaneously 
(An et al., 2008). The mechanisms underlying both outcomes were linked to interaction 
between SHP-1 and IRAK1, which results in inhibition of the kinase activity of IRAK1, 
thereby shifting the balance between proinflammatory cytokine and interferon 
production (An et al., 2008). A hypomorphic SHP1 mutation in spin mutant mice was 
found to result in inflammatory lesions associated with aberrant macrophage activation 
in response to TLR stimulation (Croker et al., 2008). MYD88 deficiency was shown to 
suppress this inflammation, further supporting that SHP1 negatively regulates MYD88-
dependent TLR signaling. 
 
MicroRNAs in immune regulation 
MicroRNAs (miRNAs) are another recently emerged class of negative regulators in 
immune pathways, which are now thought to play essential roles in fine-tuning 
mechanisms of both innate and adaptive responses (Lindsay, 2008; O’Connell et al., 
2010; O’Neill et al., 2011) They are evolutionary conserved, short single-stranded RNA 
molecules, around 22 nucleotides in length, that post-transcriptionally down-regulate 
the expression of target mRNA sequences by binding to their 3′ untranslated region 
(UTR). The first miRNA discovered was LIN-4, an important negative regulator of the 
LIN-14 protein required for development in Caenorhabditis elegans, and the subsequent 
work revealed that miRNAs drive a gene silencing mechanism (Lee et al., 1993; Fire et 
al., 1998). 
The latest version of the miRNA database (miRBase 18, November 2011) lists 
1898 mature human miRNAs, thus representing approximately 6-8 % of all human 




estimated that a large portion of the human genome can be regulated by miRNAs (Lewis 
et al., 2005). With more recent studies it has emerged that the main function of 
mammalian miRNAs is to decrease target mRNA levels, in contrast to earlier views that 
miRNAs function only to repress the translation of their target mRNAs (Guo et al., 
2010).  
Considering their dynamic nature, involvement of miRNAs in regulating the 
components of TLR signaling and innate immune pathways was no surprise. Based on 
their highly regulated expression, miRNAs can function as efficient immunomodulators 
(O’Neill et al., 2011). The first report about the role of microRNAs in the immune system 
came in 2004 which showed the relative expression of miR-142a, miR-181a, and miR-
223 in immune cells (Chen, 2004). MiRNAs were subsequently shown to target mRNAs 
of proteins responsible for regulation of inflammation, thereby altering the magnitude 
of the inflammatory response (O’Neill et al., 2011). Many studies have provided 
evidence that development of cells of the myeloid lineage and differentiation of B and T 
cells are under control of miRNAs. MiRNAs are now known to be involved in the 
regulation of a variety of responses including maturation, proliferation, differentiation 
and activation of immune cells of both the innate and adaptive systems (Lindsay, 2008; 
Ha, 2011; Rusca and Monticelli, 2011). They have also been suggested to serve as a link 
between innate and adaptive immune signaling pathways. Furthermore, they have been 
proposed to have a role in controlling the switch from a strong early pro-inflammatory 
response to the resolution phase of the inflammatory response and thereby limiting 
induction of endotoxin tolerance (Quinn and O’Neill 2011; Quinn et al., 2012).  
As discussed above, the signaling molecules that comprise innate and adaptive 
immune signaling pathways are regulated by numerous mechanisms, including physical 
interactions, conformational changes, phosphorylation, ubiquitylation and proteasome 
mediated degradation (Carpenter and O’Neill, 2009). It is thought that miRNA-mediated 
destabilization of these signaling molecules may provide a more energy-efficient way to 
regulate their activity. In comparison to rapid proteasomal degradation of these 
signaling molecules, miRNA-mediated control of their expression and function, either 
by mRNA decay or by translational inhibition, might be more advantageous in infection 
pathways, as the control of mRNA levels by miRNAs that are themselves induced by 
infection facilitates the shift from a strong initial immune response to the resolution 
phase, where the immune response is gradually dampened down (O’Neil et al., 2011).  
 
Regulation of miRNA expression by TLR signaling 
The end result of TLR signaling pathways is the activation of pro-inflammatory 
transcription factors that enhance the transcription of RNA polymerase II sensitive 
genes such as those encoding cytokines, chemokines, and antimicrobial enzymes. 
Because miRNAs are also transcribed by RNA polymerase II it is therefore quite logical 
for miRNA genes to be up-regulated by TLR signalling pathways (Cai et al., 2004; Lee et 
al., 2004). Several recent studies suggest that miRNAs that are expressed following TLR 
activation regulate the strength, location, and timing of TLR responses. MiR-155, miR-
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21 and miR-146a have been central in much miRNA research due to their enhanced 
expression levels following TLR activation. Like other TLR-regulated genes, miRNA 
genes can also be categorized as early or late response genes, as some are induced very 
early e.g., miR-155; and others at somewhat later time points e.g., miR-21 (O’Neil et al., 
2011). Other TLR-responsive miRNAs include miR-132, miR-9, miR-147 and miR-346 
(Taganov et al., 2006; Bazzoni et al., 2009; Liu et al., 2009; Alsaleh et al., 2009). These 
are up-regulated in various cell types after stimulation with TLR ligands. Other miRNAs 
have been reported to be downregulated after LPS treatment, including let-7i, which is 
thought to target TLR4 itself, and miR-125b (Chen et al., 2007; Tili et al., 2007). As many 
of the miRNAs regulated by TLR signaling are also dysregulated in cancer (Calin and 
Croce, 2006), it is possible that miRNAs form a key link between inflammation and 
cancer and that the induction of specific miRNAs by TLRs may be a key step in tumor 
progression (Fig. 2). 
 
miRNA targets in TLR signaling pathways 
There is no strong evidence for the direct targeting of TLRs by miRNAs. Only few 
bioinformatic studies have predicted active miRNA target sites in the 3′ UTRs of TLRs 
(Chen et al., 2004). However, there are many reports on miRNAs targeting the mRNAs 
of signaling components downstream of TLRs, of cytokines induced by TLRs, or of TLR 
signaling regulators. Some examples of these are discussed below and illustrated by Fig. 
2. 
MiR-146 has been shown to target IRAK1 and TRAF6, both of which are 
important components of the MYD88-dependent pathway for NF-κB  activation 
downstream of TLR2, TLR4, TLR5, TLR7, TLR8 and TLR9 (Taganov et al., 2006). Mir-
146 was also proposed to negatively regulate the MYD88-NF-κB  pathway in response 
to a bacterial infection (Taganov et al., 2006). More recently, IRAK2 has also been 
reported to be a target of miR-146 (Hou et al., 2009). MiR-145 is reported to target 
MAL/TIRAP (Starczynowski et al., 2010), and MYD88 is targeted by miR-155, which 
also targets TAB2, functioning downstream of TRAF6 in MAPK activation ((Tang et al., 
2010; Zhou et al., 2010). MiR-348 targets Bruton tyrosine kinase (BTK), recently 
implicated in NF-κB  activation downstream of TLR4, TLR7, TLR8, and TLR9 (Alsaleh et 
al., 2009). MiRNAs are also shown to target inhibitor of NF-κB  kinases (IKKs) which are 
central to NF-κB activation. For example, miR-223 targets IKKα, miR-199 targets IKKβ, 
and IKKε is a potential target of miR-155 (Li et al., 2010; Chen et al., 2008; Gottwein et 
al., 2007; Xiao et al., 2009). Furthermore, the p50 subunit of NF-κB  was found to be a 
direct target of miR-9 (Bazzoni et al., 2009). It is important to note that the above 
mentioned miRNA targets, including MYD88, MAL/TIRAP, IRAKs, TRAF6, BTK, IKKs, 
and NF-κB  are part of multiple signaling pathways. Thus, the miRNAs targeting these 
signaling components can not only dampen signaling via multiple TLRs, but also via 
other PRRs or cytokine receptors, for instance IL-1R and TNFR signaling. (O’Neil et al., 
2011). In addition, the 3′ UTRs of many cytokine mRNAs are predicted to contain 




established to what extent miRNA targeting of cytokine mRNAs contributes to the 




































Figure 2. MiRNAs involved in negative regulation of the TLR Pathway. Immune-related 
miRNAs are shown in pink color around their target proteins. See text for details. 
 
In addition to miRNAs targeting TLR signaling components or downstream 
effectors like cytokines, there is also evidence of miRNAs targeting TLR signaling 
regulators. For example, miR-155 seems to have a complex role in pro-inflammatory 
cytokine responses, as there are reports both of a function as a negative regulator and 
as a positive regulator. While the negative regulation function of miR-155 relates to the 
targeting of several TLR signaling components (see above) or to direct targeting of 
cytokine mRNAs, the positive regulatory function may be explained by the targeting of 
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SOCS1 and SHIP1, two negative regulators of TLR and cytokine signaling (Wang et al., 
2010; O’Connel et al., 2009). Expression of miR-155 was found to be inhibited by the 
anti-inflammatory cytokine IL-10. This inhibition led to an increase in the expression of 
the miR-155 target SHIP1, and thereby to a reduction of TLR4 signaling (McCoy et al., 
2010). Another link between IL-10 and miRNA regulation is that IL-10 can be induced 
in response to increased levels of miR-21. The proposed mechanism for this induction is 
that miR-21 down-regulates the translation initiation factor PDCD4, which inhibits IL-
10 translation (Sheedy et al., 2010). Finally, studies of miR-132 recently identified a link 
between TLR signaling and neuroinflammation. MiR-132 was found to target the gene 
encoding acetylcholinesterase (ACHE), which hydrolyses acetylcholine, an important 
neurotransmitter in the cholinergic anti-inflammatory pathway. Acetylcholine can 
attenuate TLR signaling by inhibiting nuclear translocation of NF-κB in macrophages. 
An increased miR-132 expression downstream of TLR signaling results in repression of 
ACHE and thus increases acetylcholine-mediated negative regulation of TLR induced 
signals (Shaked et al., 2009).  
 
miRNA in immune-related diseases 
Emerging evidence has demonstrated that miRNAs are differentially expressed in 
autoimmune diseases and that miRNA regulation may impact the development or 
prevention of autoimmunity (Pauley et al., 2009; Iborra et al., 2012). Autoimmune 
diseases that have been associated with miRNA dysregulation include rheumatoid 
arthritis, systemic lupus erythematosus, primary biliary cirrhosis, ulcerative colitis, 
psoriasis, idiopathic thrombocytopenic purpura, primary Sj¨ogren’s syndrome, and MS 
(Padgett et al., 2009; Dai et al., 2007; Alevizos and Illei, 2010; Ha, 2011). As is the case 
for other regulators of the immune response, many studies suggest that a proper 
balance of miRNAs production and withdrawal is critical to avoid inflammatory 
outbreaks in these diseases. Many of the miRNAs that are dysregulated in autoimmune 
diseases overlap with those showing aberrant expression in cancer, where 
inappropriate control of inflammation is also an important risk factor. 
Multiple miRNA profiling reports have shown increased expression of TLR-
induced miRNAs, like miR-21, miR-132, miR-146a, and miR-155 in patients with 
rheumatoid- and osteoarthriits, psoriasis, and atopic eczema (Jones et al., 2009; 
Stanczyk et al., 2008; Nakasa et al., 2008; Murata et al., 2010; Stanczyk et al., 2010; 
Ilopoulos et al., 2008; Sonkoly et al., 2007). However, a lack of miR-146a was detected 
in patients with systemic lupus erythematosus (Dai et al., 2007). As another example, 
loss of miR-145 and miR-146a has been shown to result in 5q syndrome, which is a 
haematopoietic abnormality, eventually leading to acute myeloid leukaemia 
(Starczynowski et al., 2010). Reduced expression levels of miR-146a and other anti-
inflammatory miRNAs, like miR-21 and miR-132, in patients with autoimmune diseases 
are easier to interpret than the up-regulated levels that are also often observed. In these 




pathogenesis. Alternatively, the anti-inflammatory effects of these miRNAs cause 
disease by interfering with appropriate immune responses (O’Neill et al., 2011).  
As proposed by O’Neill et al. (2011), a persistent low-grade inflammation in 
inflammatory diseases may results in dysregulated miRNA expression, which leads to 
disease progression (O’Neil et al., 2011). Another factor which may play an important 
role in miRNA-related pathogenesis is the occurrence of mutations or deletions in the 3′ 
UTRs of target mRNAs.For example, a polymorphism in the 3′ UTR of the IRAK1 mRNA 
(a target gene of miR-146a) is associated with susceptibility to rheumatoid arthritis 
(Chatzikyriakidou et al., 2010).   
In addition to the numerous studies about the link between miRNAs and 
autoimmune disorders, the role of miRNAs in allergic inflammation is also recently 
emerging. Demonstrating the potential for therapeutic modulation of miRNA in 
treatment of inflammatory diseases, a study in mice showed a reduced asthmic 
response to the house dust mite antigen when miR-126 was selectively blocked (Mattes 
et al., 2009). The more we understand the complex relationships between inflammatory 
pathogenesis and miRNAs, the bigger the possibilities for additional therapeutic 
strategies to control these diseases. 
 
Zebrafish as an infection and inflammation model 
Zebrafish has proven to be a versatile tool to study host-pathogen interactions and an 
excellent model for the study of human diseases (Renshaw and Trede, 2012). Various 
infection models for bacterial, viral, and fungal pathogens using zebrafish as a host have 
recently been developed (Meijer and Spaink, 2011). Zebrafish is also recognized as a 
good model for studying inflammatory diseases, such as inflammatory bowel disease 
(Love et al., 2007; Oehlers et al., 2011). Despite the absence of lungs, zebrafish models 
can even help understand the molecular basis of respiratory diseases (Renshaw et al., 
2007; Martin et al., 2009). Zebrafish has filled the gap between mouse and invertebrate 
models because it has a similar immune system as higher vertebrates and additionally 
provides a transparent system to visualize infection and inflammation processes in real 
time. Effective gene knockdown technology using antisense morpholino 
oligonucleotides has boosted reverse genetic screens in zebrafish (Bedell et al., 2011). 
Furthermore, zebrafish is an ideal model for forward genetic mutagenesis screens 
(Streisinger et al., 1981; Patton and Zon, 2001). As an example, the application of this 
screening technology recently led to the discovery of a new tuberculosis susceptibility 
locus (LTA4H)  that is conserved between zebrafish and humans (Tobin et al., 2010; 
Tobin et al., 2012) 
There is striking similarity in the immune system between humans and 
zebrafish with comparable immune cell types (Tobin et al., 2012). Like humans, adult 
zebrafish strongly rely on a functional adaptive immune system to control infections. 
For example, zebrafish that are impaired in adaptive immune responses (rag1 mutants) 
are hypersusceptible to tuberculosis. Moreover, wild type zebrafish, like humans, are 
able to restrict the growth of tuberculosis bacteria by the formation of immune cell 
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aggregates known as granulomas (Swaim et al., 2006).  However, during the first weeks 
of embryonic and larval development zebrafish rely solely on their innate immune 
system, because adaptive immunity is not yet matured (Lam et al., 2004). Therefore, 
these embryonic and larval stages provide a useful model to investigate the function of 
the innate immune system in the absence of adaptive responses (Meijer and Spaink, 
2011; Cui et al., 2011). TLR genes have been shown to be broadly expressed during all 
stages of embryonic development (van der Sar et al., 2006). Furthermore, several 
studies have demonstrated the function of TLR signaling in response to exposure of 
zebrafish cells or embryos to microbes or PAMPs (Phelan et al., 2005; van der Sar 2006; 
Stockhammer, 2009, 2010). Likewise, the anti-microbial function of NLRs, NOD1 and 
NOD2 has also been found to be essential to combat Salmonella infection in zebrafish 
larvae. (Oehlers et al., 2011).  
The innate immune system of zebrafish embryos responds very differently to 
acute pathogens, such as Salmonella typhimurium, and a pathogen that causes chronic 
disease, like Mycobacterium marinum. First of all, S. typhimurium and M. marinum cause 
a different pathology (Fig. 3). S. typhimurium proliferates rapidly and causes a lethal 
infection within approximately one day after intravenously injecting one-day old 
embryos. Injection of a similar dose of M. marinum bacteria leads to the formation of 
tissue aggregates of infected and uninfected macrophages and neutrophils that can be 
considered as early stages of granuloma formation, a hallmark of tuberculosis infection. 
Secondly, the expression profiles induced by S. typhimurium and M. marinum are 
specific and follow a different time course (van der Vaart et al., 2012). Within hours, S. 
typhimurium infection induces the expression of many pro-inflammatory genes and 
transcriptional activators of the immune response (Stockhammer 2009, van der Vaart 
et al., 2012). During M. marinum infection such genes are not significantly induced until 
a clear granulomatous infection has developed (van der Sar, 2009; van der Vaart et al., 
2012). Concomitant with the induction of pro-inflammatory genes and transcriptional 
activators, several negative regulators of the TLR pathway (for example atf3, socs1, 
socs3, and irak3) were found to be up-regulated during S. typhimurium infection in 
zebrafish embryos (Stockhammer et al., 2009). Additionally, the zebrafish homolog of 
the anti-inflammatory cytokine IL-10 is also rapidly induced after infection. These gene 
induction profiles suggest a tight feedback control of the inflammatory response. The 
inflammatory response may also be controlled at the protein level by additional factors, 
such as the phosphatase Ptpn6, the well conserved zebrafish homolog of the human 
negative regulator SHP1. Finally, miRNAs, which are highly conserved among all 
vertebrates, are induced upon bacterial infection in zebrafish and may play a role in 





































Figure 3. Disease progression in zebrafish larvae infected with Salmonella typhimurium 
and Mycobacterium marinum. Embryos were infected at 28 hpf with S. typhimurium (A, B) or 
M. marinum (C, D) by injection into the caudal vein. S. typhimurium rapidly proliferates and 
causes lethal infection within a day after injection. In contrast, M. marinum-infected cells 
migrate deeper into tissues and attract other non-infected cells to form tissue aggregates in 
which the bacteria can persist chronically. These tissue aggregates of M.marinum-infected cells 
are considered as the early stages of tuberculous granulomas. 
 
 
Outline of the thesis 
The studies described in this thesis made use of the zebrafish as a model to gain insight 
into the molecular mechanisms that regulate the vertebrate innate immune response. 
As discussed in this introductory chapter, dysfunctioning of these regulatory 
mechanisms may underlie many inflammatory disorders in humans.  
Chapter 2 reports on a knockdown analysis of ptpn6, the homolog of the human 
gene encoding the SHP1 non-receptor protein tyrosine phosphatase. Like the human 
gene, zebrafish ptpn6 shows specific expression in immune cells. Knockdown analysis 
in zebrafish resulted in a late larval phenotype that is associated with increased 
expression levels of inflammatory genes. Furthermore, infection of embryos with S. 
typhimurium or M. marinum resulted in a hyperactivation of the innate immune 











ptpn6 as a negative regulator of the innate immune response. Hyperinduction of the 
innate immune response in ptpn6 knockdown embryos was found to impair their 
ability to control S. typhimurium and M. marinum infections, suggesting that loss of the 
ptpn6-mediated negative control mechanisms causes a pathological inflammatory 
response that is incompatible with a functional immune response to these infections.  
In Chapter 3, recently developed fluorescent reporter lines were used to 
separate specific immune cell populations from zebrafish larvae by fluorescence 
activated cell sorting (FACS). In addition, M. marinum infected cells were FACS-
separated based on the bacterial fluorescence marker. These cell populations were 
subjected to RNA-Sequencing analysis (RNA-Seq) using a cDNA amplification kit that 
allowed the analysis of RNA samples down to concentrations below the nanogram 
range. Using this novel technology, the specific transcriptome profiles of macrophages, 
neutrophils, immature T-cells and M. marinum-infected cells could be compared and 
many specific markers for the different cell types and the infection condition could be 
determined. In addition, these cell-specific transcriptome profiles were analyzed under 
conditions of knockdown of the negative regulator ptpn6, which provided insight in the 
pathways activated under pathological conditions of inflammation. 
Chapter 4 focuses on the zebrafish homologs of miR-146a and miR-146b, which 
have putative target sites in the mRNAs of the TLR-pathways genes IRAK1 and TRAF6 
in both human and zebrafish. The results show that induction of miR-146a and miR-
146b expression during bacterial infection in zebrafish embryos is controlled by the 
Myd88-Traf6 pathway. Furthermore, this chapter reports on a morpholino knockdown 
analysis of miR-146a and miR-14bb and the effects of their down-regulation on the 
transcriptome and bacterial burden.  
As summarized and discussed in Chapter 5, the studies in this thesis have 
contributed to a better understanding of regulatory mechanisms that control the innate 
immune response in zebrafish embryos and support the use of zebrafish embryo and 
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Deficiency in the protein-tyrosine phosphatase SHP1/PTPN6 is linked with chronic 
inflammatory diseases and hematological malignancies in humans. Here we exploited 
the embryonic and larval stages of zebrafish (Danio rerio) as an animal model to study 
ptpn6 function in the sole context of innate immunity. We show that ptpn6 knockdown 
induces a spontaneous inflammation-associated phenotype at the late larval stage. 
Surprisingly, glucocorticoid treatment did not suppress inflammation under ptpn6 
knockdown conditions but further enhanced leukocyte infiltration and pro-
inflammatory gene expression. Experiments in a germ-free environment showed that 
the late larval phenotype was microbe independent.  When ptpn6 knockdown embryos 
were challenged with Salmonella typhimurium or Mycobacterium marinum at earlier 
stages of development, the innate immune system was hyperactivated to a contra-
productive level that impaired the control of these pathogenic bacteria. Transcriptome 
analysis demonstrated that KEGG pathways related to pathogen recognition and 
cytokine signaling were significantly enriched under these conditions, indicating that 
ptpn6 functions as a negative regulator that imposes a tight control over the level of 
innate immune response activation during infection. In contrast to the hyperinduction 
of pro-inflammatory cytokine genes under ptpn6 knockdown conditions, anti-
inflammatory il10 expression was not hyperinduced. These results demonstrate that 
ptpn6 has a crucial regulatory function in preventing host-detrimental effects of 




The innate immune system has been conserved in evolution from invertebrate to 
vertebrate organisms and plays an indispensable role in host protection against 
infections. The vertebrate innate immune system has been demonstrated to not only 
function as the first line of defense against microorganisms, but also to be required for 
activating the secondary adaptive defenses. However, if the innate immune system goes 
unchecked, the production of inflammatory mediators can cause considerable tissue 
damage. Recent studies indicate that defects in the initial sensing of microorganisms 
and allergens by the innate immune system can contribute to autoimmune and 
autoinflammatory diseases, which were classically viewed as specific disorders of the 
adaptive immune system (Beutler, 2009; Drexler and Foxwell, 2010; Theofilopoulos et 
al., 2011). In healthy individuals the innate immune response is tightly controlled by 
complex regulatory mechanisms that prevent excessive and chronic inflammation 
(O'Neill, 2008). The SHP1 phosphatase, encoded by the PTPN6 gene, has been 
recognized as a critical factor in this process of negative regulation. 
 SHP1 belongs to the family of protein-tyrosine phosphatases (PTPs), which 
dephosphorylate phosphotyrosyl residues in proteins that are phosphorylated by 




processes, from cell survival to proliferation, differentiation, migration and immune 
responses. SHP1 (PTPN6) and SHP2 (PTPN11) are closely related non-receptor type 
PTPs, each having two Src homology 2 (SH2) domains amino-terminal to the 
phosphatase catalytic domain (Zhang et al., 2000; Tsui et al., 2006; Pao et al, 2007). 
While SHP2 is expressed ubiquitously, SHP1 is predominantly expressed in 
hematopoietic cell lineages, and it has been implicated in the regulation of a diverse 
range of cytokine receptors, growth factor receptors, and immunoreceptors. SHP1 has 
been shown to associate with immunoreceptor tyrosine-based inhibition motifs (ITIMs) 
in these receptors (Zhang et al., 2000; Tsui et al., 2006), and has been proposed to bind 
to ITIM-like motifs in various kinases, including IRAK1, ERK1/2, p38, JNK, JAK2, JAK3, 
TAK1, IKKα, and LYN (Abu-Dayyeh et al., 2008; Abu-Dayyeh et al., 2010).  
SHP1 has been extensively studied after the discovery of two naturally occurring 
mutant mouse strains: motheaten (me), considered to carry a null allele of the Ptpn6 
gene, and motheaten viable (mev), which encodes a phosphatase with approximately 
20% of wild type catalytic activity (Shultz et al., 1993; Tsui et al., 1993; Kozlowski et al., 
1993). These mice suffer from severe immune disorders, with spontaneous 
inflammatory activity affecting multiple organs, including the lungs, kidney, joints, and 
skin, the latter resulting in their typical ‘motheaten’ appearance. The mutations result in 
lethal pneumonitis by three (me) or nine (mev) weeks of age. Backcrossing of mev mice 
to rag1 null mutants (that do not contain mature T and B cells) did not alleviate the 
motheaten inflammatory disease, indicating that the function of myeloid cells rather 
than the function of the adaptive immune system is required for major aspects of the 
shp1 mutant phenotype (Yu et al., 1996). Furthermore, pulmonary inflammation in mev 
mutants was found to depend strongly on the function of mast cells (Zhang et al., 2010). 
A viable hypomorphic allele of Ptpn6, spin (spontaneous inflammation), carrying a point 
mutation in one of the SH2 domains, was later described that elicits chronic 
inflammatory and autoimmune disease (Croker et al., 2008). Inflammation in spin 
mutants was triggered by the presence of microbes and found dependent on production 
of IL-1, subsequent IL-1 signaling, and the presence of neutrophils (Croker et al., 2008; 
Croker et al., 2011). Consistent with these findings, SHP1 was shown to negatively 
regulate Toll-like receptor (TLR)-mediated production of pro-inflammatory cytokines 
by suppressing the activation of MAPKs and the transcription factor NF-κB (An et al., 
2008). 
 SHP1 has been associated with several human inflammatory diseases. In 
patients with psoriatic inflammatory skin disease, deficient SHP1 expression in T-cells 
has been observed (Eriksen et al., 2010). Furthermore, macrophages of multiple 
sclerosis (MS) patients display SHP1 deficiency concomitant with enhanced expression 
of genes mediating inflammatory demyelination in MS pathogenesis (Christophi et al., 
2009). Finally, it has been suggested that altered expression of SHP1 may also be 
associated with human allergies and asthmatic disease, based on recent studies in mice 
that indicate a role of SHP1 in mast cells and allergic inflammatory responses (Zhu et 
al., 2010). In addition, SHP1 is considered a putative tumor suppressor. Decreased 
expression of SHP1 has been observed in many types of human lymphomas and 
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leukemias. The reduced levels of SHP1 in these malignancies have been attributed to 
mutations, epigenetic regulation, and post-transcriptional mechanisms (Wu et al., 2003; 
Witkiewicz et al., 2007). SHP1 has also been implicated as a negative regulator of 
insulin signaling and clearance of insulin in the liver, and has been linked to progression 
of diabetic retinopathy (Dubois et al., 2006; Geraldes et al., 2009).  
As many recent studies have shown, the zebrafish embryo model has specific 
advantages not only for developmental biology but also for studying immunity, 
inflammation and infections (Lieschke and Trede, 2009; Martin and Renshaw, 2009; 
Meijer and Spaink, 2011). The embryo model is particularly useful for studying 
responses of the innate immune system, as macrophages and neutrophils develop 
during the first two days of embryogenesis, when the adaptive immune system is not 
yet in place (Lam et al., 2004).  The zebrafish genome encodes orthologs of the majority 
of human PTPs, including shp1/ptpn6 and shp2/ptpn11a (van Eekelen et al., 2010). We 
have previously shown that hematopoietic expression of shp1/ptpn6 is conserved in 
zebrafish embryos and controlled by the transcription factor Pu.1 (Spi1), like its human 
counterpart (Zakrzewska et al., 2010; Wlodarski et al., 2007). The zebrafish embryo 
model was also exploited to study the role of shp2 in early development and to 
investigate the cell biological effects of activating and inactivating mutations in Shp2 
protein that underlie the Noonan and LEOPARD syndromes in humans. Defective Shp2 
signaling induced cell movement defects as early as gastrulation and zebrafish embryos 
expressing Noonan or LEOPARD Shp2 displayed craniofacial and cardiac defects, 
reminiscent of human symptoms (Jopling et al., 2007).  
Here we used morpholino knockdown to study the effect of ptpn6 deficiency in 
zebrafish embryos. No visible phenotypic effects of ptpn6 knockdown were observed 
during early development, but morphant larvae developed a late phenotype at 5 to 6 
days post fertilization (dpf). Skin lesions in these morphants were reminiscent of 
phenotypes of the murine ptpn6 mutants, motheaten and spin, which suffer from severe 
inflammation leading to patches of hair loss and foot lesions, as discussed above (Tsui 
et al., 1993; Croker et al., 2008). Based on leukocyte infiltration and pro-inflammatory 
gene expression we concluded that also the zebrafish ptpn6 morphant phenotype is 
associated with an inflammatory response. We describe infection experiments of ptpn6 
morphants with bacterial pathogens at 1 dpf, which is several days prior to the 
manifestation of the late inflammation-associated phenotype. We observed that ptpn6 
morphants responded to bacterial challenge with increased induction of pro-
inflammatory genes compared to wild type embryos, yet their ability to control these 
infections was severely impaired, indicating that this is not a functional response. In 
conclusion, our data demonstrate the role of ptpn6 as a negative regulator of the innate 








Materials and methods 
Zebrafish husbandry  
Zebrafish were handled in compliance with the local animal welfare regulations and 
maintained according to standard protocols (zfin.org). Zebrafish lines used in this study 
included AB/TL, Tg(mpx:gfp)i114 (Renshaw et al., 2006), Tg(fli1:EGFP) (Lawson and 
Weinstein, 2002) and Tg(-1.0pomca:GFP)zf44;Tg(prl:RFP)zf113 (Liu et al., 2006). 
Embryos were grown at 28.5–30°C in egg water (60 μg/ml Instant Ocean sea salts). For 
the duration of bacterial injections embryos were kept under anesthesia in egg water 
containing 200 µg/mL tricaine (Sigma-Aldrich). Embryos used for whole mount in situ 
hybridization and immunostaining were kept in egg water containing 0.003% 1-phenyl-
2-thiourea (Sigma-Aldrich) to prevent melanization. 
 
Morpholino knockdown 
Morpholino oligonucleotides (Gene Tools) were diluted to the desired concentration in 
1× Danieau buffer (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM Ca(NO3)2, 5.0 mM 
HEPES; pH 7.6) containing 1% phenol red (Sigma-Aldrich) and approximately 1 nL was 
injected at the 1-2 cell stage using a Femtojet injector (Eppendorf). For knockdown of 
ptpn6 two morpholinos were used, one targeting the exon 11/intron 11-12 splice 
junction (MO1: 5’ACTCATTCCTTACCCGATGCGGAGC3’; 0.0625 mM), and one targeting 
the translation start site (MO2: 5’CTGTGAAACCACCGAACCATCTTCC3’; 0.20 mM). As a 
control we used the standard control (SC) morpholino from GeneTools at the same 
concentrations as the ptpn6 MOs. 
 
Whole-mount in situ hybridization, immunodetection, TUNEL assay, 
and myeloperoxidase activity assay 
For all assays embryos were fixed in 4% paraformaldehyde (PFA) in phosphate-
buffered saline (PBS). Whole-mount in situ hybridization (WISH) using alkaline 
phosphatase detection with BM Purple substrate (Roche Diagnostics) was carried out 
as previously described (Stockhammer et al., 2009). Digoxigenin-labeled mfap4 and 
mpx probes were generated as described in (Zakrzewska et al., 2010). 
Immunofluorescence stainings were performed with 1:500 dilutions of polyclonal 
rabbit Ab against phospho-Histone H3 (Santa Cruz)  and L-plastin (Mathias et al., 2007). 
For detection, Alexa Fluor 568/488 goat anti-rabbit IgG secondary Ab (Molecular 
Probes) as described in (Cui et al., 2011) were used. DNA fragmentation during 
apoptotic cell death was examined by TUNEL using the ApopTag Peroxidase In Situ 
Apoptosis Detection Kit (Millipore) according to the manufacturer’s instructions. 
Embryos were fixed, permeabilized, treated with Proteinase K and refixed in 4% PFA as 
for WISH.  Embryos were then fixed in ethanol:acetic acid 2:1 for 15 min at -20ºC 
followed by PBS washes. After 15 min incubation in the equilibration buffer embryos 
were transferred to working strength TdT enzyme solution supplemented with 0.3% 
TritonX-100, and incubated for 1 h on ice followed by 1 h at 37ºC. The reaction was 
stopped by a 5 min wash in stop solution at room temperature, followed by 45 min 
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incubation at 37ºC and PBS washes.  Subsequent immunodetection with alkaline 
phosphatase-conjugated anti-DIG Fab fragments and BM purple staining was 
performed as for WISH. Histochemical staining for Mpx activity was performed with the 
Peroxidase Leukocyte  Kit (Sigma-Aldrich) as described in (Cui et al., 2011). 
  
RNA isolation, quantitative RT-PCR, and RT-MLPA 
RNA isolation and quantitative RT-PCR (qPCR) analysis was performed as described in 
(Stockhammer et al., 2009). Primer sequences for ppial, il1b, mmp9, lgals, mpeg1, 
cxcr3.2, mfap4, and marco are described in (Zakrzewska et al., 2010; Stockhammer et 
al., 2009). Additional primer sequences used were:  
lyz: FW5’TGTCCTCGTGTGAAAGCAAGAC3’, REV5’AGAATCCCTCAAATCCATCAAGCC3’; 
 mpx: FW5’AAGACAATGCACGAGAGC3’, REV5’GCAATGAAGCAAGGAACC3’; 
csf1r: FW 5’CTGCTGGTCGTAGAGGAG3’, REV 5’TGTGAAGTCAGAGGAGG3’; 
ncf1: FW5’CACAGGATGGCTGAAACATACG3, REV5’TAGTGCTGGCTGGGAAAGAATC3’. 
Reverse transcription – multiplex ligation-dependent probe amplification (RT-MLPA) 
was performed as described in (Rotman et al., 2011).  
 
Germ-free experiments 
For generating germ-free embryos we used a natural breeding method described in 
(Pham et al., 2008). Eggs were washed 3× in antibiotic gnotobiotic zebrafish medium 
(GZM) prior to performing morpholino injections in a down-flow cabinet using 
sterilized needles and equipment. Following injections, eggs were immediately washed 
with antibiotic GZM and were successively treated with PVP-I and bleach solutions. 
Embryos were grown in 6 well plates at 28°C wrapped in aluminum foil and sterile 
antibiotic GZM was refreshed daily. At the end of the experiment sterility was tested by 
plating media from the germ-free and conventionally raised embryos on tryptic soy 
agar plates. 
 
Chemical treatments  
Betamethasone 17-valerate (1 μM) , beclomethasone (25 μM), and prednisolone (25 
μM) were dissolved in 0.1% DMSO and added directly to egg water at 1 dpf or 3 dpf, 
solutions were refreshed daily. Controls were treated with DMSO only. CuSO4-induced 
inflammation was performed as in (d'Alencon et al., 2010). 
 
Infection experiments 
Salmonella typhimurium infections were performed using the S. typhimurium strain 
SL1027 and its isogenic LPS Ra mutant derivative SF1592, carrying the DsRed 
expression vector, pGMDs3 (van der Sar et al., 2003). For Mycobacterium marinum 
infection experiments the Mma20 strain was used expressing mCherry in pSMT3 vector 
(van der Sar et al., 2004). Bacteria were grown and prepared for injections as described 
in (Cui et al., 2011), and microinjected into the caudal vein of embryos at 28 hours post 




marinum per embryo. After injections embryos were transferred to fresh egg water and 
incubated at 28°C. For plating assays, infected embryos were homogenized using a 
Retsch mixer mill with a metal bead for 1 min at maximum speed. 
 
Microarray analysis  
For microarray analysis of S. typhimurium infection in ptpn6 morphants, three 
independent infection experiments were performed. In each experiment, RNA was 
isolated from pools of 15-20 embryos per treatment group. Knockdown of ptpn6 was 
performed using MO1 and control embryos were injected with Danieau buffer/phenol 
red. The ptpn6 morphants and control embryos were infected at 28 hpf with S. 
typhimurium SL1027 bacteria, or mock-injected with PBS as a control. RNA extraction 
was performed at 8 hpi. Microarray analysis was performed using a previously 
described custom-designed 44K Agilent chip (Agilent Technologies) (Stockhammer et 
al., 2009). All RNA samples were labeled with Cy5 and hybridized against a Cy3-labeled 
common reference, which consisted of a mixture of all samples from the infection study. 
Labeling, hybridization and data analysis using Rosetta Resolver 7.0 was performed as 
previously described (Stockhammer et al., 2009). The raw data were submitted to the 
Gene Expression Omnibus database under accession no. GSE34930. KEGG pathway 
analysis was performed using DAVID v6.7 (http://david.abcc.ncifcrf.gov/home.jsp) 
(Huang da et al., 2009). 
 
Microscopy and image analysis 
Bright field images of embryos were obtained with a Leica M165C stereomicroscope 
equipped with a DFC420C digital color camera (Fig. 1; Fig. 2 A-D; Fig. 3 E-H; 
Supplementary Fig. S1 C, D) Composite images of different focal planes were created 
with Adobe Photoshop. Fluorescence images were taken with a Leica MZ16FA stereo 
fluorescence microscope equipped with a DFC420C digital color camera (Fig. 2 E-L ; Fig. 
3 A, B, I-L; Fig. 5 C-F, H-M; Supplementary Fig. S1 E-H, K, L;). Overlay images of bright 
field and fluorescence stereomicroscopy were made in Adobe Photoshop. Confocal 
microscopy was performed with a Leica TCS SPE confocal microscope (Fig. 3 C, D: HC 
PLAN APO objective 20x/0.70 NA; Fig. 4 I-T: HCX APO objective 40x/0.80 NA; Fig. 5 N-
Q) or Zeiss LSM5 Exciter system (Fig. 4 A-F: APO objective 10x/0.3 N/A). Maximum 
intensity projections of z-stacks of different focal planes were obtained using image J. 












Knockdown of ptpn6 causes a late phenotype in zebrafish larvae that 
is characterized by enhanced proliferation, apoptosis, and 
inflammation 
In order to study the function of the ptpn6 gene in zebrafish, a knockdown study of this 
gene was performed using a splice blocking morpholino that causes deletion of the 
phosphatase catalytic domain (MO1) and a translation blocking morpholino (MO2) 
(Supplementary Fig. S1 A, B). Both morpholinos did not have strong effects on embryo 
morphology at 1-3 dpf, except that the heads and eyes of ptpn6 morphants were slightly 
smaller compared with the controls (Fig. 1 A, B, H, I; Fig. 2). Furthermore, L-plastin 
immunostaining, in situ hybridization with mfap4 and mpx markers, and Mpx activity 
assays demonstrated that macrophage and neutrophil numbers and the migratory 
responses of these cells towards injury were normal (Fig. 2).  
However, at later stages of development, pleiotropic effects on larval 
morphology were observed that became progressively severe. At 3 dpf, some embryos 
showed a minor oedema of the heart cavity (Fig. 1 B, I), which became more prominent 
at 4 dpf (Fig. 1 C, J). At 5-6 dpf, morphant larvae additionally developed lesions on the 
eyes and skin, and in severe cases they also developed oedema between the trunk and 
the yolk sac and yolk extension (Fig. 1 D-G, K-N). After injection with MO1 between 80-
90% of the larvae at 5-6 dpf showed these phenotypic abnormalities, while the effect of 
MO2 injection was lower, with only 5-10% of larvae displaying severe oedema and skin 
lesions (Supplementary Fig. S1 C, D). The heart beat frequency was unaffected in ptpn6 
morphants until 4 dpf, but was approximately 40% reduced in larvae of 6 dpf, as the 
likely result of the increased cardiac oedema at this stage (data not shown). Morpholino 
injection of Tg(fli1:EGFP) embryos did not reveal defects in vascular development 
(Supplementary Fig. S1 E-H). 
Since mammalian ptpn6/shp1 has been implicated in negative regulation of 
growth factor, MAPK, and NF-κB signaling pathways, we investigated proliferation, 
apoptosis, and inflammation in ptpn6 morphants. Phosphohistone H3 immunolabeling 
revealed increased numbers of mitotic cells in ptpn6 morphants in a specific region on 
the dorsal side of the brain and in the retina at 5 dpf (Fig. 3 A-D). Furthermore, 
increased numbers of apoptotic cells were detected with a TUNEL assay, particularly in 
the brain and in the region of cardiac oedema at this stage (Fig. 3 E-H). To determine if 
the phenotype of the zebrafish ptpn6 morphants was associated with inflammation, we 
performed immunofluorescence staining using anti-L-plastin Ab, which stains all 
leukocytes (Mathias et al., 2007). The results showed that leukocytes in 5 dpf ptpn6 
morphants accumulated around the oedemic area of the heart cavity and at skin lesions, 
while they had largely disappeared from their normal location in the caudal 
hematopoietic tissue (Fig. 3 I-L). In addition, we checked the expression of the pro-
inflammatory genes il1b and mmp9. Quantitative RT-PCR (qPCR) showed that, 




expression levels of il1b and mmp9 were enhanced in ptpn6 MO1 and MO2  morphant 
embryos compared to the controls at 5dpf and 6dpf, but not at 4dpf (Fig.  3 M-P). We 
conclude, based on leukocyte infiltration and enhanced il1b and mmp9 expression, that 
the late pleiotropic phenotype of ptpn6 morphant larvae is associated with 
inflammation. 
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Figure 1. Late pleiotropic phenotype in ptpn6 morphant zebrafish larvae. (A-G) Embryos 
injected with standard control morpholino (con). (H-N) embryos injected with ptpn6 
morpholino (MO1). Phenotypes are shown at 2-6 dpf in lateral (A-E, H-L) or dorsal view (F, G, 
M, N) with the anterior side to the left. Dorsal views show head and trunk (F, M) or the tail 
region (G, N). Skin lesions in ptpn6 morphants are indicated with arrow heads and cardiac 
oedema is indicated with arrows. 
 
The ptpn6 morphant phenotype is independent of the presence of 
microbes 
Since inflammation might be triggered by the presence of microbes, we investigated 
whether the zebrafish ptpn6 morphant phenotype also developed in a germ-free 
environment. To this end, eggs were bleached, treated with iodine, and cultured in the 
presence of antibiotic and antifungal compounds following established protocols (Pham 
et al., 2008). At the end of the experiment sterility was confirmed by plating culture 
medium on tryptic soy agar plates, showing that bacterial colonies developed from 
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conventionally reared larvae but not from germ-free cultured larvae. When reared in 
the germ-free environment, 80-90% of the ptpn6 morphant larvae developed oedema 
and skin lesions, similar to the conventionally raised morphant larvae. Therefore, the 
inflammation-associated phenotype of ptpn6 morphants is apparently not driven by the 
presence of culturable microbes. 
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Figure 2. Unaltered leukocyte development and migratory response in ptpn6 morphants. 
(A, B) In situ hybridization with macrophage marker mfap4 (Zakrzewska et al., 2010) at 1 dpf. 
(C, D) In situ hybridization with neutrophil marker mpx at 1 dpf. (E, G) Histochemical staining 
for Mpx enzyme activity at 2-3 dpf. (F, H) immunolabeling of the same embryos as in E and G 
with Ab against the general leukocyte marker L-plastin. (I-L) Histochemical staining for Mpx 
enzyme activity in larvae incubated for 2 h with (J, L) or without (I, K) 10 µM CuSO4 at 3 dpf. 
Chemically induced inflammation by CuSO4 treatment (d’Alençon et al 2010) is due to damage 
of hair cells of the lateral line neuromasts, which attracts neutrophils (arrows in J, L). Embryos 
were injected with standard control (con) or ptpn6 morpholino (MO1) and are shown in lateral 
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Figure 3. Enhanced proliferation, apoptosis, and inflammation in ptpn6 morphants. (A-D) 
Phosphohistone H3 immunolabeling (E-H) TUNEL assay. (I-L) Immunolabeling with Ab against 
the general leukocyte marker L-plastin. Embryos were injected with standard control (con) or 
ptpn6 morpholino (MO1) and all assays were performed at 5 dpf. Larvae or head details are 
shown in lateral (A- D, E, F, I-L) or dorsal (G, H) view with the anterior to the left. Stereo 
microscope images (A, B, E-L) and confocal Z-stack projections (C, D, transmitted light and 
fluorescence overlay) are representative examples of ≥ 20 larvae in each group. Arrows indicate 
regions with increased numbers of proliferating cells (B, D), increased numbers of apoptotic 
cells (F, H), and accumulation of leukocytes around sites of cardiac oedema and skin lesions (J, 
L) in ptpn6 morphants. Also note the absence of immune cells in the caudal haematopoietic 
tissue (CHT) of ptpn6 morphants (J) compared with the control (I). (M-P) Increased expression 
of proinflammatory genes in ptpn6 morphants. Embryos were injected with splice blocking 
(MO1) or translation blocking (MO2) morpholinos targeting ptpn6 or with standard control 
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morpholino (con). RNA was isolated at 4-6 dpf from pools of 10-20 larvae, which were picked 
randomly in the case of con and MO1 morpholino injections. In the case of MO2, which has a 
lower penetrance, 10-20 larvae showing the oedema and skin lesion phenotype were selected. 
Gene expression levels of il1b (M, N) and mmp9 (O,P) were determined by qPCR and relative 
expression levels are shown with the lowest expression level set at 1. Data are the mean ± SEM 
of three independent experiments. Asterisks indicate significant differences (**, P < 0.01; ***, P 
<0.001) tested with an unpaired t-test. 
 
Glucocorticoid treatment enhances the ptpn6 morphant phenotype 
The immunosuppressive action of glucocorticoids is known to be conserved between 
zebrafish and mammals (Schaaf et al., 2009). Since the ptpn6 morphant phenotype was 
associated with enhanced pro-inflammatory gene expression and leukocyte infiltration 
of affected tissues, we tested whether these effects could be suppressed by 
glucocorticoid treatment. Surprisingly, treatment with the synthetic glucocorticoid 
betamethasone 17-valerate, which was previously demonstrated to act as a potent 
glucocorticoid in zebrafish (Schoonheim  et al., 2010), enhanced rather than suppressed 
the development of oedema and skin lesions in ptpn6 morphants. Treatment with two 
other glucocorticoids, beclomethasone and prednisolone, also enhanced the 
development of oedema and skin lesions (data not shown). The affected tissues in 
morphants treated with betamethasone 17-valerate were accompanied by a more 
abundant leukocyte infiltration, as demonstrated using a transgenic marker line for 
neutrophils (Tg(mpx:gfp)i114, (Renshaw et al., 2006) and by L-plastin-immunostaining 
of neutrophils and macrophages (Fig. 4 A-F). In addition, approximately 10% of ptpn6 
morphants that were treated with betamethasone 17-valerate from 1 dpf died at 5 dpf, 
while all untreated morphants were viable until 7-8 dpf. In line with the enhanced 
phenotype, the induction levels of il1b and mmp9 were also further increased in 
morphants treated with betamethasone 17-valerate as compared to the control group 
(Fig. 4 G, H). The increase of il1b and mmp9 at 5 dpf was more pronounced when 
betamethasone 17-valerate treatment was performed for 4 days starting at 1 dpf 
compared to a 2-day treatment starting at 3 dpf (Fig. 4 G, H). However, no general 
insensitivity to glucocorticoids was observed. Expression of fkbp5, a well-known 
glucocorticoid receptor target gene (Schaaf et al., 2009), was inducible by 
betamethasone 17-valerate in both ptpn6 morphants and control embryos (data not 
shown). In addition, betamethasone 17-valerate could still repress the expression of the 
pomc gene in the anterior lobe of the pituitary gland of ptpn6 morphants (Fig. 4 I-T), a 
phenotype often used to score for glucocorticoid responsiveness (Schoonheim et al., 
2010). Overall, these results show that glucocorticoids are not able to suppress the 
inflammatory response observed in ptpn6 morphants, and that instead they 
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Figure 4. Enhanced leukocyte infiltration and inflammatory gene expression by 
glucocorticoid treatment of ptpn6 morphants. (A-F) Embryos of the Tg(mpx:gfp)i114  
neutrophil marker line were injected with standard control (con) or ptpn6 morpholino (MO1)  
and  treated at 1 dpf with 1 μM betamethasone 17-valerate (BV) in 0.1% DMSO or with 0.1% 
DMSO alone as a control. Immunolabelling with Ab against the general leukocyte marker L-
plastin was performed at 3 and 5 dpf. Confocal Z-stacks (fluorescence and transmission 
overlay) of the larval heads (lateral view, anterior to the left) are representative examples of ≥ 
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20 larvae in each group. Accumulation of leukocytes around sites of cardiac oedema and skin 
lesions in ptpn6 morphants is indicated with arrows and arrowheads, respectively. (G,H) 
Embryos were injected with standard control or ptpn6 (MO1) morpholino and treated with 
betamethasone 17-valerate (BV) for 2 days starting at 3 dpf or for 4 days starting at 1 dpf. RNA 
was isolated at 5 dpf from pools of 10-20 larvae. Gene expression levels of il1b (G) and mmp9 
(H) were determined by qPCR and are represented as the fold increase of expression level of 
the MO1 group relative to that of the control morpholino group. Data are the mean ± SEM of 
three independent experiments. Asterisks indicate significant differences (* , P < 0.05; **, P 
<0.01) tested by two-way ANOVA analysis with Bonferroni method as post-hoc test. (I-T) 
Glucocorticoid repression of pomc expression in the anterior lobe of the pituitary gland in ptpn6 
morphants and control embryos. Double transgenic zebrafish embryos expressing prolactin:rfp 
in the anterior lobe of the pituitary gland and pomc:gfp in the anterior and posterior lobes (Tg(-
1.0pomca:GFP)zf44;Tg(prl:RFP)zf113, Liu et al., 2006) were injected with standard control (con, 
I-N) or ptpn6 (MO1, O-T) morpholinos and treated from 1 dpf with 1 μM betamethasone 17-
valerate ( BV) in 0.1% DMSO (L-N, R-T) or with 0.1% DMSO as a control (I-K, O-Q). The pituitary 
gland was imaged at 5 dpf and confocal Z-stacks are representative of 15-20 embryos per 
group. In ptpn6 morphants the pituitary gland is twisted to the right compared to that in control 
embryos, but pomc:gfp expression in the anterior lobe is down-regulated by glucocorticoid 
treatment similar as it is in the control embryos. 
 
Knockdown of ptpn6 impairs the ability of embryos to combat S. 
typhimurium and M. marinum infections 
To investigate the function of ptpn6 in the innate immune response to infection, we 
challenged ptpn6 morphants and control embryos by intravenous injection of S. 
typhimurium bacteria. Importantly, bacterial injections were performed at 28 hpf, i.e. 
several days before the appearance of inflammation and other phenotypic effects in 
ptpn6 morphants. In both ptpn6 MO1 morphants and controls, S. typhimurium infection 
was lethal around 24-30 hours post infection (hpi). However, CFU counts at 2, 8 and 20 
hpi showed that S. typhimurium proliferated faster in the ptpn6 morphants (Fig. 5 A). 
Subsequently, we performed infections with the non-pathogenic S. typhimurium LPS O- 
Ag mutant strain Ra (van der Sar et al., 2003). While this Ra strain hardly proliferated in 
control embryos, clear proliferation of the DsRed-labeled Ra bacteria was observed in  
approximately 55% of ptpn6 MO1 morphants at 1 day post infection (Fig. 5 B-D). At 5 
days post infection (dpi), control embryos had cleared the infection or showed very low 
DsRed fluorescence signal, while the majority of ptpn6 morphants were heavily infected 
or had died at 5 dpi (Fig. 5 B, E, F). Increased proliferation of wild type and Ra S. 
typhimurium bacteria was also observed in embryos injected with ptpn6 MO2 
(Supplementary Fig. S1 I-L). 
Next we examined the response of ptpn6 morphants to infection with M. 
marinum, a pathogen known to cause a chronic infection in zebrafish embryos, whereby 
infected and uninfected macrophages cluster into aggregates that resemble tuberculous 
granulomas (Davis et al., 2002; van der Sar et al., 2009). At 3 dpi ptpn6 morphants 
showed increased fluorescence signal of mCherry labeled M. marinum bacteria and 
increased numbers of granuloma-like aggregates compared to control embryos (Fig. 5 




to those in control embryos (Fig. 5 G, J-M). Furthermore, immunohistochemical analysis 
using an L-plastin Ab of granulomas at 4 dpi showed that the bacteria were mostly 
extracellular in ptpn6 morphants, while in control embryos bacteria were mostly 
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Figure 5. Impaired control of S. typhimurium and M. marinum infection in ptpn6 
morphants. (A) Infection with S. typhimurium wild type strain. Embryos were injected with 
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standard control morpholino (con) or ptpn6 MO1 and infected with S. typhimurium at 28 hpf. 
Groups of 5 embryos were crushed in PBS at 2, 8, and 20 hpi, and dilutions were plated for CFU 
counting on LB medium with carbenicillin selection of the DsRED marker plasmid in S. 
typhimurium. A representative example of three independent experiments is shown. (B-F)  
Infection with S. typhimurium LPS O-Ag mutant Ra strain. Embryos were injected with standard 
control morpholino (con) or ptpn6 MO1 and infected with S. typhimurium Ra at 28 hpf. The 
bacterial burden was analyzed at 1 and 5dpi based on fluorescence of the DsRED marker 
plasmid. A quantification of phenotypes (B) and stereo fluorescence images (lateral view, 
anterior to the left,) of 3 embryos per group (C-F) are shown for a representative example of 
three independent experiments. The bacterial burden in embryos at 1 dpi was scored as low 
(representative image in C) or high (representative image in D). At 5 dpi embryos had either 
cleared the infection, or had died, or showed low (representative image in E) or high 
(representative image in F) bacterial burden. (G-Q) Infection with M. marinum Mma20 strain. 
Embryos were infected with approximately 100 CFU at 28 hpf, and formation of M. marinum 
granulomas was analyzed at 3, 4 and 5 dpi based on fluorescence of the mCherry marker 
plasmid. Fluorescence images of more than 60 embryos per treatment group accumulated from 
two independent experiments were analyzed with pixel quantification software (Stoop et al., 
2011) including an uninfected group as the blank. Pixel quantification data  ± SEM (G) and 
representative fluorescence images (lateral view, anterior to the left)  of 3 embryos per group 
(H-M) are shown.  (N-Q) Confocal Z-stacks of granulomas in ptpn6 MO1 morphants and control 
embryos. 
 
In conclusion, when challenged with bacteria during early development, prior to 
the manifestation of the late inflammation-associated phenotype, ptpn6 morphants 
were severely impaired in their ability to control the progression of infection. This 
impaired control was observed with S. typhimurium and M. marinum strains that induce 
very different pathologies, indicating a general inability of ptpn6 morphants to mount a 
functional immune response. 
 
Bacterial challenge of ptpn6 morphants leads to hyperinduction of 
il1b and mmp9 gene expression  
To further investigate the function of ptpn6 in the innate immune response to infection, 
we performed qPCR analysis for two genes, il1b and mmp9, which were previously 
shown to represent robust pro-inflammatory markers associated with bacterial 
infection (Stockhammer et al., 2009) and with the late phenotype observed after ptpn6 
knockdown (see above). We chose to analyze the response to S. typhimurium infection 
at 8 hpi (36 hpf) based on a previous time-course analysis (Stockhammer et al., 2009).  
As expected, control embryos showed a strong induction of il1b and mmp9 expression 
levels. Upon knockdown of ptpn6 with MO1 or MO2, the induction levels of il1b and 
mmp9 were significantly higher than in the control embryos (Fig. 6 A, B). Therefore, we 
conclude that ptpn6 functions as a negative regulator of il1b and mmp9 induction 
during S. typhimurium infection. Unlike the strong pro-inflammatory gene expression 
that is induced by S. typhimurium infection at 8 hpi (Fig. 6 A, B), control embryos or 
ptpn6 morphants infected with M. marinum did not show significant il1b and mmp9 
induction at this time point (Fig. 6 C, D). However, at 3 dpi mmp9 (but not il1b) 




uninfected morphants and infected controls (Fig. 6 C, D). In summary, a hyperinduction 
of pro-inflammatory genes was observed upon bacterial infections of ptpn6 morphants, 

































Figure 6. Increased induction of il1b and mmp9 expression in ptpn6 morphants 
challenged with bacterial pathogens. (A, B) qPCR analysis of  il1b (A) and mmp9 (B) 
expression in RNA samples of PBS-injected or S. typhimurium-infected control embryos (con) 
and ptpn6 morphants (MO1 and MO2). Embryos were injected at the 1-2 cell stage with 
standard control (con) or ptpn6 (MO1 or MO2) morpholinos, injected with PBS or with 250 CFU 
of S. typhimurium at 28 hpf, and RNA was isolated at 8 hpi for qPCR analysis. Relative 
expression levels are shown with the lowest expression level set at 1. Values are the means ± 
SEM of three biological replicates. (C, D) Gene expression levels of il1b (C) and mmp9 (D) in 
response to M. marinum infection. Embryos were injected with standard control morpholino 
(con) or ptpn6 MO1, approximately 100 CFU of M. marinum bacteria were injected at 28 hpf, 
and RNA was isolated at 8 hpi or 3 dpi. Relative expression levels are shown with the lowest 
expression level set at 1. Data are plotted on a logarithmic scale and are the mean ± SEM of 
three replicate experiments. Asterisks indicate significant differences (*, P < 0.05; **, P <0.01; 

















































































































































































Microarray analysis demonstrates an overall enhancement of the 
innate immune response to S. typhimurium infection upon ptpn6 
knockdown 
The S. typhimurium infection model was chosen for further investigation of the specific 
effects of ptpn6 knockdown on the innate immune response by microarray analysis. The 
advantage of this model for functional analysis of ptpn6 was that the response to S. 
typhimurium infection can be analyzed at 36 hpf (8 hpi) (Stockhammer et al., 2009; 
Ordas et al., 2011), thus avoiding that the microarray analysis is affected by secondary 
effects of the late inflammatory phenotype (observed at 4-6 dpf). RNA samples from 
infected and mock-injected ptpn6 MO1 morphants or control embryos from three 
replicate experiments were analyzed using a common reference approach (Fig. 7 A). 
First we analyzed the basal expression differences between mock-injected ptpn6 
morphants and control embryos. KEGG pathway analysis showed that p53 signaling and 
cell cycle were the most significantly affected pathways, and minor effects were 
observed on cytosolic DNA-sensing, sucrose metabolism and pyrimidine metabolism 
(Fig. 7 B). There was little overlap with the genes that were induced by infection in 
ptpn6 morphants: only 7% of the microarray probes that showed basal expression 
differences between controls and ptpn6 morphants were responsive to infection in 
ptpn6 morphants (Fig.  7 B). The infection-responsive gene set showed significant 
alteration of many KEGG pathways related to the immune response, such as TLR, NLR, 
RIG-I, p53, MAPK, and JAK-STAT signaling (Fig. 7 B). For further analysis of ptpn6 
function we concentrated on the differences between the responses to infection in 
ptpn6 morphants and controls.  
The total number of probes showing significant responsiveness to infection was 
approximately 2-fold larger in ptpn6 morphants than in controls (Fig. 7 C).  
Furthermore, the absolute fold changes of many infection-responsive probes were 
larger in ptpn6 morphants (see Supplementary Table 1 for a complete overview of the 
microarray data).  In fact, a total of 598 probes (representing 258 different genes) 
showed significantly higher up-regulation in ptpn6 morphants and 78 probes 
(representing 51 different genes) showed significantly stronger down-regulation (Fig. 
8). Analysis of the gene group with higher up-regulation in ptpn6 morphants showed 
significant overrepresentation of TLR, NLR, RIG-I, p53, MAPK, JAK-STAT and other 
immune-related KEGG pathways (Fig. 7 C). More specifically, genes showing higher up-
regulation in ptpn6 morphants included cytokine/chemokine/interferon genes such as 
il1b, il8, tnfa, tnfb, and ifnphi1, matrix metalloproteinases such as mmp9 and mmp13, 
and many transcriptional regulators of the ATF, CEBP, AP1, NFκB, and STAT families 
(Fig. 8). The higher up-regulation of il1b and mmp9 was consistent with the qPCR 
experiments described above (Fig. 6 A, B) and with qPCR validation of the samples used 
for the microarray study (Supplementary Fig. S2 A, B). As observed in previous S. 
typhimurium infection studies, several negative regulators of immunity signaling are 
induced concomitantly with the induction of pro-inflammatory genes (Stockhammer et 




genes, infected ptpn6 morphants also showed increased induction levels of several of 
these negative regulators, such as irak3, socs3a and socs3b, and NFκB inhibitor genes 
(nfkbiaa, nfkbiab, nfkbib, nfkbiz). In contrast, the anti-inflammatory cytokine gene il10 
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starch and sucrose metabolism (P=0.091)
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Toll-like receptor signaling (P=3.55E-06)
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Toll-like receptor signaling (P=1.93E-05)
cytosolic DNA-sensing (P=5.12E-04)





cytokine-cytokine receptor interaction (P=0.0033)
NOD-like receptor signaling (P=0.0034)
apoptosis (P=0.0054)
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Figure 7. Enhanced innate immune response to S. typhimurium in ptpn6 morphants. (A) 
Experimental set-up of the microarray analysis. Embryos were injected with ptpn6 MO1 or 
Danieau’s buffer at the 1-2 cell stage, and approximately 250 CFU of S. typhimurium bacteria 
were injected into the caudal vein at 28 hpf after the onset of the blood circulation, or PBS was 
injected as a control. Microarray analysis was performed on RNA samples extracted from pools 
of 15-20 embryos at 8 hpi.  RNA samples from the four treatment groups (control/PBS, 
control/S. typhimurium, ptpn6 MO1/PBS, ptpn6 MO1/S. typhimurium) were obtained from three 
independent experiments and hybridized against a common reference consisting of RNA from 
all treatment groups. Next, four expression ratios were derived by Rosetta Resolver re-ratio 
analysis of the sample data against the common reference. The significance cut-offs were set an 
absolute fold change ≥1.5 and P ≤ 0.0001. (B) Venn diagram showing the overlap between the 
effect of ptpn6 knockdown on basal gene expression levels (con vs. MO1) and the effect of S. 
typhimurium on gene expression in ptpn6 morphants (MO1 vs MO1 St). The numbers of probes 
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with significantly changed expression are shown in the Venn diagram and significantly enriched 
KEGG pathways for each comparison are indicated below. (C) Venn diagrams showing 
comparisons of the numbers of probes that were up-regulated or down-regulated by S. 
typhimurium infection in control embryos (con vs. con St) or in ptpn6 morphants (MO1 vs. MO1 
St). KEGG pathways that were significantly enriched in the dataset of infected ptpn6 morphants 
compared with the dataset of infected controls (con St vs. MO1 St) are indicated below. A 
complete overview of the microarray data is given in Supplementary Table 1. 
 
The smaller gene group that showed stronger down-regulation upon infection in 
ptpn6 morphants than in the controls included two CCL chemokine genes (ccl1 and ccl-
c11a) and several leukocyte markers such as coro1a, cpa5, cxcr3.2, lgals9l1, lcp1, lyz, 
and mpx (Fig. 8). However, there was no generally enhanced down-regulation of 
leukocyte markers in infected ptpn6 morphants, as mpeg1 was less repressed in 
infected ptpn6 morphants than in infected controls, and csf1r and mfap4 showed 
unaltered expression under all conditions. qPCR analysis of leukocyte markers showed 
the same trend as the microarray data, particularly increased down-regulation of 
lgals9l1, lyz, and mpx during infection, less pronounced down-regulation of mpeg1, and 
unaltered expression of other markers, including csf1r and mfap4 (Supplementary Fig. 
S2 C-F). In conclusion, microarray analysis indicated that under ptpn6 knockdown 
conditions, embryos responded to S. typhimurium infection by an enhanced gene 
induction profile of the innate immune response. 
 
Increased pro-inflammatory gene induction in S. typhimurium-
infected ptpn6 morphants is confirmed by RT-MLPA analysis 
In addition to the microarray analysis, we used a recently described RT-MLPA assay 
that allows the simultaneous semi-quantitative PCR analysis of 34 innate immune genes 
(Rotman et al., 2011). Further confirming the microarray results, RT-MLPA analysis 
showed over 2-fold increased S. typhimurium-induced up-regulation in ptpn6 
morphants compared to controls for several cytokine/chemokine/interferon genes (ccl-
c5a, cxcl-c1c, ifnphi1, il1b, il8, and tnfa), immune-related transcription factor genes (fos, 
jun, junb, nfkb2, and rel), the matrix metalloproteinase gene, mmp9, and the acidic 
chitinase gene, chia.6 (Fig. 9). Additionally, five other genes that did not meet the 
significance thresholds in the microarray analysis (ccl20, ccl-c24i, cxc46, fkbp5, tlr5a) 
also showed over 2-fold higher up-regulation in ptpn6 morphants based on RT-MLPA 
(Fig. 9). Of note, in both microarray and RT-MLPA analysis, the anti-inflammatory il10 
gene showed equal induction levels during S. typhimurium infection of ptpn6 morphants 
and controls (Fig. 9, Supplementary Table 1). Based on the increased pro-inflammatory 
gene induction profile of S. typhimurium-infected ptpn6 morphants, observed in 
microarray analysis and RT-MLPA, we conclude that ptpn6 functions as a negative 
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Figure 8. Gene groups showing higher up-regulation or stronger down-regulation upon S. 
typhimurium challenge of ptpn6 morphants compared with S. typhimurium challenge of 
control embryos.  A two-dimensional hierarchical clustering (average link, cosine correlation) 
was performed of the probes that were up-regulated or down-regulated by S. typhimurium 
infection in control embryos or in ptpn6 morphants (fold change ≥1.5 and P ≤ 0.0001). Up-
regulated probes are indicated by increasingly brighter shades of yellow, and down-regulated 
probes are indicated by increasingly brighter shades of blue.  Cluster 1 contains 78 probes 
(representing 51 different genes) that showed a stronger down-regulation in S. typhimurium-
infected ptpn6 morphants than S. typhimurium-infected control embryos, and cluster 2 contains 
598 probes (representing 258 different genes) with stronger up-regulation in the ptpn6 
morphants. The gene symbols corresponding to the probes with stronger up- or down 
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regulation are indicated next to the two clusters, categorized in functional annotation groups. 
Only gene symbols of genes with assigned gene names are indicated in the figure, the number of 
other genes without a gene name in each annotation group is indicated between brackets; the 
full list is given in Supplementary Table 1. Symbols of genes that also showed differential 





































































































































































































































































































Figure 9.  Hyperinduction of proinflammatory genes in S. typhimurium-infected ptpn6 
morphants shown by RT-MLPA analysis. Relative expression levels of 34 innate immune 
response genes were determined as described in Rotman et al. 2011. The figure shows the 
absolute fold difference in expression of S. typhimurium-infected control embryos (con) and 
ptpn6 morphants (MO1) versus the corresponding mock-injected groups. Data are plotted on a 
logarithmic scale. Values are the means ± standard deviation of three independent sample sets, 
which were the same as previously used for microarray analysis. Down-regulated expression is 
indicated with triangles. Numbers indicate ≥ 2-fold-change differences in up-regulated 
expression between S. typhimurium-infected ptpn6 morphants and S. typhimurium-infected 
control embryos.  
 
Discussion 
The association of SHP1/PTPN6 deficiency with several types of chronic inflammatory 
disorders and with lymphoid and myeloid malignancies has raised substantial interest 
in this hematopoietic phosphatase as a drug target (Kundu et al., 2010). Here we 
exploited the zebrafish embryo as a novel animal model for studies on the function of 
the ptpn6 gene. The late onset of adaptive immunity during zebrafish development 
permits studying ptpn6 function in the sole context of innate immunity during embryo 
and larval development. Our results show that ptpn6 deficiency in this model leads to  
pleiotropic defects at the late larval stage, accompanied by leukocyte infiltration and 
up-regulated inflammatory gene expression. Moreover, when embryos were challenged 
with bacteria during earlier stages of development, ptpn6 knockdown enhanced the 
innate immune response to this infection. Despite this increased inflammatory 
response, ptpn6-deficient embryos were severely impaired in their ability to control 
infections, indicating the crucial importance of negative regulation by ptpn6 for a 




Inflammation-associated effects of ptpn6 deficiency 
Under normal culture conditions, without challenge by infection, ptpn6 morphant 
larvae developed severe oedema and skin lesions by 5 to 6 days of age. The affected 
tissues in zebrafish ptpn6 morphants were strongly infiltrated by leukocytes and 
increased numbers of TUNEL-positive apoptotic cells were also detected in these areas. 
Simultaneously, the overall expression levels of pro-inflammatory markers il1b and 
mmp9 were over 10-fold increased. The observed inflammation in zebrafish ptpn6 
morphants is consistent with the function of mammalian SHP1 as a negative regulator 
of cytokine signaling, and is most likely caused by increased cytokine excretion by 
leukocytes which have been shown to exclusively express ptpn6 (Zakrzewska et al., 
2010). It remains unknown whether inflammation is the primary cause or the 
consequence of oedema and skin lesions in ptpn6 morphants.  
The observed phenotype is highly reminiscent of the severe skin inflammation 
observed in murine Ptpn6 mutants, me, mev, and spin (Shultz et al., 1993; Tsui et al., 
1993; Croker et al., 2008). In mice, Ptpn6 deficiency, besides causing inflammation, was 
also associated with hyperproliferation of immune cells (Van Zant and Shultz, 1989), 
but we did not detect enhanced proliferation of myeloid cells during zebrafish 
embryonic and larval development. Among the three mutant alleles of Ptpn6 in mice, 
spin causes the least severe functional knockdown (Croker et al., 2008). Inflammatory 
foot lesions of spin mutants did not develop when homozygotes were raised in a germ-
free environment, showing the requirement of the normal microbiota to trigger this 
phenotype (Croker et al., 2008). However, me homozygotes born into a specific 
pathogen-free colony survived no better than under conventional conditions (Lutzner 
and Hansen, 1976). Similarly, we found that the late inflammation-associated 
phenotype of ptpn6 morphant zebrafish larvae was equally severe when cultured using 
an established protocol to generate germ-free conditions (Pham et al., 2008). Complete 
germ-free conditions cannot be guaranteed during morpholino injections, but at least a 
major reduction of microbes was achieved in our experiments, since no bacterial 
colonies were observed when the culture medium of morpholino-injected larvae was 
plated on rich culture medium. Therefore, like in the me mutant, most likely another 
mechanism than the response to microbes is responsible for the development of 
spontaneous inflammation in ptpn6 morphants.  
In addition to the general inflammation-associated defects in ptpn6 morphants, 
the dorsal area of the brain contained increased numbers of apoptotic cells as well as 
increased numbers of cells positive for the proliferation marker phosphohistone H3. 
Deregulation of pathways such as MAPK and NF-κB signaling, known to be affected by 
mammalian SHP1, may explain enhanced proliferation and apoptotic cell numbers in 
ptpn6 morphants. The expression of ptpn6 in wild type embryos and larvae by whole 
mount in situ hybridization was only detectable in myeloid cells and in the larval 
thymus (Zakrzewska et al., 2010). However, it cannot be excluded that ptpn6 is also 
expressed in other tissues at lower levels, which may explain the specific 
hyperproliferative area in the brain of ptpn6 morphants. In rodents, Ptpn6 expression is 
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also predominantly hematopoietic, but has been detected in other tissues as well, 
including the CNS (Massa et al., 2000; Horvat et al., 2001). 
Treatment with glucocorticoids enhanced the inflammatory phenotype, which is 
surprising since glucocorticoids are well known for their anti-inflammatory effects. 
They are widely used clinically to treat a variety of human immune-related diseases 
(Barnes, 2006) and their immune-suppressive effects appear to be well conserved 
between mammals and fish (Schaaf et al., 2009). Most anti-inflammatory effects of 
glucocorticoids are a result of the inhibitory interaction between the glucocorticoid 
receptor (GR) and transcription factors like AP-1 and NF-κB which are important for 
the up-regulation of many pro-inflammatory genes (De Bosscher and Haegeman, 2009). 
However, interaction with other transcription factors can enhance the activity of these 
proteins, and this may even lead to specific pro-inflammatory effects of glucocorticoids. 
In particular, interactions between GR and members of the STAT family, like STAT3, -5, 
and -6 have been demonstrated to be synergistic in nature (Zhang et al., 1997; Biola et 
al., 2000; Hermoso et al., 2004; Stoecklin et al., 1997; Rogatsky and Ivashkiv, 2006; 
Engblom et al., 2007).  Interestingly, the JAK/STAT signaling pathway has been shown 
to be negatively regulated by SHP1 in many studies (Valentino and Pierre, 2006). Thus, 
the enhancement of the inflammatory phenotype upon ptpn6 knockdown in zebrafish 
by glucocorticoids might be explained by a synergistic interaction between the GR and 
transcription factors, like the members of the STAT family, that have become activated 
due to the Ptpn6 deficiency (Fig. 10). Since in humans SHP1/PTPN6 deficiency has been 
shown to be possibly involved in the pathogenesis of several immune-related diseases, 
care should be taken when patients suffering from these diseases are treated with 
glucocorticoids. The SHP1 deficiency could be the cause of resistance to glucocorticoid 
treatment that is observed in a significant subpopulation of patients (Barnes and 
Adcock, 2009) and could theoretically even underlie a worsening of the disease state in 
response to this therapy. 
Function of ptpn6 in the response to bacterial infections 
Knockdown of ptpn6 impaired the ability of zebrafish embryos to control the 
proliferation of two bacterial pathogens that induce very different disease pathologies 
in the zebrafish embryo model: S. typhimurium, which causes acute disease, and M. 
marinum, which causes a chronic disease where bacteria persist in granulomatous 
aggregates. Even the growth of a normally non-pathogenic strain (S. typhimurium LPS 
O-Ag Ra mutant) could not be efficiently controlled and caused lethality. In contrast, 
murine spin mutants displayed increased resistance to Listeria monocytogenes (Croker 
et al., 2008). As discussed above, the spin phenotype is ascribed to a hypomorphic allele 
of Ptpn6, which may explain why this mutant is immunocompetent while zebrafish 
ptpn6 morphants are not. The immunodeficiency of ptpn6 morphants was apparent at 
early developmental stages well before the spontaneous increase in basal levels of pro-
inflammatory genes and developmental defects that occur later during larval 
development. We found that the expression levels of immune-related transcription 




hyperinduced upon infection in ptpn6 morphants. In agreement, the whole set of 
hyperinduced genes showed significant enrichment of KEGG pathways related to 
pathogen recognition and cytokine signaling. These results support the function of 
ptpn6 as a negative regulator of the innate immune response to bacterial infection. 
Since ptpn6 morphants displayed decreased resistance, the hyperactivation of their 
innate immune response is apparently contra-productive for the organism’s defense 
against bacterial pathogens. 
The hyperinduction of innate immune response genes upon infection of ptpn6 
morphants was specific, since for example the expression levels of several myeloid 
markers were unchanged or reduced. In addition to many pro-inflammatory cytokines 
and transcription activators of the immune response, we also observed hyperinduction 
of other negative regulators than ptpn6 itself. Apparently, in the absence of ptpn6, 
increased induction of other negative regulators was insufficient to prevent excessive 
inflammation and a contra-productive defense response against bacterial pathogens. 
This may be explained by the presumed inhibitory effect of Ptpn6 on many cytokine and 
immuno-receptors as well as central kinases in innate immunity signaling pathways 
(Abu-Dayyeh et al., 2008; Abu-Dayyeh et al., 2010), (Fig. 10). Furthermore, the anti-
inflammatory cytokine gene il10 was not induced to higher levels in infected ptpn6 
morphants than in controls. The fact that increased production of pro-inflammatory 
cytokines is not counteracted in ptpn6 morphants by increased anti-inflammatory IL10 
production is a possible explanation for their non-functional immune response against 
bacterial pathogens.  
 
Figure 10. Model of 
PTPN6/SHP1 function in 
innate immunity signaling 
and interaction with glu-
cocorticoid signaling.  
PTPN6/SHP1 has been pro-
posed to inhibit cytokine 
receptors (like the CRFB 
family) as well as several 
kinases in TLR and cytokine 
signaling pathways (Abu-
Dayyeh et al., 2008, Abu-
Dayyeh et al., 2010). The 
putative inhibition motifs in 
these proteins are evo-
lutionary conserved (Supple-
mentary Table 2). Under 
conditions of PTPN6 defi-
ciency the activation of transcriptional regulations like NFκB, AP-1 and STATs is enhanced 
(green arrows). Upon stimulation with glucocorticoids, the GR inhibits NF κB and AP-1 activity, 
but may have a synergistic interaction with STATs.  
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Interestingly, virulence factors of Leishmania parasites have been proposed to 
block macrophage functions by activation of SHP1 (Abu-Dayyeh et al., 2008; Gomez et 
al., 2009). Similarly, SHP1 activation by lipoarabinomannan (ManLAM) has been 
suggested as a host evasion strategy of Mycobacterium tuberculosis (Knutson et al., 
1998; Rajos et al., 2002). Our results show the important regulatory function of this 
phosphatase in the host innate immune response to bacterial pathogens, which 
therefore could indeed be an attractive target for bacteria to manipulate. In our study, 
deficiency of ptpn6 favored growth of S. typhimurium and M. marinum despite an 
enhanced innate immune response to these pathogens. These results are in line with 
studies of zebrafish embryos defective in TNF signaling or eicosanoid biosynthesis, 
which indicated that the outcome of M. marinum infection is worsened either when the 
fish produce high levels of anti-inflammatory lipoxins inhibiting TNF production, or 
when the fish produce pro-inflammatory leukotrienes and excessive levels of TNF (Clay 
et al., 2008; Tobin et al., 2010; Tobin et al., 2012). We have shown that the role of ptpn6 
is crucial for tightly regulating the induction levels of many key players in the innate 
immune response, identified by our microarray analysis, and conclude that the loss of 
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Supplementary Figure S1. Splice blocking morpholino effect and phenocopy with 
translation blocking morpholino. (A) The Ptpn6 protein sequence (Reference sequence 
NP_956254) is encoded by 16 exons. Amino acid sequences derived from different exons are 
indicated with alternating black and blue colours. The amino acid sequence deleted by injection 
of the splice blocking morpholino (MO1) is indicated in red. This sequence comprises the 
phosphatase catalytic domain. We note that the ptpn6 genomic sequence on chromosome 16 in 
Ensembl Zv9 is erroneously split over two genes, ENSDARG00000089043, comprising coding 
exons 1-7, and ENSDARG00000013916, comprising coding exons 8-16. (B) Efficiency of the 
splice blocking morpholino. Embryos were injected at the 1-2 cell stage with Danieau’s buffer (-
) or with 1 nl of 0.06 mM ptpn6 MO1 in Danieau’s buffer (+) and RNA was isolated at 1 and 5 
dpf. RT-PCR with forward primer in coding exon 8 (ATATTCAGAGCAGAGTAAATCAG) and 
reverse primer in exon 13 (TTCGTCACCTTCGTTTCC) results in a 698 bp product for the intact 
mRNA and a 563 bp product when exon 12 is skipped due to MO1 knockdown. MO1 knockdown 
of the intact mRNA is near complete at 1 dpf and partial at 5 dpf. SL, size  ladder. (C) Phenotype 
of 5 dpf larva injected with standard control morpholino (con). (D). Phenotype of 5 dpf larva 
injected with translation blocking morpholino (MO2). In different experiments 5-10% of MO2-
injected larvae showed cardiac oedema (arrow) and skin lesions (arrowheads) similar as 
observed with MO1 (Fig.1). (E-H) Fli1:EGFP embryos were injected with standard control mo 
(con, E,G) or ptpn6 MO1 (F,H), Representative fluorescence images (lateral view, anterior to the 
left) were taken at 2 dpf (E, F) and 6 dpf (G, H). (I-L) Phenocopy of the S. typhimurium infection 
phenotype with a translation blocking morpholino (MO2). (I). Infection with S. typhimurium 
wild type strain. Embryos were injected with standard control morpholino (con) or ptpn6 MO2 
and infected with S. typhimurium at 28 hpf. Groups of 5 embryos were crushed in PBS at 2, 8, 
and 20 hpi, and dilutions were plated for CFU counting on LB medium with carbenicillin 
selection of the DsRED marker plasmid in S. typhimurium. A representative example of three 
independent experiments is shown. (J-L).  Infection with S. typhimurium LPS mutant Ra strain. 
Embryos were injected with standard control morpholino (con) or ptpn6 MO2 and infected with 
S. typhimurium Ra at 28 hpf. The bacterial burden was analyzed at 1 dpi based on fluorescence 
of the DsRED marker plasmid. A quantification of phenotypes (J) and stereo fluorescence 
images (lateral view, anterior to the left) of 3 embryos per group (K, L) are shown for a 
representative example of three independent experiments. The bacterial burden in embryos at 











































































































































































































Supplementary Figure S2.  qPCR analysis of il1b, mmp9, and leukocyte-specific genes in 
ptpn6 morphants and control embryos infected with S. typhimurium. (A, B) Increased ilb 
(A) and mmp9 (B) induction in infected ptpn6 morphants compared to infected controls. (C-F)  
qPCR analysis of leukocyte-specific genes. qPCR analysis was performed on  RNA samples from 
mock-injected (PBS) or S. typhimurium-infected (St) control embryos (con) and ptpn6 
morphants (MO1). Relative expression levels are shown with the lowest expression level set at 
1. Values are the means ± SEM of three independent sample sets, which were the same as 
previously used for microarray analysis. Asterisks in A and B indicate significant differences (**, 
P <0.01; **) tested by two-way ANOVA analysis with Bonferroni method as post-hoc test. Data 
for the leukocyte-specific genes were not significant by two-way ANOVA analysis and 
Bonferroni post-hoc test, but showed the same trend as the microarray data, i.e. stronger S. 
typhimurium-mediated down-regulation of  lgals9l1, lyz and mpx show in ptpn6 morphants than 
in controls (C),  less pronounced S. typhimurium-mediated down-regulation of mpeg1 in ptpn6 
morphants than in controls (D),  unchanged expression of cxcr3.2, csfr1, and mfap4 during S. 
typhimurium infection of ptpn6 morphants and controls (E), and S. typhimurium-inducible 






Supplementary Table 1. microarray data of the ptpn6 knockdown effect on the immune 
response to Salmonella typhimurium infection. Supplementary table can be found online at: 
https://www.dropbox.com/s/t3gyu0euewldyyv/Chapter2.suppl.table1.xlsx 
 
Supplementary Table 2. Putative SHP1 binding sites in immune-related kinases. 
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The zebrafish is an excellent model for studying inflammatory and infectious diseases 
due to the optical transparency of its embryonic and larval stages and the availability of 
transgenic reporter lines that express fluorescent proteins in different leukocyte 
subtypes. However, the gene expression signatures of myeloid and lymphoid cell types 
in zebrafish and homologies with the human system are still largely unknown. Here we 
performed RNA-Seq profiling of eGFP-positive macrophages, neutrophils, and early T-
cells from zebrafish larvae, which were obtained by fluorescence activated cell sorting 
(FACS) of transgenic mpeg1:egfp, mpx:egfp, and lck:egfp lines. Our RNA-Seq analysis 
resulted in comprehensive gene signatures for the different cell types and gave insight 
in genes that are more abundant or more specific than the currently used markers and 
thus highly useful for developing new reporter lines and lineage-specific antibodies. 
Mycobacterium marinum, which infects and persists in macrophages, markedly altered 
the gene expression signature of this cell type. M. marinum-infected cells displayed a 
general down-regulation of macrophage marker genes, along with up-regulation of 
ribosomal protein genes and genes involved in oxidative phosphorylation, proteolysis, 
ion transport, chromatin assembly, lipid metabolism, carbohydrate binding, and 
immunosuppression. The macrophage gene signature was also specifically altered 
under knockdown conditions of ptpn6, a protein tyrosine phosphatase gene known as a 
negative regulator of immune responses. In particular, deficiency of ptpn6 resulted in a 
strong up-regulation of matrix metalloproteinase genes mmp9 and mmp13a in 
uninfected macrophages as well as in M. marinum-infected cells. The up-regulation of 
these genes may be a major cause of the inflammatory phenotype and increased M. 
marinum susceptibility of ptpn6-deficient zebrafish larvae. 
 
Introduction 
The processes that occur during inflammation and immune responses to combat 
infection are orchestrated by complex changes in the gene expression profiles of 
different immune cell populations (Chaussabel et al., 2010). The analysis of cellular 
transcriptomes has been greatly advanced by recent developments in deep sequencing 
technology (Wang et al., 2009; Martin and Wang, 2011). RNA sequencing (RNA-Seq) is a 
powerful method to characterize transcriptional landscapes and discover novel 
transcripts or alternative splice forms (Cloonan et al., 2008; Mortazavi et al., 2008; 
Nagalaskhmi et al 2008; Sultan et al., 2008; Trapnell et al., 2010). RNA-Seq has also 
proved to be an accurate method for quantitative analysis of differential gene 
expression (Mortazavi et al., 2008). In this respect, RNA-Seq analysis has several 
advantages over microarray technology, including a higher sensitivity, a lower 
background, and independency of prior knowledge of the transcriptome (Marioni et al., 
2008; Malone and Oliver, 2011). In RNA-Seq analysis, cDNA read lengths of over a 
hundred nucleotides can now routinely be obtained with the use of paired-end 




reads are subsequently aligned to a reference database of exons or transcripts, and read 
count data is compared between samples using different statistically algorithms in 
R/Bioconductor packages such as DESeq, DEGseq, bayseq, and EdgeR (Anders and 
Huber, 2010; Hardcastle and Kelly, 2010; Robinson et al., 2010; Wang et al., 2010). The 
application of RNA-Seq technology has great potential to advance the understanding of 
the immune system during health and disease. 
The immune system of vertebrates consists of two cooperative components, the 
innate and adaptive immune system (Janeway and Medzhitov, 2002). The innate 
immune response, which forms the first line of defence against infections, is initiated by 
phagocytic cells such as macrophages and neutrophils. In zebrafish embryos, these cells 
are the first to develop and consequently, the fish are solely dependent on their innate 
immune system during the early life stages (Herbomel et al., 1999; Le Guyader et al., 
2008; Ellet and Lieschke, 2010). The first cells of the adaptive immune system, 
expressing early T-cell markers, can be detected by 4 days post fertilization (dpf), after 
the larval thymus is invaded by hematopoietic precursor cells (Kissa et al., 2008). 
However, the adaptive immune system is not considered to be functional until the fish 
reach several weeks of age (Lam et al., 2004). Therefore, zebrafish embryo and larval 
models are well suited for studies that specifically address the function of the innate 
immune defenses. Owing to the transparency of zebrafish at these early life stages, 
high-resolution imaging of the behavior of immune cells and interaction with pathogens 
is possible using fluorescent transgenic reporter lines (Hall et al., 2009). Furthermore, 
the combination of efficient forward and reverse genetics makes the zebrafish a very 
powerful model system (Lawson and Wolfe, 2011). Exploiting these unique advantages, 
many embryo/larval-based zebrafish models for human inflammatory and infectious 
diseases have recently been developed and are contributing to a better understanding 
of human disease mechanisms (Renshaw et al., 2007; Meeker and Trede, 2008; Meijer 
and Spaink, 2011; Oehlers et al., 2011; Renshaw and Trede, 2012). 
In our previous work, transcriptome responses of zebrafish embryos during 
infection were analyzed at the whole organism level (Stockhammer et al., 2009; 
Stockhammer et al., 2010; van der Sar et al., 2009; Ordas et al., 2011; van Soest et al., 
2011; Van der Vaart et al., 2012 ). In addition, we determined an expression profile of 
early myeloid precursor cells obtained from one-day-old embryos by fluorescence 
activated cell sorting (FACS) of a spi1:egfp transgenic line (Zakrzewska et al., 2010). 
Other recently developed fluorescent reporters can now be used for cell-specific 
analysis of different immune cell populations in zebrafish larvae. In this study, we used 
mpeg1:egfp (Ellett et al., 2011), mpx:egfp (Renshaw et al., 2006), and lck:egfp (Langenau 
et al., 2004) transgenic lines to determine the expression profiles of macrophages, 
neutrophils, and early T-cells, respectively. In addition, we used the mCherry marker 
present in a Mycobacterium marinum strain to isolate and profile infected cells from 
zebrafish larvae. Using an ultra-low input cDNA amplification method we could obtain 
libraries for Illumina RNA-Seq analysis from RNA quantities down to 100-200 pg. To 
detect transcripts that are induced under pathological inflammatory conditions, we also 
analyzed the profiles of macrophages, neutrophils, immature T-cells, and M. marinum-
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infected cells under knockdown conditions of the ptpn6 gene. This gene encodes a 
protein tyrosine phosphatase (Shp1) that is conserved between human and zebrafish 
and that functions as a negative regulator of the innate immune response (An et al., 
2008; Croker et al., 2008; Chapter 2). The knockdown of ptpn6 in zebrafish was 
previously shown to enhance the expression of pro-inflammatory genes and to result in 
a hyperactivation of the innate immune response during infection (Chapter 2). Our 
current data show a major effect of ptpn6 knockdown on matrix metalloproteinase gene 
expression in uninfected macrophages as well as M. marinum-infected cells. 
 
Materials and Methods 
Zebrafish husbandry  
Zebrafish were handled in compliance with the local animal welfare regulations and 
maintained according to standard protocols (zfin.org). Zebrafish lines used in this study 
included AB/TL, Tg(mpx:egfp)i114 (Renshaw et al., 2006), Tg(mpeg1:egfp)gl22 (Ellett et 
al., 2011) and Tg(lck:egfp)cz2 (Langenau et al., 2004). Embryos were grown at 28.5–
30°C in egg water (60 μg/ml Instant Ocean sea salts). For the duration of bacterial 
injections embryos were kept under anesthesia in egg water containing 200 µg/ml 
tricaine (Sigma-Aldrich).  
 
Morpholino knockdown 
Morpholino oligonucleotides (Gene Tools) were diluted to the desired concentration in 
1× Danieau buffer (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM Ca(NO3)2, 5.0 mM 
HEPES; pH 7.6) containing 1% phenol red (Sigma-Aldrich) and approximately 1 nl was 
injected at the 1-2 cell stage using a Femtojet injector (Eppendorf). For knockdown of 
ptpn6 a splice morpholino targeting the exon 11/intron 11-12 splice junction (ptpn6 
MO1: 5’ACTCATTCCTTACCCGATGCGGAGC3’; 0.0625 mM) was used (Chapter 2).  
 
Infection experiments 
For infection experiments, a Mma20 strain of Mycobacterium marinum expressing 
mCherry in a pSMT3 vector was used (van der Sar et al., 2004). Glycerol stocks of the 
bacteria were prepared as described by Benard et al., (2012) and microinjected into the 
caudal vein of embryos at 28 hours post fertilization (hpf), using a dose of 100-150 CFU 
per embryo. After injections, embryos were transferred to fresh egg water and 
incubated at 28°C.  
 
Fluorescent Activated Cell Sorting (FACS) 
Macrophages, neutrophils and early lymphocytes from 5-6 dpf larvae were isolated by 
FACS as described in Cui et al. (2011). Briefly, live embryos were rinsed in calcium free 
Ringer for 15 min. Digestion was performed with 0.25% trypsin for 60-90 min at 28°C. 
Digestion was stopped with 1 mM CaCl2 and 10% fetal calf serum. The resultant single 




medium L15 supplemented with 1% fetal calf serum, 0.8 mM CaCl2, 50 units/ml 
penicillin and 0.05 mg/ml streptomycin. FACS was performed at 4°C using FACSAriaIII 
(BD Biosciences) with the BD FACSDiva software (version 6.1.3). For collecting 
mCherry-positive cells a Coherent Sapphire solid-state 561 nm yellow green laser with 
36 mW power was used. Laser settings applied were 600LP, 615/20 BP. For sorting 
EGFP positive cells a Coherent Sapphire solid-state 488 nm laser with 15.4 mW power 
was used. Laser settings applied were 505 LP, 530/30 BP. The percentage of mCherry-
positive cells in the life gate of cell suspensions from Mma20-infected embryos (from 
±200 embryos) was between 0.1 to 1% over a time of ±25 min. The percentages of 
eGFP-positive cells in the life gate were:  0.09-0.2% over a time of ±20 min for lck:egfp 
cell suspensions (from ±150 embryos), 0.02-0.04% over a time of ±30 min for  
mpx:egfp cell suspensions (from ±250 embryos), and 0.04-0.1% over a time of ±25 min 
for mpeg1:egfp cell suspensions (from ±250 embryos). For negative controls in all cases 
a maximum of 500,000 non-fluorescent cells were obtained from the whole cell 
suspension. Fluorescent and non-fluorescent cell fractions were separately collected in 
supplemented L15 medium with addition of 10% zebrafish embryo extract (ZFIN) and 
RNA isolation was performed directly after sample collection. 
 
RNA isolation and Illumina sequencing 
RNA extraction of the cell fractions was done using the RNAqueous-Micro Kit (Ambion). 
RNA quality was checked by lab-on-a-chip analysis with an Agilent Bioanalyzer 2100 
using the RNA 6000 Pico kit (Agilent, Santa Clara).  RNA samples from non-fluorescent 
cell fractions had RIN values above 8. RNA integrity of samples from fluorescent cells 
was judged by the presence of ribosomal peaks in lab-on-a-chip analysis, but the 
quantity was generally too low for an accurate estimation of the RIN value and 
concentration. A total of 50 pg to 10 ng of RNA was used to make RNA-Seq libraries, 
using the Clontech SMARTer Ultra Low RNA Kit for Illumina Sequencing according to 
the manufacturer’s instructions (Clontech Laboratories, Inc. Mountain View, CA, USA). 
After shearing the cDNA the Illumina TruSeq DNA Sample Preparation Kit v2 (Illumina 
Inc., San Diego, USA) was used to make the libraries. In the manufacturer’s instructions 
three modifications were made. In the adapter ligation step the adapters were diluted 
20-fold. In the library size selection step the library fragments were isolated with a 
double Ampure XP purification with a 0.7x beads to library ratio. The library 
amplification step was done with 15 cycles. The resulting mRNA-Seq library was 
sequenced using an Illumina HiSeq2000 instrument according to the manufacturer’s 
description with a read length of 2 x 50 nucleotides. Image analysis and base calling was 
done by the Illumina HCS version 1.15.1. Sequence reads were quality trimmed using 
the quality_trim module in the CLCbio Assembly Cell v4.0.6. Filtered reads were 
mapped to Ensembl transcripts (Zv9_63) using the ref_assemble_short module in the 
CLCbio Assembly Cell v4.0.6. Accumulation of transcripts to Ensembl genes was done by 
first converting the mapping files to a table with the assembly_table module in the 
CLCbio Assembly Cell v4.0.6. Secondly, a custom script was used that sums all reads 
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belonging to the same gene. Non-uniquely mapped reads were divided between genes 
according to their ratio of uniquely mapped reads. Finally, read counts of transcripts 
belonging to the same gene were summed to obtain count data at Ensembl gene level.  
Fold-change and differential expression significance values were calculated from gene 
level read counts using the DESeq package (version 1.8.3) available in Bioconductor 
(version 2.10). DESeq utilizes a negative binomial distribution for modeling read counts 
per gene and implements a method for normalizing the counts (Anders and Huber, 
2010). 
 
Results and Discussion 
RNA-Seq analysis of FACS-sorted macrophages from mpeg1:egfp 
transgenic zebrafish 
To determine a gene expression signature for macrophages, we took advantage of a 
recently described zebrafish line that expresses enhanced GFP (eGFP) under control of 
the mpeg1 gene promoter (Ellett et al., 2011). For isolation of eGFP-labeled 
macrophages we dissociated 5 or 6 day old larvae by trypsinization and subjected the 
resulting single cell suspensions to FACS sorting. The eGFP-labeled cells constituted 
between 0.04 to 0.1% of the total cell population and by sorting for 25 min we could 
obtain 4000-10,000 eGFP-labeled cells from pools of approximately 250 dissociated 
larvae. After testing different RNA isolation methods, we concluded that the 
RNAqueous-Micro Kit (Ambion) yielded good quality RNA from such small quantities of 
cells. The SMARTer Ultra Low RNA Kit for Illumina Sequencing was used to make RNA-
Seq libraries. We succeeded in making RNA-Seq libraries even from samples with an 
estimated RNA input below 100 pg, where ribosomal peaks were just above the 
detection limit of lab-on-a-chip analysis with the RNA 6000 Pico kit. Approximately 10 
million paired-end reads were obtained per library. To determine the reproducibility of 
the method we compared the results of RNA-Seq analysis of 4 biological replicates. For 
each replicate DESeq analysis identified several hundreds of genes with enriched 
expression in the eGFP-positive cell fraction versus the eGFP-negative fraction. Pairwise 
comparison of the replicates showed an overlap of around 50% of significant genes 
between each pair, and 29% of the significant genes were common to all 4 replicates 
(Supplementary Table 1). This demonstrates that consistent results can be obtained 
from RNA-Seq analysis of FACS-sorted eGFP-labeled macrophages, despite that there 
are many steps in the procedure where variation can be introduced (different pools of 
embryos, dissociation and FACS sorting, cDNA amplification from ultra low RNA start 
material). By combining the 4 replicates, which increases the statistical power of DESeq 
analysis (Anders and Huber, 2010), we identified a total of 925 genes with significantly 
enriched expression in macrophages (Supplementary Table 2). As expected, gene 
ontology analysis using DAVID (Huang et al., 2009) showed specific enrichment of 






Comparison of macrophage, neutrophil, and early T-cell gene 
signatures  
In addition to the mpeg1:egfp line for macrophages, we used mpx:egfp and lck:egfp 
transgenic lines for FACS sorting and RNA-Seq analysis of neutrophil and early T-cell 
populations. First, we looked at the expression levels of several marker genes that are 
commonly used to identify different leukocyte and lymphoid subpopulations in 
Table 1. KEGG pathways and Gene Ontology terms enriched in macrophage and neutrophil 
cell fractions* 
Category Term Fold Enrichment 
    mpeg1+ mpx+ 
cytokine-cytokine receptor interaction 4,4 4,6 
lysosome 4,1  
Toll-like receptor signaling pathway 4,6  
natural killer cell mediated cytotoxicity 4,6  
intestinal immune network for IgA production 8,9  
NOD-like receptor signaling pathway 5,4 7,8 
Jak-STAT signaling pathway 3,2  
apoptosis 3,3  
KEGG pathways 
VEGF signaling pathway 3,3   
immune response 5,4  
defense response 7,2 8,0 
innate immune response 9,8  
response to bacterium 7,4 16,6 
ntigen processing and presentation 5,2  
GO:Biological Process 
chemotaxis 16,8  
cytokine binding 8,6   
cysteine-type endopeptidase activity 5,2  
peptidase activity, acting on L-amino acid peptides 2,2 2,9 
nucleotide receptor activity, G-protein coupled 9,5  
purinergic nucleotide receptor activity, G-protein 
coupled 9,5  
peptidase activity 2,1 2,8 
cysteine-type peptidase activity 3,6  
fucosyltransferase activity 12,8  
endopeptidase activity 2,4 3,9 
nucleotide receptor activity 8,7  
purinergic nucleotide receptor activity 8,7  
cytokine receptor activity 8,0  
lipid binding 2,7  
voltage-gated chloride channel activity 12,1  
GO:Molecular Function 
metalloendopeptidase activity   9,2 
MHC class II protein complex 7,5   
GO:Cellular Component 
vacuole 6,2   
*Ensembl ID codes of the significantly enriched genes in eGFP-positive macrophages from mpeg1:egfp 
transgenic zebrafish (mpeg1+) or in eGFP-positive neutrophils from mpx:egfp transgenic zebrafish 
(mpx+) were analyzed using DAVID. The table shows the fold enrichment of KEGG pathways and GO 
terms for Biological Process, Molecular Function, and Cellular Component in the eGFP-positive cell 
fractions with a false discovery rate of less than 5%. 
86 
 
zebrafish (Table 2). As expected, mpeg1, mpx, and lck RPKM values (read count per 
kilobase per million mapped reads) were highest in the eGFP-positive cell fractions of 
macrophages, neutrophils, and T-cells, respectively. Other macrophage markers, 
including csf1r, cxcr3.2, irf8, marco, mfap4, and mhc2dab were also enriched in 
mpeg1:egfp-positive cells. Among all macrophage markers, mfap4 showed the highest 
expression level, and mhc2dab showed the highest specificity, with an over 60-fold 
higher RPKM value than in mpx:egfp-positive neutophils. In addition to mpx, 
neutrophils showed higher expression of lyz, mmp9 and mmp13a than macrophages. 
The lck:egfp-positive cell fraction  showed highly specific expression of T-cell markers, 
which apart from lck included cd2, cd28, cd4, ikzf1 (ikaros), rag1, and rag2. However, 
expression of cd8 was not detectable, suggesting that cytotoxic T-cell activity is not yet 
present at 5 dpf. Finally, the hematopoietic transcription factor gene spi1 was specific 
for the myeloid cell fractions, while coro1a, lcp1 (L-plastin), ptprc (cd45), and ptpn6 
were commonly expressed in myeloid and lymphoid cells.   
More than 70% of all 283 genes that were significantly enriched in mpx:egfp-
positive neutrophils compared to the eGFP-negative background were also significantly 
enriched in  mpeg1:egfp-positive macrophages (Fig. 1). In contrast, only 11% of all 2578 
genes enriched in lck:egfp-positive T-cells were also enriched in either one or both of 
the myeloid cell fractions (Fig. 1). Next, we searched for genes in the mpeg1:egfp gene 
set with higher expression level or better macrophage specificity than  mpeg1, which 
had an RPKM of 126 in mpeg:egfp-positive cells and 12 in mpx:egfp-positive cells. Genes 
with higher abundance than mpeg1 belonged to the families of chemokines, 
immunoglobulins, olfactomedins, granulins, cathepsins, fibrinogens (mfap4 and 2 
paralogues), lectins, transmebrane receptors, complement factors (C1q), MHC II class 
proteins, and also included some predicted non-coding RNAs (Table 3A). Among these, 
the most specific marker for macrophages was granulin 2 (grn2), which was expressed 
at over 10-fold higher level than mpeg1 and showed an approximately 300-fold higher 
RPKM in macrophages than in the neutrophil or T-cell fractions. Other highly specific 
macrophage markers were the immunoglobulin gene dicp1.1, the transmembrane 
receptor gene ocstamp, and MHC class II genes, like cd74 and mhc2dab. In neutrophils, 
the lysozyme (lyz) and nephrosin (npsn) genes were expressed at approximately 28-
and 4-fold higher level, respectively, than mpx (Table 3B). However, the specificity of 
mpx (17-fold higher RPKM than in macrophages) was better than that of lyz (12-fold 
higher) and npsn (8-fold higher). In addition, interleukin 34 (il34 (1 of 2)) also showed 
high neutrophil specificity (21-fold higher RPKM than in macrophages), but its 
expression level was 4-fold lower than that of mpx. Markers for T-cells expressed at 
higher or similar level as lck were all highly specific for lymphoid cells and barely or not 
detectable in myeloid cells (Table 4). These markers included for example rag1, 
cytokine receptor genes (ccr9b, il17r), various other receptor genes (T-cell-specific 
immunoglobulins, a member of the signaling lymphocyte activation (SLAM)-family, 
p2rx1, rorc), and the transcription factor gene foxp3a. In conclusion, our RNA-Seq 




and T-cells, that are good candidates for developing new transgenic lines and 
antibodies for distinguishing leukocyte lineages in the zebrafish model. 
 
Table 2. Expression levels of commonly used lineage markers for different leukocyte cell 
types* 
Lineage specificity Gene symbol Ensembl ID mpeg1+ mpx+ lck+  GFP- 
csf1ra ENSDARG00000007889 9 3 0 1 
cxcr3.2 ENSDARG00000041041 62 26 0 3 
irf8 ENSDARG00000056407 25 9 0 3 
marco ENSDARG00000059294 4 0 0 0 
mfap4 ENSDARG00000090783 980 130 3 14 
mhc2dab ENSDARG00000079105 192 3 0 1 
macrophage-
enriched 
mpeg1 ENSDARG00000055290 126 12 0 5 
lyz ENSDARG00000057789 1461 18294 0 64 
mpx ENSDARG00000019521 37 662 0 2 
mmp9 ENSDARG00000042816 357 1341 15 34 
neutrophil-enriched 
mmp13a ENSDARG00000012395 320 638 5 13 
common myeloid spi1 ENSDARG00000000767 340 253 1 7 
cd2 ENSDARG00000091109 0 0 31 1 
cd28 ENSDARG00000095070 3 8 14 2 
cd4 ENSDARG00000070668 0 0 27 1 
ikzf1 ENSDARG00000013539 5 5 24 2 
lck ENSDARG00000059282 1 0 237 3 
rag1 ENSDARG00000052122 0 0 409 11 
lymphoid 
rag2 ENSDARG00000052121 0 0 48 2 
coro1a ENSDARG00000054610 164 170 197 19 
lcp1 ENSDARG00000023188 63 92 14 10 
ptprc ENSDARG00000071437 49 54 23 3 common leukocyte 
ptpn6 ENSDARG00000089043/     
ENSDARG00000013916 
82 97 25 8 
*RNA-Seq libraries were prepared from eGFP-positive (+) and negative (-) cell fractions obtained by 
dissociating and FACS-sorting 5-6 dpf larvae of transgenic lines expressing enhanced GFP under control 
of the mpeg1, mpx, or lck promoters. RPKM values (read counts per kilobase per million mapped reads) 
are averaged from 4 biological replicates of eGFP-positive cells from mpeg1:egfp larvae (mpeg1+, 2x 
5dpf, 2x 6 dpf), 3 biological replicates from mpx:egfp larvae (mpx+, 5 dpf), and 2 biological replicates 
from lck:egfp larvae (lck+, 5 dpf). The RPKM value for eGFP-negative cells is the average of all libraries. 
Enriched expression in macrophages, neutrophils, or T-lymphoblasts is indicated in orange, green, and 
blue, respectively. RPKM values in the range of 10-50, 50-100, 100-200, 200-500, and over 500 are 
shown with increasingly darker shades of color. Genes classified as macrophage-enriched have at least 2-
fold higher expression than in neutrophils, and genes classified as neutrophil-enriched have at least 2-











Table 3. Myeloid-specific markers* 
Gene symbol Annotation group Ensembl ID 
mpeg1
+ mpx+ lck+ GFP- 





















ENSDARG00000074322 1552 166 0 15 









ENSDARG00000003902 1119 91 1 14 
zgc:173915 
fibrinogen family 
(paralogue of mfap4) 




ENSDARG00000087623 996 42 18 7 




ENSDARG00000012450 642 52 18 18 
havcr1 
immunoglobulin v-
set family receptor 
ENSDARG00000040178 571 46 3 8 
lgals2a lectins ENSDARG00000054942 535 82 3 14 












ENSDARG00000095820 427 24 0 2 
si:ch1073-
403i13.1 
MHC class II ENSDARG00000001832 422 29 4 6 
cd74 MHC class II ENSDARG00000036628 346 6 20 5 




ENSDARG00000022139 237 3 0 2 
mhc2dab MHC class II ENSDARG00000079105 192 3 0 1 
zgc:194314 lipid metabolism  ENSDARG00000078859 189 24 3 5 
si:dkey-15g19.2 non-coding RNA ENSDARG00000095693 169 4 2 6 
si:zfos-2330d3.3 
fibrinogen family 
(paralogue of mfap4) 




















ENSDARG00000055290 126 12 0 5 








ENSDARG00000013771 109 14 0 2 
si:dkeyp-2h4.2 MHC class II ENSDARG00000031745 103 3 2 3 
B. Neutrophil markers      




ENSDARG00000010423 266 2347 0 7 
mpx peroxidases ENSDARG00000019521 37 662 0 2 
si:dkey-238m4.4 unknown ENSDARG00000093248 66 454 0 1 




ENSDARG00000054755 49 294 0 3 
CU682604.2 
lamin B receptor 
family 
ENSDARG00000075664 15 224 0 3 
il6r cytokine receptors ENSDARG00000070398 21 188 0 3 
il34 (1 of 2) cytokines ENSDARG00000091003 8 171 1 3 
il34 (2 of 2) cytokines ENSDARG00000069128 21 152 10 7 
sult2st1 sulfate transferases ENSDARG00000033170 15 118 2 5 
*Macrophage-specific genes (A) were selected based on significantly enriched expression in mpeg1:egfp-
positive cells (mpeg1+, log2 fold change > 2, adjusted P-value <0.1), a minimum RPKM value of 100, and 
>5-fold higher RPKM than in mpx:egfp-positive cells (mpx+), >10-fold higher RPKM than in lck:egfp-
positive cells (lck+), and >20-fold higher RPKM than in eGFP-negative cells. Neutrophil-specific genes (B) 
were selected based on significantly enriched expression in mpx:egfp-positive cells (log2 fold change > 2, 
adjusted P-value <0.1), a minimum RPKM value of 100, and >5-fold higher RPKM than in mpeg1:egfp-
positive cells, >10-fold higher RPKM than in lck:egfp-positive cells, and >20-fold higher RPKM than in gfp-
negative cells. RNA-Seq library preparation, averaging of RPKM values from biological replicates, and the 
use of increasingly darker shades of different colors to indicate higher expression levels were as in Table 2. 
The full lists of significantly enriched genes in mpeg1:egfp-positive and mpx:egfp-positive cells with fold 
















Table 4. Lymphoid-specific markers* 





ENSDARG00000075807 1 0 1718 19 




ENSDARG00000094770 3 2 650 4 














ENSDARG00000059282 1 0 237 3 









ENSDARG00000087195 0 0 155 4 
plp2 (2 of 2) 
endomembrane 
system 
ENSDARG00000042972 1 0 140 5 
foxp3a transcription factors ENSDARG00000055750 0 0 138 1 
si:ch211-132g1.1 non-coding RNA ENSDARG00000040250 6 0 132 2 
sh2d1a (1 of 2) SH2-domain family ENSDARG00000074854 2 2 123 2 
rhoh ras family ENSDARG00000070121 0 2 116 1 
il7r cytokine receptors ENSDARG00000078970 5 3 103 3 
*Genes specific for early T-lymphocytes in zebrafish larvae were selected based on significantly enriched 
expression in lck:egfp-positive cells (lck+, log2 fold change > 2, adjusted P-value <0.1), a minimum RPKM 
value of 100, and >10-fold higher RPKM than in mpeg1:egfp-positive cells (mpeg1+), >10-fold higher RPKM 
than in mpx:egfp-positive cells (mpx+), and >20-fold higher expression than in gfp-negative cells. RNA-Seq 
library preparation, averaging of RPKM values from biological replicates, and the use of increasingly darker 
shades of different colors to indicate higher expression levels were as in Table 2. The full list of significantly 
































Figure 1. Overlap between genes enriched in GFP-positive cell fractions from mpeg1:egfp, 
mpx:egfp, and lck:egfp larvae. RNA-Seq libraries were prepared from GFP-positive (+) and 
negative (-) cell fractions obtained by dissociating and FACS-sorting 5-6 dpf larvae of transgenic 
lines expressing enhanced GFP under control of the mpeg1, mpx, or lck promoters. DESeq 
analysis was used to compare the read count data of the GFP-positive versus the GFP-negative 
cell fractions with 4 biological replicates of mpeg1:egfp larvae (2x 5dpf, 2x 6 dpf), 3 biological 
replicates of mpx:egfp larvae (5 dpf), and 2 biological replicates of lck:egfp larvae (5 dpf). The 
Venn-diagram shows the overlap between genes enriched in the GFP-postive cell fractions of 
the different transgenic lines (log2 fold change >2 and adjusted P-value <0.1). 
 
Expression profile of M. marinum-infected cells 
The mycobacterium genus comprises several intracellular pathogens that reside in 
macrophages, including the human pathogen Mycobacterium tuberculosis and the fish 
pathogen M. marinum. The hallmark of infectious diseases caused by M. tuberculosis or 
M. marinum is that infected macrophages are manipulated to attract uninfected 
macrophages and other immune cells to form tissue aggregates, known as tuberculous 
granulomas. These granulomas form a niche for the chronic persistence of 
mycobacteria inside their host. Zebrafish embryos are a well-characterized model to 
study the early stages of M. marinum-macrophage interaction and granuloma formation 
(Davis et al., 2002, Ramakrishnan, 2012). To investigate the effect of M. marinum on 
gene expression in macrophages, we infected 1-day-old embryos with mCherry-labeled 
M. marinum Mma20 bacteria and isolated the infected cells by FACS sorting at 4 days 
post infection (dpi) when early stage granulomas are formed. We compared the RNA-
Seq profile of the Mma20-infected cells to the eGFP-negative background from 
uninfected mpeg1:egfp larvae, and  investigated the overlap between Mma20-positive 
cells and eGFP-positive macrophages from uninfected mpeg1:egfp larvae (Fig. 2). This 
comparison showed that out of 188 genes enriched in Mma20-infected cells 
(Supplementary Table 3), only 40 were overlapping with the gene set of uninfected 
macrophages. The overlapping genes included some of the most specific macrophage 
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markers that we described above, such as grn2 and the MHC class II gene cd74. 
Expression of mfap4 and two mfap4 paralogues was also detected, however, mpeg1 was 
notably absent. Furthermore, the majority of the 40 macrophage-specific genes were 
expressed at over 10-fold lower levels in Mma20-infected cells compared with 
uninfected macrophages. One possible explanation could be that only a small portion of 
the Mma20-infected cell population consists of macrophages. However, this is very 
unlikely, because it has been well described that M. marinum is rapidly phagocytosed by 
macrophages after injection of bacteria into the blood circulation, and that the infection 
spreads to newly attracted macrophages, which phagocytose infected macrophages 
undergoing apoptosis (Davis and Ramakrishnan., 2009). Furthermore, a preliminary 
RNA-Seq analysis of red/green double fluorescent mpeg1:egfp-cells infected with 
mCherry-labelled Mma20 also shows strong down-regulation of macrophage markers 
(data not shown). Therefore, the down-regulation of macrophage markers is more 
likely due to M. marinum-induced transformation of infected macrophages . Indeed, it is 
well known that infected macrophages in tuberculous granulomas are manipulated to 
adopt epithelial and multinucleate morphologies (Russell, 2011) and such 
morphological changes have also been observed in the granulomas of zebrafish larvae 














Figure 2. Overlap between genes enriched in M. marinum-infected cells and genes 
enriched in macrophages. Embryos were infected by intravenous injection of mCherry-
labeled M. marinum Mma20 bacteria at 1 dpf, and at 4 dpi (5dpf) RNA-Seq libraries were 
prepared from mCherry-positive and negative cell fractions obtained by FACS-sorting. Read 
counts of the mCherry-positive fraction from two biological replicates of infected embryos were 
compared by DESeq analysis against the GFP-negative cell fractions of two biological replicates 
of uninfected mpeg1:egfp larvae (5 dpf). The Venn-diagram shows the overlap of genes enriched 
in Mma20-infected cells with genes enriched in mpeg1:efgp-positive macrophages from two 
biological replicates of uninfected larvae (log2 fold change >2 and adjusted Pvalue <0.1. 
 
 The genes enriched in Mma20-infected cells that did not overlap with 
macrophage markers (148 out of 188 genes) were analyzed using DAVID, which 
identified five enriched clusters of GO-terms: ribosome, oxidative phosphorylation, 
proteolysis, ion transport, and chromatin assembly (Supplementary Table 4). This 




infected cells.  For example, the ion transport cluster contained the antimicrobial 
hepcidin gene (hamp1), and it has recently emerged that ribosomal protein genes, such 
as rps3 which was up-regulated, have extra-ribosomal regulatory functions in the 
innate immune system (Gao and Hardwidge, 2011). It is an interesting possibility, 
warranting further investigation, that the increased expression of genes involved in 
chromatin assembly might be associated with the mycobacterium-induced 
morphological changes in macrophages or suppression of the macrophage immune 
defenses. By manual inspection of the gene list we defined three additional annotation 
clusters. The first consisted of genes involved in lipid metabolism and transport. An 
elevation of host lipid metabolism has also been observed in microarray analysis of 
caseating human tuberculous granulomas (Kim et al., 2010). The second cluster was a 
group of lectin genes, including members of the galactoside-binding lectin family, which 
in human macrophages have been shown to accumulate around mycobacterium-
containing phagosomes (Beatty et al., 2002), and a member of the mannose-binding 
lectins, associated with human tuberculosis susceptibility (Denholm et al., 2010; Singla 
et al., 2012). Finally, the third cluster consisted of a group of three genes for 
immunosuppressive proteins, including two FK506-binding proteins and a 
vasointestinal peptide, which has been implicated in switching off activated 
macrophages during M. tuberculosis infection (Ma et al., 2003; Souza-Moreira et al., 
2011). In conclusion, our analysis of M. marinum-infected cells showed a general down-
regulation of macrophage marker genes accompanied by the induction of several 
specific gene groups that may be linked to processes of host defense and to the 
immunosuppressive effects of mycobacteria on host cells. 
 
Ptpn6 knockdown effect on expression profiles of leukocyte popu-
lations and M. marinum-infected cells 
Ptpn6, also known as Shp-1, is a hematopoietic SH2-domain containing non-receptor 
type protein tyrosine phosphatase and a well-known negative regulator of innate and 
adaptive immune responses in human and mice (Blanchette et al., 2009; Kumagai et al., 
2012;  Henshall et al., 2001; Oh et al., 2009). We have previously shown that 
morpholino knockdown of ptpn6 in zebrafish leads to increased susceptibility to M. 
marinum infection (Chapter 2). In addition, uninfected ptpn6 morphants developed an 
inflammation-associated phenotype at the late larval stage (Chapter 2). RNA-Seq 
analysis demonstrated ptpn6 expression in both myeloid and lymphoid cells (Table 2), 
in agreement with previous in situ hybridization results (Zakrzewska et al., 2010). To 
gain a better understanding of the underlying causes of the ptpn6 morpholino 
knockdown effects, we performed RNA-Seq analysis on FACS-sorted leukocyte 
populations from ptpn6 morphants and controls at 5 dpf, including M. marinum-infected 
cells, macrophages, neutrophils and T-cells. In addition, we analyzed the eGFP-negative 
background from uninfected mpeg1:egfp larvae. The results of all comparisons are 




In agreement with previous qPCR analysis (Chapter 2), RNA-Seq analysis 
revealed increased mmp9 expression in ptpn6 morphants. Notably, in Mma20-infected 
cells from ptpn6 morphants not only mmp9, but also mmp2, mmp13a and the mmp 
(matrix metalloproteinase) inhibitor gene timp2b were increased compared with 
infected cells of control embryos. The mmp9 and mmp13a genes were also specifically 
up-regulated in macrophages from ptpn6 morphants, while mmp2 was also up-
regulated in neutrophils and in the eGFP-negative background of ptpn6 morphants. 
There was no general up-regulation of pro-inflammatory genes in any of the ptpn6 
morphant cell types. Therefore, the effect of ptpn6 knockdown on the immune response 
of zebrafish embryos towards M. marinum infection is markedly different from the 
effect of ptpn6 knockdown during S. typhimurium infection, where the up-regulation of 
mmp9 and mmp13a genes goes together with a general up-regulation of pro-
inflammatory cytokines and immune-related transcription factors (Chapter 2).  
In addition to the up-regulation of mmp pathway genes, Mma20-infected cells of 
ptpn6 morphants showed strongly increased expression of serum amyloid A (saa). This 
apolipoprotein family gene encodes a major acute phase protein that is known to be 
highly expressed in response to inflammation and tissue injury. Interestingly, several 
reports have suggested a link between expression of saa and mmp genes, which may 
also underlie connection between chronic inflammation and cancer (Malle et al., 2009). 
Transcription of MMP9 was found to be induced by SAA in human monocytic cells via 
the formyl methionine receptor (Lee et al., 2005). Furthermore, an SAA-activating 
factor (SAF-1) was shown to function cooperatively with the AP-1 transcription factor 
complex to activate MMP9 transcription (Ray et al., 2005). SAA has also been linked to 
granulomatous inflammation (Chen et al., 2010). Increased expression of mmp9 has 
been shown to be essential for granuloma formation in zebrafish embryos (Volkman et 
al., 2010). In this study, mmp9 secretion by epithelial cells nearby granulomas was 
proposed to drive macrophage recruitment. Our RNA-Seq data do not exclude mmp9 
expression by epithelial cells, but do show that the major induction of mmp9 occurs 
directly in Mma20-infected cells and is enhanced by ptpn6 knockdown together with a 
strong induction of mmp13a in these cells. As granuloma formation is accelerated in 
ptpn6 morphants, we propose that Saa-dependent induction of mmp9 and mmp13a in 
Mma20-infected cells plays a major role in the formation and expansion of granulomas 
(Fig. 3). 
Another gene that showed increased up-regulated in Mma20-infected cells 
under ptpn6 knockdown conditions was hamp1, and a ptpn6-dependent increase of 
hamp1 expression was also observed in lck:egfp-positive T-cells and in eGFP-negative 
background cells. Hepcidin, the product of hamp1, regulates iron homeostasis by 
mediating the degradation of the iron export protein ferroportin 1, and is known to 
inhibit growth of M. tuberculosis (Sow et al., 2007, Sow et al., 2011). Three other genes 
connected with responses to nutrients also showed increased up-regulation in Mma20-
infected cells of ptpn6 morphants. These included the genes for the peptide hormones 
leptin b (lepb) and glucagon a (gcga) and the steap4 gene, which encodes a plasma 




suggested to play a role in the early immune response to pulmonary tuberculosis, and 
mice deficient in leptin b or in the leptin receptor displayed disorganized granulomas 
(Wieland et al., 2005, Lemos et al., 2011).  The steap 4 gene is homologous to the human 
tumor necrosis factor alpha-induced protein 9 gene (TNFAIP9, also known as STEAP4 or 
STAMP2), which has been proposed to play an important role in integrating 
inflammatory and metabolic responses and to act as an anti-inflammatory protein in 
macrophages (Wellen et al., 2007; Ten Freyhaus et al., 2012). We have previously 
shown that that an alternative splice variant of this gene is induced by M. marinum 
infection in adult zebrafish (Hegedus et al., 2009). Any possible antimicrobial effects of 
hamp1, lepb, gcga or steap4 were not sufficient to prevent increased M. marinum 
Mma20 infection in ptpn6 morphants. 
Knockdown of ptpn6 also led to down-regulation of genes in Mma20-infected 
cells in comparison with infected cells of control embryos, for example, a chemokine 
gene (si:ch211-149o7.4) and the chemokine receptor gene cxcr4b. Both these genes are 
highly expressed in macrophages and other immune cell types of zebrafish larvae 
(Table 3, Supplementary Table 2). As we have shown that M. marinum infection lead to 
a general down-regulation of macrophage markers, the down-regulation of si:ch211-
149o7.4 and cxcr4b might reflect the advanced stage of infection in ptpn6 morphants. 
Both genes were also down-regulated in macrophages of uninfected ptpn6 morphants, 
along with other macrophage-expressed genes, such as tnfa, tnfrsf1a, mbp, grn2, 
mhc2dab, cd74 and cd74a. In contrast, ptpn6 knockdown in uninfected macrophages led 
to up-regulation of among others actin, myosin and parvalbumin genes, several 
immune-related proteases (cpa5, npsn, cpn1 in addition to the mmp9 and mmp13a 
genes discussed above), and of typical neutrophil markers like lyz and mpx. These data 
suggest a complex role of ptpn6 in regulating the activation status of macrophages.  
Under uninfected conditions, the ptpn6 knockdown effects on different cell 
populations were very specific. The up-regulation of mmp and other protease genes was 
observed in ptpn6-deficient macrophages but not in ptpn6-deficient neutrophils or T-
cells. An up-regulation of genes involved in p53 signaling (tp53, mdm2, ccng1) was only 
observed in ptpn6-deficient neutrophils. Furthermore, neutrophils showed specific 
down-regulation of apolipoprotein and protease genes under ptpn6 knockdown 
conditions, while down-regulation of ribosomal protein genes was specific for T-cells. 
There was no effect on p53 signaling genes in the eGFP-negative background cells of 
ptpn6 morphants and no indication of a general toxicity effect in the RNA-Seq data. 
Therefore, enhanced mmp genes secretion by macrophages might be a major cause of 








Table 5. Effect of ptpn6 knockdown on gene expression in M. marinum-infected cells and 
different leukocyte populations* 






















Total no. of genes 22 58 23 39 88 38 40 25 12 37 
Matrix 
metalloproteinases/ 
inhibitors              
mmp2 √  √  √       
mmp9, mmp13a √ √           
timp2b √            
Other proteases             
try     √    √   
cpa5  √   √       
npsn, cpn1  √           
cela1, cpb1, ela2, cpa4          √   
adamts1     √       
Iron transport             
hamp1 √   √ √       
steap4 √    √       
tfa       √    √ 
hbm       √     
Peptide hormones             
lepb √   √         
gcga √            
prl, adm     √       
lepa    √         
Acute phase proteins             
saa √            
apcs       √     
Apolipoproteins     √       
apom, apoc2       √     
apoc1l       √  √   
apoa2          √ √ √ 
apod (3 of 3)     √    √   
Actin/myosin/tropomy
osin             
tnnc2, myl3  √           
mylz2  √  √ √       
mylz3, tnni2a.4  √   √       
acta2 √            
acta1a, acta1b, actc1b, 
myhz1.1, myl10, tnnc1b, 
tnni2b.2, tnnt3b  
√ 





            
pvalb1, pvalb2  √   √       
pvalb3, pvalb7, pvalb4 √           
pvalb5            √ 
ATPases             
atp2a1  √           
atp1b4, atp1a1b, 
atp6v1b2, atp6v0cb     √       
Ribosomal proteins             
rplp0  √         √  
rpl36, rpl10a, rps14, 
rpl7a           √  
rps27l √  √          
rpl22l1            √ 
p53 signaling proteins             
tp53, ccng1   √          
mdm2  √           
MHCII class 
            
mhc2dab, cd74, cd74a         √    
Cytokine/chemokine 
signaling             
tnfa, tnfrsf1A (1 of 2)         √    
ccl25b  √           
cxcl14    √         
cxcr4b       √ √    
ccr9a             √     √ 
*Embryos injected with a morpholino against ptpn6 (ptpn6 MO1) or control embryos were infected 
with mCherry-labelled M. marinum Mma20 bacteria at 1 dpf and RNA-Seq libraries were prepared from 
mCherry-positive (+) and negative (-) cell fractions at 4 dpi (5 dpf) as in Supplementary Table 4. 
Likewise, ptpn6 MO1 was injected in embryos from mpeg1:egfp, mpx:egfp, and lck:egfp transgenic 
embryos to compare macrophage (mpeg1+), neutrophil (mpx+), and T-lymphoblast (lck+) expression 
levels at 5 dpf with those from control larvae. The eGFP-negative cell fractions from mpeg1:egfp larvae 
were used to determine the effect of ptpn6 MO1 on gene expression levels in the background without 
macrophages. Two biological replicates were used for all comparisons. Genes are ordered by annotation 
groups to show up- or down-regulation by ptpn6 MO1 in the different cell fractions. Significance cut-offs 
in DESeq analysis were log2 fold change >2 and P <0.1. As an additional criterion, genes up-regulated by 
ptpn6 MO1 showed a minimum RPKM of 30 in both replicates of the respective ptpn6 MO1 groups of 
each FACS-sorting, and genes down-regulated by ptpn6 MO1 showed a minimum RPKM of 30 in both 
replicates of the respective control groups. The full list of up- or down-regulated genes with fold change, 
















morphants at 4 dpi
Mma20-infected control 
larvae at 4 dpi  
 
Figure 3. Model for granuloma expansion in wild type zebrafish larvae and ptpn6 
morphants. Intravenously injected M. marinum bacteria are rapidly phagocytosed by 
embryonic macrophages in the blood circulation of 1 day-old embryos. Infected macrophages 
migrate into tissue and attract other uninfected macrophages to form granuloma-like 
aggregates (Davis et al., 2002). These early stages of granulomas are exploited by mycobacteria 
for spreading to other macrophages that facilitate tissue dissemination of the infection (Clay et 
al., 2007, Davis et al., 2009) and granuloma formation has been shown to require the function of 
mmp9 (Volkman et al., 2010). In this study we show that the expression of macrophage marker 
genes is down-regulated upon proliferation of M. marinum inside these cells (indicated by a 
lighter color green of macrophages in the figure). As the infection progresses, infected cells up-
regulate expression of serum amyloid A (saa) and matrix metalloproteinase (mmp) genes. Up-
regulation of mmp9 and mmp13a is proposed to be regulated by saa. Under conditions of ptpn6 
morpholino knockdown an increased bacterial burden and size of granuloma-like aggregates is 
observed. In the present study, ptpn6 morphants showed increased expression of saa, mmp9, 
and mmp13a at 4 days post infection compared to control infected larvae, which had smaller 




By means of RNA-Seq analysis of FACS-sorted leukocyte and lymphoid subpopulations 
from fluorescent reporter lines we could determine gene expression signatures of 
macrophages, neutrophils and early T-cells in zebrafish larvae. Commonly used 
markers, including mpeg1 for macrophages, mpx for neutrophils, and lck for T-cells, 
faithfully distinguished the different leukocyte subtypes in the RNA-Seq data. In 
addition, our RNA-Seq analysis identified other more abundant or more specific 
markers for macrophages, neutrophils, and T-cells, which will be highly useful for 
developing new reporter lines and lineage-specific antibodies for zebrafish. For 
example, the granulin gene grn2 was highly abundant and almost exclusively detectable 
in macrophages, whereas mpeg1 expression showed some overlap with neutrophils and 




specific for macrophages. The macrophage gene signature was markedly changed by M. 
marinum infection. This infection led to a general down-regulation of macrophage 
marker genes accompanied by an induction of ribosomal protein genes and genes 
involved in oxidative phosphorylation, proteolysis, transport of iron and other ions, 
chromatin assembly, lipid metabolism, carbohydrate binding, and immunosuppression. 
Knockdown of the protein tyrosine phosphatase gene ptpn6, which is known as a 
negative regulator of immune responses, also had specific effects on the macrophage 
expression profile of zebrafish larvae. Notably, expression of matrix metalloproteinase 
genes mmp9 and mmp13a was specifically up-regulated in ptpn6-deficient 
macrophages. Likewise, these matrix metalloproteinase genes were also strongly up-
regulated in M. marinum-infected cells of ptpn6 morphants, along with the expression of 
the serum amyloid A gene (saa), which has been implicated in regulating matrix 
metalloproteinase gene expression. The induction of these genes at high levels in M. 
marinum-infected cells is not beneficial to the host, as the bacterial burden is strongly 
enhanced in ptpn6 morphants. Increased expression of these genes in infected ptpn6-
deficient macrophages may accelerate the formation of granulomas, which are 
exploited by mycobacteria for their expansion and tissue dissemination (Fig. 3).  
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Supplementary Table 1. Overlap in significant genes in biological replicates of FACS-
sorted macrophages from mpeg1:egfp transgenic embryos* 
replicates #2 #3 #4 
#1 51% 42% 68% 
#2   47% 62% 
#3     56% 
*Four independent pools of approximately 250 5-day-old (#1, #2) or 6-day-old (#3, #4) larvae 
from mpeg1:egfp transgenic zebrafish were subjected to FACS-sorting on different days. For each 
replicate the eGFP-positive cell fraction was compared against the eGFP-negative background by 
DESeq analysis to determine the number of genes showing significant enrichment in eGFP-positive 
macrophages. The overlap in significant genes between replicates is shown as the percentage of 
the total number of genes in the smaller group of the replicate pair. 
 
Supplementary Table 2. Genes enriched in eGFP-positive cell fractions from mpeg1:egfp, 




Supplementary Table 3. Overview of 148 genes enriched in M. marinum-infected cells. 






























Supplementary Table 4. Genes enriched in M. marinum-infected cells* 
Annotation 
group Description Genes in group 
actin, myosin, troponin 
acta1b, myl1, mylpf (2 of 2), mylz3, 
tnni2a.4, tpma 
cathepsin L ctsl.1 
colony stimulating factor 3 csf3 
granulins grn1, grn2 
lectins hbl4, lgals1l1 
leukocyte cell-derived chemotaxin 2 like  lect2l 
lysozyme g-like  lygl1 
mediator complex subunit  med11(2 of 2) 
MHC class II cd74 
microfibrillar-associated proteins mfap4, zgc:173915, si:zfos-2330d3.3 
nephrosin npsn 
parvalbumins pvalb2, pvalb4 
riboflavin kinase  rfk 
S100 calcium binding protein A11 s100a11 
transducin beta-like tbl2(1 of 2) 
macrophage 
ubiquitin-like with PHD and ring finger 
domains 1  uhrf1(1 of 2) 
Finkel-Biskis-Reilly murine sarcoma virus 
(FBR-MuSV) ubiquitously expressed a  
faua 
histones h3f3c, hist2h4b (7 of 7) 
ribosomal proteins mrpl11, rpl13, rpl24, rpl28, rpl37, rps10, 
rps14, RPS17, rps19, rps21, rps26l, rps3 
translation initiation factors eif2b2, eif3k 
ubiquitin A-52 residue ribosomal protein 




VAMP (vesicle-associated membrane 
protein)-associated protein A, like  
vapal 
ATP synthases, H+ transporting, 
mitochondrial  atp5d, atp5j 
cytochrome c oxidase subunits cox5a (1 of 3), cox5ab, cox6a1 
NADH dehydrogenase (ubiquinone) 
ndufa13, ndufa2, ndufa5, ndufa6, 
ndufb3, ndufb7, ndufb8, ndufb9, ndufs5, 
ndufs7, ndufv2, ndufv3 
oxidative 
phosphorylation 
succinate dehydrogenase complex, 
subunit B, iron sulfur (Ip) 
sdhb 
elastases ela2, ela2l, ela3l 
lon peptidase 1, mitochondrial  lonp1 
proteasome subunits psma1, psmb1, psmb2, psmb6, psmd3 
proteolysis 
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ATP synthases, H+ transporting, 
mitochondrial  atp5d, atp5j 
betaine-homocysteine 
methyltransferase bhmt 
hemoglobin zeta  hbz 
hepcidin antimicrobial peptide 1 hamp1 
myeloid cell leukemia sequence 1a  mcl1a 
potassium channel, subfamily K, 
member 10a  kcnk10a 
ribosomal protein L37 rpl37 
succinate dehydrogenase complex, 




zinc finger-like gene 2a  znfl2a 
histones h3f3c, hist2h4b (7 of 7) 
single-minded homolog 1 sim1 (3 of 3) 
chromatin 
organization 
SRY-box containing gene 19b sox19b 
apolipoproteins apoa1, apoa1 (2 of 2), apoc2 
enolase 3 eno3 
fatty acid binding proteins fabp10a, fabp1b.1 
lipid metabolism 
phospholipase D family, member 3 pld3 
galactoside-binding lectins lgals2b, lgals1l1 
hexose-binding lectin 4  hbl4 
intelectin 3 itln3 
lectins 
mannose-binding lectin 2-like lman2l (2 of 2) 
FK506 (fkbp5) binding proteins fkbp11, fkbp3 
immunosuppression 
vasoactive intestinal peptide vip (2 of 2) 
*Embryos were infected by intravenous injection of mCherry-labeled M. marinum Mma20 bacteria at 1 
dpf, and at 4 dpi (5dpf) RNA-Seq libraries were prepared from mCherry-positive (+) and negative (-) 
cell fractions obtained by FACS-sorting. Read counts from two biological replicates of infected embryos 
were compared by DESeq analysis against the eGFP-negative cell fractions of two biological replicates 
of uninfected mpeg1:egfp larvae (5 dpf). Ensembl ID codes of 148 significantly enriched genes (log2 
fold change > 2, adjusted P-value <0.1) in mCherry-positive Mma20-infected cells were analyzed using 
DAVID, which showed enrichment of five annotation clusters: translation, oxidative phosphorylation, 
proteolysis, ion transport/binding, and chromatin assembly. Furthermore, overlap with genes enriched 
in mpeg1:egfp-positive cells identified a macrophage gene group, and manual annotation identified 
three additional gene groups: lipid metabolism, lectins, and genes involved in immunosuppression. The 
full list of significantly enriched genes with fold change, P-value, and RPKM values of the biological 
replicates in given in Supplementary table 3. 
 
Supplementary Table 5. Genes affected by ptpn6 knockdown in M. marinum-infected cells and 
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MicroRNAs (miRNAs) have recently been shown to play important roles in 
development of the immune system and in fine-tuning of immune responses. Human 
miR-146 is known as an inflammation-inducible miRNA involved in negative feedback 
regulation of Toll-like receptor (TLR) signaling. Dysregulation of miR-146 has often 
been linked to inflammatory diseases and malignancies. In this study, we used zebrafish 
embryos, in which adaptive immunity is not yet active, as an in vivo system to 
investigate the role of miR-146 in the innate immune response to bacterial infections. 
Both members of the miR-146 family, miR-146a and miR-146b, were induced upon 
infection of embryos with Salmonella typhimurium or Mycobacterium marinum. 
Knockdown of traf6 and use of myd88 knockout mutants showed that this induction is 
partially dependent on the MyD88-Traf6 pathway that mediates transduction of TLR 
signals. RNA-Seq analysis of miR-146 knockdown embryos showed increased induction 
of the matrix metalloproteinase 9 (mmp9) gene upon S. typhimurium infection, but no 
general hyperinduction of other pro-inflammatory markers was observed. While the 
overall knockdown effect was relatively minor, apoliprotein-mediated lipid transport 
emerged as an infection-inducible pathway under miR-146 knockdown conditions, 
suggesting a function of miR-146 regulating lipid metabolism during inflammation. 
Bacterial burden in infection experiments with the attenuated S. typhimurium Ra strain 
was not significantly affected in miR-146 knockdown embryos compared to control 
embryos. In contrast, chronic infection with M. marinum under miR-146 knockdown 
conditions led to increased bacterial burden. This effect was primarily due to 
knockdown of miR-146b, suggesting a protective function of miR-146b-mediated 
control during M. marinum infection. 
 
Introduction 
Timely activation as well as termination of inflammatory responses is vital for proper 
functioning of the immune system. A balanced output of the vertebrate immune 
response is dependent on several regulatory mechanisms, in which microRNAs 
(miRNAs) have recently emerged as novel players with critical importance (O’Neill et 
al., 2011). Several human diseases, including autoimmune diseases and chronic 
inflammations, have been associated with dysregulation of miRNA expression, and 
oncogenic and tumor suppressor functions of miRNAs have also been reported (O’Neill 
et al., 2011; Sonkoly and Pivarcsi, 2009; Schetter et al., 2009, 2010; Persengiev, 2012; 
Visone and Croce, 2009; Sassen et al., 2008). MiRNAs are evolutionary conserved, 
genome-encoded small RNAs (~22 nucleotides) involved in post-transcriptional gene 
repression (Fire, 1999; Grishok et al., 2001). They down-regulate gene expression at the 
post-transcriptional level by either translational repression or by mRNA degradation 
through binding to the 3‘-UTR of their target mRNAs (Ambros, 2004). Over recent 
years, miRNAs were found to play roles in diverse processes, ranging from 




regulation of the immune system (Belver et al., 2011; O’Connell et al., 2011; Schulte et al 
2011; Ambros, 2004;  Nahid et al., 2011; Liu et al., 2011; Quinn et al 2012). 
It has been well established that miRNAs have diverse roles in pathogenic 
infections, including responses to viral and bacterial pathogens. The anti-viral function 
of miRNAs was first discovered in plants, and subsequent plant research also 
demonstrated a miRNA-mediated resistance mechanism to bacterial infection via 
down-regulation of auxin signaling (Ding and Voinnet, 2007; Navarro et al., 2006). It 
has been reported that miRNAs produced by the host can stimulate viral replication 
(Jopling et al., 2005; Jopling, 2008; Umbach and Cullen, 2009). However, host miRNAs, 
such as miR-29a, miR-32, miR-24, and miR-93, have anti-viral activities by suppressing 
viral mRNAs (Lecellier et al., 2005; Pederson et al., 2007; Nathans et al., 2009; Otsuka et 
al., 2007). In addition, several viruses encode their own miRNAs that affect host mRNA 
expression, or produce virulence factors that interfere with host miRNA functions 
(Sullivan et al., 2005, 2009; Aparicio et al., 2006; Hussain et al., 2008; Seo et al., 2008, 
2009). The strong connections between miRNAs and viral infections, together with 
evidence for substantial roles of miRNAs in immune cell differentiation, inflammation, 
and immune-related diseases, stimulated research into the function of miRNAs in 
bacterial infections (Baltimore et al., 2008; Lindsay, 2008). MiRNAs were observed to 
be differentially regulated by Toll-like receptor (TLR)-mediated recognition of bacterial 
molecules; for instance, lipopolysaccharide (LPS) recognition by TLR4 and downstream 
NF-κB activity induced expression of miR-146a and miR-146b (miR-146a/b) and miR-
155 (Taganov et al., 2006; O’Connell et al., 2007; Tili et al., 2007; Androulidaki et al., 
2009; Ceppi et al., 2009; Liu et al., 2009). More recently, Salmonella typhimurium was 
found to induce a highly specific change in the expression of a subset of host miRNAs in 
macrophages. This study implicated the let-7 miRNA gene family in anti-bacterial 
defense by showing that the down-regulation of let-7 miRNAs promotes the expression 
of the key cytokines, IL-6 and IL-10, in cells invaded by S. typhimurium (Schulte et al., 
2011). IL-10 production was also found to be regulated by miR-98 (Liu et al., 2011). 
Furthermore, miR-29 was found to suppress immune responses to Listeria 
monocytogenes and Mycobacterium tuberculosis by targeting interferon γ (IFN-γ) (Ma et 
al., 2011). 
MiRNA-146 is expressed as a family with two members, miR-146a and miR-
146b, which have the same seed sequence (i.e. the sequence essential for the binding of 
the miRNA to the mRNA) and are located on chromosome 5 and 10 respectively, within 
different genes (Labbaye and Testa, 2012). The structural differences of both miRNAs 
are limited, since they differ in their mature sequence by only two nucleotides at the 
3’end. The first indication of the role of miR-146a/b in innate immunity came from 
work of Taganov et al., (2006), showing increased expression of these miRNAs in the 
human monocytic THP-1 cell line when triggered by LPS. Promoter analysis revealed 
that induction of the miR-146a gene by LPS, TNFα, and IL-1 is mediated by the NF-κB 
transcriptional factor (Taganov et al., 2006). In addition, 3’UTR luciferase reporter 
assays demonstrated that the TLR signaling intermediators IRAK1 and TRAF6 are 
potential targets of miR-146a/b (Taganov et al., 2006). These data suggested that miR-
112 
 
146a/b function in a negative feedback pathway of TLR and cytokine signaling by 
targeting IRAK1 and TRAF6 mRNAs for down-regulation, a conclusion supported by 
recent analysis of miR-146a knockout mice (Boldin et al., 2011). MiR-146a/b were also 
reported to be expressed highly in synovial tissues of rheumatoid arthritis patients 
compared to normal individuals, and this induction was stimulated by inflammatory 
cytokines, such as TNFα and IL-1 (Nakasa et al., 2008). MiR-146a has also been 
proposed to function as a negative regulator of IFN signaling by targeting the IRF5 and 
STAT-1 transcription factors (Tang et al., 2009). 
Like several other miRNAs that have been implicated in regulation of the 
immune system, MiR-146 has also been linked to cancer processes. Dysregulation of 
miR-146a/b has been observed in many types of malignant tumors (Rusca and 
Monticelli, 2011; Labbye and Testa, 2012). Overexpression of miR-146a/b in a highly 
metastatic human breast cancer cell line was shown to significantly reduce NF-κB 
activity by negatively regulating IRAK1 and TRAF6 (Bhaumik et al., 2008). The up-
regulation of miR-146a/b in breast cancer was associated with reduced metastasis 
(Bhaumik et al., 2008; Hurst et al., 2009). Similarly, miR-146b was found to inhibit 
glioma cell migration and invasion by targeting matrix metalloproteinases (MMPs) (Xia 
et al 2009). Thus, modulating the levels of miR-146 could have a therapeutic potential 
to suppress cancer metastasis. 
The zebrafish provides a useful model to study innate immunity, which is the 
primary line of defence against infections during the first few weeks of development, 
when there is no functional adaptive immunity present (Stockhammer et al., 2009; 
Meijer and Spaink, 2011). The zebrafish miRNA family is well characterized (Chen et al., 
2005; Soares et al., 2009) and previous microarray analysis showed that infection-
responsive miRNAs are well conserved between human and zebrafish (Ordas, 2010). As 
in human, the zebrafish miR-146 family has two members, named dre-miR-146a and 
dre-miR-146b, which are present within genes located on chromosome 13 and 21 
respectively. The IRAK1 and TRAF6 homologs of both zebrafish and human contain 
putative target sites for miR-146 in their 3’UTRs, suggesting that miR-146 feedback 
control of TLR signaling is evolutionary conserved (Ordas, 2010).  
Here we have used zebrafish embryos as an in vivo model for a functional study 
of the role of miR-146a and miR-146b towards S. typhimurium and Mycobacterium 
marinum infection. The pathologies caused by these two pathogens have been well 
characterized in zebrafish. S. typhimurium is known to cause an acute infection after 
intravenous injection into one-day old embryos. This infection is accompanied by a 
strong pro-inflammatory response and is lethal within approximately one day, while an 
LPS mutant (Ra) of S. typhimurium is non-pathogenic (van der Sar et al., 2003; 
Stockhammer et al., 2009). Infection of zebrafish embryos or adults with M. marinum 
causes a different pathology accompanied by the formation of tissue aggregates of 
infected and uninfected immune cells that resemble the human tuberculous granuloma 
in which mycobacteria can persist chronically (Davis et al., 2002; Swaim et al., 2006). 
We demonstrate the requirement of the Myd88-Traf6 pathway for the infection-




knockdown to suppress the function of miR-146a/b and analyzed the effects of this 
down-regulation on the transcriptome and bacterial burden. While the effect of miR-
146a/b knockdown on pro-inflammatory gene expression in the immediate response to 
acute S. typhimurium infection was minor, miR-146b deficiency increased bacterial 
burden in chronic M. marinum infection. 
 
Materials and Methods 
Zebrafish husbandry  
Zebrafish were handled in compliance with the local animal welfare regulations and 
maintained according to standard protocols (zfin.org). Embryos from the zebrafish 
AB/TL line were used for the infection experiments. In addition, an infection 
experiment was performed using embryos from a myd88 knockout mutant line and wild 
type siblings as a control (van Soest, 2012; van der Vaart et al., unpublished). Embryos 
were grown at 28–30°C in egg water (60 μg/ml Instant Ocean sea salts). For the 
duration of bacterial injections embryos were kept under anesthesia in egg water 
containing 200 µg/mL tricaine (Sigma-Aldrich). Embryos used for immunostaining and 
Myeloperoxidase (Mpx) assay were kept in egg water containing 0.003% 1-phenyl-2-
thiourea (Sigma-Aldrich) to prevent melanization. 
 
Morpholino knockdown 
Morpholino oligonucleotides (GeneTools) were diluted to the desired concentration in 
1× Danieau buffer (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM Ca(NO3)2, 5.0 mM 
HEPES; pH 7.6) containing 1% phenol red (Sigma-Aldrich) and approximately 1 nl was 
injected at the 1-2 cell stage using a Femtojet injector (Eppendorf). For knockdown of 
miR-146a and miR-146b two morpholinos were used against each of them. The first 
morpholino for miR-146a (146aMO1: 5’ACCATCTATGGAATTCAGTTCTCAG3’) targets 
the miRNA guide strand and the second morpholino (146aMO2: 
5’GAGCCCAUAGAUGAACUUUUCAUGA3’) overlaps with the star strand and the dicer 
cleavage site on the star strand (Supplementary Fig. 1A,B). For miR-146b, the first 
morpholino (146bMO1: 5’GACACCCTTGGAATTCAGTTCTCAA3’) also targets the guide 
strand, and the second morpholino (146bMO2: 5’CGTGGGCTGAATATAAAGCAGACAC3’) 
overlaps with both dicer cleavage sites and part of the star strand (Supplementary Fig. 
1B). All miR-146 morpholinos could be used at a concentration of 0.75 mM without 
causing morphological defects, except146b-MO2, which was highly toxic. Another 
morpholino design for miR-146b was not recommended by GeneTools. For traf6 
knockdown we used a previously described morpholino (Stockhammer et al., 2010). As 
a control the standard control morpholino (scMO) from GeneTools was used as 







S. typhimurium infections were performed using strain SL1027 and its isogenic LPS Ra 
mutant derivative SF1592, carrying the DsRed expression vector, pGMDs3 (van der Sar 
et al., 2003). For Mycobacterium marinum infection experiments, the Mma20 strain was 
used expressing mCherry in pSMT3 vector (van der Sar et al., 2004). Bacteria were 
grown and prepared for injections as described in Cui et al., (2011) and microinjected 
into the caudal vein of embryos at 28 hours post fertilization (hpf), using a dose of 200-
250 CFUs of S. typhimurium or 100 CFU of M. marinum per embryo. As a control, 
embryos were mock-injected with phosphate-buffered saline (PBS). After injections, 
embryos were transferred to fresh egg water and incubated at 28°C. M. marinum-
infected zebrafish adults (Mma20 strain, 6 dpi) were from a previous study (van der Sar 
et al., 2009). 
 
RNA isolation and quality check 
Embryos were snap frozen in liquid nitrogen and kept at -80°C. Total RNA was isolated 
using the miRNeasy Mini kit (Qiagen) with an on-column DNA purification with RNase 
Free DNase set (Qiagen). RNA from adult zebrafish was isolated as previously described 
(Ordas, 2010). RNA quality of samples for deep sequencing was analyzed with an 
Agilent Bioanalyzer 2100 using the RNA 6000 Nano series Kit (Agilent, Santa Clara, CA, 
USA). All samples had a RNA integrity value (RIN) of 10.     
  
Quantitative RT-PCR analysis 
For quantification of miR-146a/b expression levels, RT-PCR reactions were performed 
using a TaqMan microRNA reverse transcription kit (Applied Biosystems) according to 
the manufacturer’s instructions. Briefly, 10 ng of total RNA was reverse transcribed 
using 5x RT primers (Custom TaqMan small RNA Assay-Applied Biosystems) in a total 
reaction volume of 15 μl. Reactions were kept on ice for 5 min and then were 
transferred to the thermal cycler for incubations at 16°C and 42°C- for 30 min each, 
followed by an incubation at 85°C for 5 min. Quantitative RT-PCR with 0.665 μl cDNA 
input per reaction was performed using a Custom TaqMan small RNA Assay for each 
miRNA and a TaqMan Universal PCR Master Mix (Applied Biosystems) in a total of 10 μl 
per reaction. Cycle threshold values were calculated under the parameters of 40 cycles 
of 10 min at 95°C, 15 sec at 95°C and 60 sec at 60°C. All reactions were performed in at 
least two technical replicates. For normalization, miR-222, which showed no changes in 
response to bacterial challenge, was taken as reference. Results were analyzed using the 
∆∆Ct method. Quantification of mmp9 expression was performed as previously 
described (Stockhammer et al., 2009). 
 
RNA-Seq analysis 
For RNA-Seq analysis, embryos were injected with a combination of 146aMO1 and 
146bMO1, or with the scMO. Subsequently, at 28 hpf they were infected with S. 




(hpi). Two independent experiments were performed for RNA-Seq analysis of biological 
duplicates. A total of 3 μg of RNA was used to make RNA-Seq libraries using the Illumina 
TruSeq RNA Sample Preparation Kit v2 (Illumina Inc., San Diego, USA). In the 
manufacturer’s instructions two modifications were made. In the adapter ligation step 1 
µl instead of 2.5 µl adapter was used. In the library size selection step the library 
fragments were isolated with a double Ampure XP purification with a 0.7x beads to 
library ratio. The resulting mRNA-Seq library was sequenced using an Illumina 
HiSeq2000 instrument according to the manufacturer’s description with a read length 
of 2 x 50 nucleotides. Image analysis and base calling was done by the Illumina HCS 
version 1.15.1. Sequence reads were quality trimmed using the quality_trim module in 
the CLCbio Assembly Cell v4.0.6. Filtered reads were mapped to Ensembl transcripts 
(Zv9_63) using the ref_assemble_short module in the CLCbio Assembly Cell v4.0.6. 
Accumulation of transcripts to Ensembl genes was done by first converting the mapping 
files to a table with the assembly_table module in the CLCbio Assembly Cell v4.0.6. 
Secondly, a custom script was used that sums all reads belonging to the same gene. 
Non-uniquely mapped reads were divided between genes according to their ratio of 
uniquely mapped reads. Finally, read counts of transcripts belonging to the same gene 
were summed to obtain count data at Ensembl gene level.  Fold-change and differential 
expression significance values were calculated from gene level read counts using the 
DESeq package (version 1.8.3) available in Bioconductor (version 2.10). DESeq utilizes 
a negative binomial distribution for modeling read counts per gene and implements a 
method for normalizing the counts (Anders and Huber, 2010). KEGG pathway analysis 
of RNA-Seq data was performed using DAVID (Huang et al., 2009).  
 
Detection of leukocytes  
Embryos were fixed in 4% paraformaldehyde (PFA) in PBS. Immunofluorescence 
detection of leukocytes was performed with a 1:500 dilution of polyclonal rabbit Ab 
against L-plastin (Mathias et al 2007) and Alexa Fluor 488 goat anti-rabbit IgG 
secondary Ab (Molecular Probes), as described in Cui et al., (2011). Histochemical 
detection of neutrophils was performed by Mpx activity staining using the Peroxidase 
Leukocyte Kit (Sigma-Aldrich) as described in Cui et al.,  (2011). 
 
Microscopy and image analysis 
Fluorescence images were taken with a Leica MZ16FA stereo fluorescence microscope 
equipped with a DFC420C digital color camera. Composite images of different focal 
planes were made using Adobe Photoshop. Pixel counts on stereo fluorescence images 









miR-146a/b are induced during zebrafish infection with S. 
typhimurium and M. marinum 
Previous microarray data suggested that miR-146a/b are infection-inducible miRNAs in 
zebrafish embryos and adult fish (Ordas, 2010). To confirm these results we analyzed 
miR-146a/b expression by TaqMan qPCR analysis using miR-222 as a control for 
normalization, since it showed unaltered expression in the microarray study. In 
agreement with the microarray data, miR-146a/b were specifically induced in embryos 
at 8 hours post injection (hpi) with S. typhimurium wild type or LPS mutant (Ra) strains 
(Fig. 1A, B). This infection-dependent increase in miR-146a/b levels could be blocked 
by injection of morpholinos targeting these miRNAs (Fig. 1A, B). Induction of miR-
146a/b was also detected in zebrafish larvae containing a granulomatous M. marinum 
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Figure 1. Expression of miR-146a/b is enhanced upon bacterial infections.  (A) MiR-
146a/b induction in zebrafish embryos by S. typhimurium. Embryos were infected with S. 
typhimurium wild type bacteria (inf) or injected with PBS (mock) at 28 hpf and expression of 
miR-146a/b was analyzed at 8 hpi. Infection-dependent induction of miR-146a/b was blocked 
by morpholinos (MO) targeting miR-146a (146aMO1) or miR-146b (146bMO1). As a control, a 
standard control morpholino (scMO) was injected. (B) MiR-146a/b induction in zebrafish 
embryos by the attenuated S. typhimurium Ra strain. Experimental conditions were the same as 
for infection with wild type S. typhimurium (A). (C) MiR-146a/b induction in zebrafish larvae 
with a granulomatous M. marinum infection. Embryos were infected with M. marinum Mma20 
bacteria (inf) or injected with PBS (mock) at 8 hpf, and expression of miR-146a/b was analyzed 
in larvae at 6 dpi. Infection-dependent induction of miR-146a was reduced by a morpholino 
(MO) targeting this miRNA (146aMO1), but a morpholino against miR-146b (146bMO1) had 
lost its effect during this late stage of larval development. (D) MiR-146a/b induction in M. 
marinum-infected zebrafish adults. Adult zebrafish were injected intraperitoneally with M. 
marinum Mma20 or mock-injected with PBS and RNA was collected at 6 dpi (van der Sar et al., 
2009). Expression levels in all experiments were determined by TaqMan qPCR and relative 
expression levels are shown with the mock control set at 1. Data are the mean ± SEM of two or 
three independent experiments, except for the miR-146a S. typhimurium Ra infection where a 
single experiment is shown. Asterisks indicate significant differences (*, P < 0.05; **, P <0.01; 
***, P <0.001) tested by one-way ANOVA analysis with Tukey’s method as post-hoc test (A-C) or 
by an unpaired t-test (D). 
 
Infection-inducible expression of miR-146a and miR-146b is partially 
dependent on signaling via the MyD88-Traf6 pathway 
We used the S. typhimurium embryo infection model to investigate the dependency of 
miR-146a/b induction on TLR pathway genes. First, we used a previously described 
morpholino knockdown model for traf6, a central intermediate in TLR and TNF 
receptor signaling (Stockhammer et al., 2010). The S. typhimurium-induced expression 
levels of miR-146a/b were significantly lower in traf6 knockdown embryos compared 
to controls (Fig. 2A). 
 Next, we analyzed miR-146a/b induction in a knockout mutant of myd88 (van 
Soest 2012, van der Vaart et al., unpublished). Similar as under Traf6 knockdown 
conditions, miR-146a/b were still infection-inducible in myd88 knockout embryos, but 
their induction levels were significantly higher in wild type siblings (Fig. 2B). Therefore, 
we conclude that miR-146a/b induction is partially dependent on Myd88 and Traf6, but 









Figure 2. The Traf6-MyD88 
pathway is involved in up-
regulation of miR-146a/b ex-
pression levels upon infection. 
(A) Traf6-dependent miR-146a/b 
induction. Embryos were injected 
with traf6 morpholino (MO) or a 
mismatch morpholino (MM) as a 
control. Embryos were infected at 
28 hpf with S. typhimurium (inf) or 
mock-injected with PBS and 
samples were collected at 8 hpi. (B) 
Myd88-dependent miR-146a/b in-
duction. Mutant (myd88-/-) and 
wild type siblings (myd88+/+) were 
infected with S. typhimurium at 28 
hpf followed by sample collection 
at 8 hpi. Expression levels in both 
experiments were determined by 
TaqMan qPCR and relative ex-
pression levels are shown with the 
mock control set at 1. Data are the 
mean ± SEM of two or three 
independent experiments. Aste-
risks indicate significant differ-
ences (*, P < 0.05; **, P <0.01) 
tested by one-way ANOVA analysis 
with Tukey’s method as post-hoc 
test. 
 
MiR-146a/b do not affect leukocyte development in zebrafish 
embryos 
Loss of function studies in mice and zebrafish suggested a possible role of miR-146a in 
the development of myeloid cells, in addition to its proposed inhibitory effect on pro-
inflammatory signaling (Ghani et al., 2011). To investigate the possible requirement of 
miR-146a/b for leukocyte development in zebrafish embryos, we designed two 
different morpholinos for each miRNA (Supplementary Fig. 1). The efficiency of the 
knockdown was confirmed by TaqMan qPCR analysis, showing an approximately 10-
fold decrease in the expression levels of miR-146a and miR-146b at 2 dpf with each 
morpholino (Fig. 3G). Immunostaining for L-plastin, a pan-leukocytic marker, was 
performed to determine the number of immune cells over a time course of 26, 28, 30, 
and 32 hpf. During this period primitive myeloid cells first appear over the yolk sac, and 
subsequently invade the head. This first wave of primitive myeloid cells is rapidly 
followed by differentiation of the first erythro-myeloid precursor cells in the caudal 
blood island region. The total number of L-plastin-positive leukocytes showed a similar  
 















































































































































































































































































Figure. 3 Knockdown of miR-146a/b does not affect leukocyte development. Embryos 
were injected at the 1-cell stage with morpholinos targeting miR-146a (146aMO1 and 
146aMO2) or miR-146b (146bMO1 and 146bMO2) or were injected with standard control 
morpholino (scMO). (A-F) Representative images of L-plastin immunostaining of 32 hpf 
embryos injected with the indicated morpholinos. The pattern of L-plastin-positive immune 
cells was comparable between embryos injected with scMO (A), 146aMO1 (B), 146aMO2 (C), 
and 146bMO1 (D). 146bMO2 gave non-specific phenotypes and the number of immune cells 
was more variable dependent upon the severity of phenotype (E,F). (G) Confirmation of 
morpholino knockdown. Embryos were injected with the indicated morpholinos and RNA was 
collected at 2dpf. Knockdown of miR-146a and miR-146b was confirmed by TaqMan qPCR. (H) 
Quantification of L-plastin-positive leukocytes at 26, 28, 30 and 32 hpf. Embryos were injected 
with the indicated morpholinos. L-plastin-labeled cells were counted manually on the left side 
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of each embryo and the numbers present in the head, on the yolk sac, and in the caudal blood 
island were accumulated (n ≥ 16 embryos per time point). (I) Quantification of L-plastin-
positive leukocytes at 2 dpf. Embryos were injected with the control morpholino (scMO) or with 
a combination of 146a/bMOs. L-plastin-labeled cells were counted manually as described above 
(n ≥ 26 embryos per group). (J) Quantification of Mpx-positive neutrophis at 2dpf. Embryos 
were injected with the indicated morpholinos. Neutrophils stained for Mpx activity were 
counted manually as described above (n ≥ 13 embryos per group). 
 
increase over the time course between control embryos and embryos injected with 
146aMO1, 146aMO2, or 146bMO1 (Fig. 3A-D, H). 146bMO2 could not be included in 
this quantitative analysis, because this morpholino resulted in non-specific phenotypes 
even at very low concentration (0.01mM) in comparison to the high inject-able doses of 
the other morpholinos (0.75mM) that had no overt effects on embryo development. 
Nevertheless, L-plastin positive immune cells were still present in 146bMO2 morphants 
with mild (Fig. 3E) or severe phenotypes (Fig. 3F). In addition, we analyzed a 
combination of morpholinos for miR-146a/b (146aMO1 and 146bMO1 (146a/bMOs)) 
at 2 dpf. As in the 28-32 hpf time course with the separate morpholinos, no difference 
was observed between controls and morphants in the numbers of L-plastin-stained 
immune cells at this stage (Fig. 3I). The number of neutrophils was also comparable 
between controls and morphants as visualized by histochemical staining for Mpx 
activity at 2dpf (Fig. 3J). Based on these results, we conclude that miR-146a/b are not 
required for leukocyte differentiation during zebrafish embryo development. 
 
Combined knockdown of miR-146a/b does not have a major effect on 
pro-inflammatory gene expression during S. typhimurium infection 
In previous work, we observed that knockdown of a negative regulator of the immune 
response (the ptpn6/shp1 phosphatase gene) resulted in a hyperinduction of pro-
inflammatory gene expression during S. typhimurium infection (Chapter 2). Since miR-
146 has also been proposed as a negative regulator of innate immunity (Taganov et al., 
2006), we hypothesized that miR-146 knockdown might have a similar effect. To test 
this hypothesis, we used a combination of miR-146a/b morpholinos and analyzed the 
response to S. typhimurium  infection by RNA deep sequencing (RNA-Seq) (Fig. 4A). 
First we analyzed the basal expression differences between uninfected miR-146a/b 
morphants and embryos injected with a control morpholino. Only 78 genes were 
affected by miR-146a/b knockdown, among which 5 genes in p53 signaling (Fig. 4B). 
This might reflect a non-specific effect of the miR-146 knockdown, since morpholino 
effects on the p53 pathway are relatively common (Robu et al., 2007). S. typhimurium 
infection resulted in differential expression of 726 genes in embryos injected with a 
control morpholino and 884 genes in miR-146 morphants. In agreement with previous 
studies (Chapter 2, Stockhammer et al., 2009, 2010, Ordas et al., 2011), S. typhimurium 
infection resulted in significant alteration of KEGG pathways related to the immune 
response and metabolism (Fig. 4B). While the total numbers of S. typhimurium up- and 
down-regulated genes in miR-146 morphants were somewhat higher than in control 




miR-146 morphants. The only pro-inflammatory marker that was up-regulated to 
higher levels in infected miR-146 morphants compared with the infected controls was 
the matrix metalloproteinase 9 (mmp9) gene (Supplementary Table 1). RNA-Seq showed 
a 1.5-fold higher up-regulation of this gene in miR-146 morphants, which was 
confirmed by qPCR analysis (Supplementary Fig. 2). We did not observe effects of miR-
146 knockdown on the expression of traf6 and irak1, genes known to be targeted by 
miR-146 in human. Instead of an effect on innate immunity signaling, KEGG pathway 
analysis revealed a possible effect on lipid transport in S. typhimurium-infected miR-
146 morphants. Six members of the apolipoprotein family (Fig. 4C) were significantly 
induced during S. typhimurium infection of miR-146 morphants but not in infected 
control embryos. In conclusion, miR-146a and miR-146b knockdown in zebrafish 
embryos did not have a strong effect on innate immunity signaling in the first 8 hours of 
the response to S. typhimurium infection, despite the increased expression of these 
miRNAs during this phase. Furthermore, bacterial burden in S. typhimurium infection 
(analyzed with an attenuated Ra strain; data not shown), was not significantly affected 
by miR-146a/b knockdown. 
 
Knockdown of miR-146a/b increases bacterial burden of M. marinum 
infection 
To see the effect of miR-146a/b knockdown under chronic infection conditions, we 
infected the embryos with M. marinum. First we analyzed the effect of combined miR-
146a/b knockdown. Fluorescent pixel quantification of mCherry-labelled M. marinum 
bacteria at 3 days post infection demonstrated a significantly increased bacterial 
burden in miR-146a/b morphants in comparison with embryos injected with the 
control morpholino (Fig. 5A). Subsequently, two independent experiments were 
performed to elucidate whether this effect could be attributed to knockdown of miR-
146a or miR-146b or both. These experiments consistently showed miR-146b 
knockdown to result in more bacterial proliferation as compared to miR-146a 
knockdown or control embryos (Fig. 5B, C). The bacterial burden was not significantly 
different between miR-146b knockdown embryos and embryos with combined miR-
146a/b knockdown. Thus, miR-146b knockdown was the major contributor to the 
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Figure 4.  Transcriptome response of miR-146a/b morphants to S. typhimurium infection. 
(A) Experimental set-up of the deep sequencing methodology. Embryos were injected at the 1-2 
cell stage with a combination of 146aMO1 and 146bMO1 (146a/bMOs) or with the standard 
control morpholino (scMO).  Approximately 250 CFU of S. typhimurium bacteria were injected 
into the caudal vein at 28 hpf after the onset of the blood circulation, or PBS was injected as a 
control. RNA-Seq analysis was performed on RNA samples extracted from pools of >50 embryos 
at 8 hpi.  RNA samples from the four treatment groups (control/PBS (con), control/infected 
(con St), 146a/bMOs/PBS (146MO), and 146a/bMOs/infected (146MO St)) were obtained from 
two independent experiments. DESeq was used for statistical comparison of transcript count 
data. The significance cut-offs were set at an absolute fold change ≥1.5 and Padj ≤ 0.1. (B) Venn 
diagram showing the overlap between the effect of 146a/b knockdown on basal gene 
expression levels (con vs. 146MO) and the effect of S. typhimurium on gene expression in 
146a/b morphants (146MO vs. 146MO St). The numbers of genes with significantly changed 
expression are shown in the Venn diagram and significantly enriched KEGG pathways for each 
comparison are indicated below. The 5 genes indicated for p53 signaling were up-regulated in 
146a/b morphants compared with control embryos. (C) Venn diagrams showing comparisons 
of the numbers of genes that were up-regulated or down-regulated by S. typhimurium infection 
in control embryos (con vs. con St) or in miR-146a/b morphants (146MO vs 146MO St). KEGG 
pathways that were significantly enriched in the DESeq comparison of infected miR-146a/b 
morphants with infected controls (con St vs. 146MO St) are indicated below. The 6 genes 
indicated for p53 signaling and 6 genes for lipid transport were up-regulated in infected 146a/b 






















































































































































Figure 5. Knockdown of miR-146b increases bacterial burden of M. marinum infection. 
(A) Increased M. marinum infection by combined miR-146a/b knockdown. Embryos were 
injected at the 1-cell stage with a combination of 146aMO1 and miR-146bMO1 (146a/bMOs) or 
with standard control morpholino (scMO). At 28 hpf the embryos were infected with M. 
marinum Mma20 strain by injecting into the caudal vein. Bacterial burden was determined at 3 
dpi by fluorescent pixel quantification of mCherry-labeled bacteria. Data are the mean ± SEM of 
cumulative data of 3 independent experiments. (B,C) Knockdown of miR-146b as the major 
contributor to increased M. marinum infection. Embryos were injected at the 1-cell stage with 
146aMO1, 146bMO1, with the combination of both (146a/bMOs), or with standard control 
morpholino (scMO). Infection and quantification of bacterial burden was performed as in (A) in 
two independent experiments (B,C). Due to differences in the injection dose, bacterial burden 
was analyzed at different time points in these experiments, at 3dpi (B, ≥ 39 embryos per group) 
and at 4dpi (C ≥ 30 embryos per group).  Asterisks indicate significant differences (*, P < 0.05; 
**, P <0.01; ***, P <0.001) tested by unpaired t-test (A) or one-way ANOVA analysis with 
Tukey’s method as post-hoc test (B, C). 
 
Discussion 
Recent studies have demonstrated the involvement of miRNAs in immune processes 
and inflammatory disorders, which has increased interest to find the molecular 
pathways responsible for miRNA action. MiR-146 has been recognized as a modulator 
of the innate and adaptive immune responses. Here, we exploited the zebrafish at the 
embryonic and larval stages, when adaptive immunity is not functional yet, to study the 
role of miR-146 in the innate immune response to bacterial infections. Both of the miR-
146 family members, miR-146a and miR-146b, were found to be inducible by S. 
typhimurium and M. marinum, which are used as models for acute and chronic 
infections, respectively. The induction of miR-146a and miR-146b was in line with 
earlier microarray studies, which identified miR-146a and miR-146b as infection-
inducible miRNAs along with some other miRNAs, like miR-9, miR-21, miR-29, miR-132, 
miR-155, and miR-147 (Bazzoni et al., 2009; Liu et al., 2009; Ordas, 2010; Sheedy et al., 
2010; Boldin et al., 2011). The miR-146a and miR-146b sequences are conserved 
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between zebrafish and human as well as target sites in the 3’UTR of mRNAs of innate 
immune pathway genes such as IRAK1 and TRAF6, which are experimentally validated 
targets of miR-146 (Taganov et al., 2006, Boldin et al., 2011). To determine the pathway 
by which miR-146 expression is induced in zebrafish embryos upon infection we used 
traf6 knockdown and myd88 knockout models. The induction levels of miR-146a and 
miR-146b upon S. typhimurium infection were reduced under conditions of traf6 or 
myd88 deficiency, but induction was not completely abolished. This showed that 
infection-induced expression of miR-146 is partially dependent on the Myd88-Traf6 
pathway and suggests that parallel signaling routes also contribute to miR-146 
induction. The partial dependence on the Myd88-Traf6 pathway suggests that miR-
146a and miR-146b may function in feedback control of TLR signaling, like the human 
and murine counterparts (Taganov et al., 2006, Boldin et al., 2011). 
 A recent study by Ghani et al., (2011) suggested miR-146a to be required for 
myeloid cell differentiation in mouse and zebrafish. In this study, in situ hybridization 
of zebrafish embryos with the pan-leukocytic L-plastin marker suggested an almost 
complete absence of myeloid cells under conditions of miR-146a morpholino 
knockdown. This observation is in strong contrast to the phenotype of miR-146a 
knockout mice, which showed hyperproliferation of myeloid cells leading to 
autoimmunity (Boldin et al., 2011). Our analysis of miR-146a knockdown in zebrafish 
embryos also contrasts the data of Ghani et al. We used two morpholinos for miR-146a 
(one of which was the same as a miR-146a morpholino used by Ghani et al.), and 
verified the knockdown effect by TaqMan qPCR. With L-plastin immunostaining, which 
is more sensitive than in situ hybridization, we detected no differences in myeloid cell 
development between miR-146 morphants and controls over an elaborate time course 
between 26 and 32 hpf, which comprises the critical embryonic stages when myeloid 
cells differentiate and enter the circulation. Furthermore, no effect on neutrophil 
differentiation at 2 dpf was detected. Thus, we found no evidence for an inhibitory 
effect of miR-146 deficiency on myeloid cell development in zebrafish embryos.  
Knockout mice of miR-146a are hyperresponsive to LPS, showing increased up-
regulation of pro-inflammatory cytokines, such as TNF and IL-6 (Boldin et al 2011). We 
used S. typhimurium infection of zebrafish embryos, which is accompanied by strong 
pro-inflammatory gene induction, to analyze the knockdown effect of miR-146a and 
miR146b by RNA-Seq analysis. We used a combination of morpholinos against miR-
146a and miR-146b in the RNA-Seq study to avoid that the two miRNAs might 
compensate for each other’s loss-of-function, as their mature sequences differ only by 
two nucleotides. The combined morpholino knockdown led to increased induction of 
mmp9 during S. typhimurium infection; however, this induction of mmp9 was not 
accompanied by a general hyperinduction of other pro-inflammatory markers in the 
RNA-Seq analysis. In addition to mmp9, mmp2 was also up-regulated in miR-146a/b 
morphants, but independent of S. typhimurium infection. One of the matrix 
metalloproteinase genes, MMP16, has previously been described as a target gene for 
human miR-146b (Xia et al., 2009). MMP2 and MMP9 are not predicted target genes of 




upon miR-146a/b overexpression in MDA-MB-231 breast cancer cells and in THP-1 
macrophages (Bhaumik et al., 2008; Yang et al., 2011). This down-regulation was 
suggested to occur via TLR-mediated and NF-κB-dependent pathways rather than by 
direct targeting of MMP9 (Bhaumik et al., 2008; Yang et al., 2011). Likewise, the 
induction of zebrafish mmp9 under miR-146a/b knockdown conditions might be an 
indirect consequence of effects on upstream signaling proteins. In agreement, we have 
previously shown that mmp9 induction by S. typhimurium infection is mediated by 
Traf6, which is a known target of miR-146 (Stockhammer et al., 2010; Taganov et al., 
2006; Boldin et al., 2011). The observation that an increase of other Traf6-dependent 
pro-inflammatory markers was not seen in our RNA-Seq analysis of miR-146a/b 
knockdown may be explained by the fact that mmp9 is the most strongly induced pro-
inflammatory marker in S. typhimurium infection (Stockhammer et al., 2009).  
While the overall knockdown effect observed in our RNA-Seq analysis was 
relatively minor and no general hyperinduction of inflammation markers was observed, 
apoliprotein-mediated lipid transport emerged as an infection-inducible pathway under 
miR-146a/b knockdown conditions. Numerous studies have linked apolipoproteins to 
immunoregulation and host defense (Khovidhunkit et al., 2004; Li et al., 2008) MiR-
146a has been suggested to be involved in negative regulation of oxidized low-density 
lipoprotein- (LDL) accumulation in macrophages (Yang et al., 2011). Lipid accumulation 
in macrophages is associated with the inflammatory processes that lead to 
atherosclerosis. The expression of miR-146a was found to be down-regulated upon 
oxidized LDL stimulation of THP-1 macrophages. Furthermore, miR-146 
overexpression reduced intracellular LDL cholesterol content and secretion of IL6, IL8, 
and MMP9 via TLR4-mediated signaling. A similar effect on LDL accumulation was 
observed by silencing miR-155, another important miRNA regulator of immune 
processes (Huang et al., 2010). Our results support the inhibitory function of miR-146 
in lipid-mediated inflammatory responses and its proposed application as a potential 
therapeutic for atherosclerosis treatment (Yang et al., 2011).  
Several genes in the p53 pathway, including tp53 itself, were up-regulated in 
miR-146 morphants as compared to controls under infected as well as non-infected 
conditions. This might be attributed to the well known off-target effects of morpholino 
oligonucleotides (Robu et al., 2007). However, as miR-146 has been frequently linked 
with cancer, a direct effect on the p53 pathway cannot be excluded (Labbaye and Testa, 
2012; Sassen et al., 2008; Visone and Croce, 2009).  In fact, one of the genes in the p53 
pathway up-regulated by miR-146 knockdown , cdkn1a (p21), is an experimentally 
validated target of miR-146a in human (Borgdorff et al., 2010). In total we found 73 
genes which were significantly up-regulated in miR-146 infection as compared to 
control infection. Besides cdkn1a, only one other gene, fibrinogen beta chain (fgb), 
showed an overlap with the predicted targets of zebrafish miR-146a and miR-146b in 
miRBase. Fibrinogen has roles in cell adhesion, hematopoiesis, and in coagulation and 
complement cascades associated with primary defence against bacterial infections 
(Rivera et al., 2007). Expression levels of other known targets of miR-146 involved in 
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innate immunity, such as irak1, traf6, irf5 and stat1, were not affected, but miR-146-
dependent modulation of these genes may occur post-transcriptionally.   
By targeting components of TLR signaling miR-146 has been shown to function 
as a negative regulator of the innate immune response (Taganov et al., 2006; Boldin et 
al., 2011).  However, in our study of S. typhimurium infection in zebrafish embryos, miR-
146 knockdown did not make a strong impact on the induction of proinflammatory 
genes. Notably, the effect of miR-146 knockdown was minor in comparison with 
knockdown analysis of ptpn6, which encodes a SH2-domain phosphatase that functions 
as a negative regulator of innate immunity (An et al., 2008; Croker et al., 2008). In the 
same experimental set-up, S. typhimurium infection of zebrafsh embryos under 
knockdown of ptpn6 resulted in hyperinduction of mmp9 and a wide range of cytokines, 
other immune effectors genes, and transcriptional regulators of the immune response 
(Chapter 2), while in case of miR-146a/b knockdown only mmp9 was hyperinduced. 
Furthermore, hyperinflammation in ptpn6 morphants impaired control of S. 
typhimurium infection, while miR-146 knockdown had no such effect. These results 
support that Ptpn6 functions as a much stronger negative feedback regulator than miR-
146a/b in the early response of zebrafish embryos to S. typhimurium infection. This 
would be consistent with the idea that miRNAs function in more subtle fine-tuning  of 
the immune response (O’Neill, 2011) 
Compared to acute lethality of S. typhimurium infection, M. marinum infection 
shows a chronic progression in zebrafish embryos and larvae. An increased bacterial 
burden of M. marinum was observed after combined knockdown of miR-146a and b. 
MiR-146b knockdown alone was sufficient for a significant increase of bacterial burden 
compared with the infection level of the control group, suggesting that miR-146b rather 
than miR-146a regulates responses to this type of infection. Similarly, knockdown of 
ptpn6 also resulted in an increased bacterial burden of M. marinum infection (Chapter 
2). Together, these results suggest that both ptpn6 and miR-146b-mediated control 
mechanisms are protective and are required for a functional innate immune response 
to M. marinum infection. 
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A. Stem-loop dre-miR-146a:  
        -------U       CU  U  Cu         au           UGUUCA  
GAGUUUGU        UUGAGCA  UU CC  gagaacuga  uccauagaugg      U 
||||||||        |||||||  || ||  |||||||||  |||||||||||        
CUUAAACA        AAUUUGU  AA GG  UUCUUGACU  GGGUAUCUACU      G 
                UCGUCUGU       CU  C  UC         -C           UGAAAA 
 
B. Stem-loop dre-miR-146b:  
  -   UG    u              aa    gUCUGCU  
GC UCU  GCUU gagaacugaauucc  gggu       U 
|| |||  |||| ||||||||||||||  ||||         
CG AGG  UGAA UUCUUGACUUGAGG  CCCG       U 
  U   UU    -              CA    ACUUAUA 
 
Supplementary Figure 1. Target sites of miR-146a and miR-146b morpholinos on their 
respective miRNAs. The stem-loop sequences of the zebrafish miR-146a and miR-146b 
homologs, dre-miR-146a (A) and dre-miR-146b (B) are shown with the miRNA guide strand in 
lower case. Regions targeted by the morpholinos are indicated in blue (146aMO1 and 
146bMO1) or yellow (146aMO2 and 146bMO2), and overlap between two morpholino regions 
is shown in green.  
 
 
Supplementary Figure 2. Increased mmp9 expression in S. 
typhimurium-infected miR-146a/b morphants. Expression 
of mmp9 was analyzed by qPCR in the two independent RNA 
sample series that were used for RNA-Seq analysis. Embryos 
were injected with standard control morpholino (scMO) or 
with a combination of morpholinos against miR-146a and miR-
146b (146a/bMOs), and infected with S. typhimurium (inf) or 
injected with PBS (mock). The mmp9 induction level upon S. 
typhimurium infection was significantly higher in miR-146a/b 
morphants than in control embryos, consistent with the results 
of RNA-Seq analysis (Supplementary Table 1). Relative 
expression levels are shown with mock control set at 1. Data 
are the mean ± SEM of two independent experiments. Asterisks 
indicate significant differences (*, P < 0.05; **, P <0.01) tested by one-way ANOVA analysis with 
Tukey’s method as post-hoc test. 
 
Supplementary Table 1. Genes showing significantly up- or down-regulated expression in S. 
typhimurium-infected miR-146a/b morphants compared with S. typhimurium-infected control 
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Infectious diseases, caused by pathogenic microorganisms, continue to pose major 
health challenges in developed as well as developing countries. A proper functioning 
immune system is essential for defense against infectious agents. The immune system is 
functionally organized into two components:  innate (natural) and adaptive (acquired) 
immunity. The innate immune system is inborn and provides immediate protection 
against invading microorganisms by recognizing important and conserved structural 
components, such as molecules of microbial cell walls. A variety of immune cells 
orchestrate responses of the innate immune system. These include: macrophages, 
neutrophils, eosinophils, basophils, dendritic cells, natural killer cells, and mast cells. 
Innate immune cells function cooperatively with T- and B-lymphocytes of the adaptive 
immune system, which execute a more specific response due to recognition of 
distinctive molecules (antigens) of different pathogens.  
  Upon detection of an infection or other indications of danger, the cells of innate 
immune system initiate the release of pro-inflammatory mediators, which are proteins 
and lipids that stimulate inflammation. Increased blood flow and attraction of immune 
cells during inflammation helps to limit the spread of infection. However, this process 
needs to be properly controlled, because excessive inflammation is harmful to the 
body’s own tissues. Inappropriate regulation of the immune system may lead to auto-
immune and auto-inflammatory diseases. Both groups of disorders result from the 
immune system attacking the body’s own tissues, which in turn results in increased 
inflammation. In most auto-immune diseases, such as type 1 diabetes, coeliac disease, 
multiple sclerosis, systemic lupus erythematosus, Crohn’s disease, and rheumatoid 
arthritis, defective responses of the adaptive immune system play a major role. Auto-
inflammatory diseases are a relatively new category of diseases and are mainly caused 
by the defects in the innate immune system, causing inflammation for unknown 
reasons.  
As reviewed in Chapter 1, both the innate and adaptive immune systems rely on 
many signaling molecules for their proper functioning. These molecules have roles in 
pathogen recognition (e.g., pattern recognition receptors such as TLRs, NLRs, and 
RLRs), signal propagation (e.g. adaptor proteins, kinases, phosphatases, and 
transcription factors) and control of gene expression (e.g. miRNAs). Functional defects 
in any of these molecules may increase susceptibility to infectious diseases or result in 
conditions like auto-immune and auto-inflammatory diseases. The zebrafish is a recent 
addition to biomedical research as a model for the study of inflammation and infectious 
diseases. The molecular components that orchestrate immune responses are well 
conserved between human and zebrafish. Infection and inflammation processes can be 
excellently visualized in zebrafish embryos and larvae, as these are optical transparent. 
The absence of functional adaptive immunity in embryos and larvae makes them  highly 
suitable for modeling innate immune responses in vivo. In addition, high production 
rates and small size facilitate high-throughput assays using zebrafish. Several infection 
models in zebrafish have been well established, including Salmonella typhimurium and 





thesis we have made use of the zebrafish to study the importance of different regulatory 
pathways in innate immunity.  
  In Chapter 2 we have demonstrated the importance of a negative regulator of 
the innate immune response, which is encoded by the protein tyrosine phosphatase 
non-receptor type 6 gene (ptpn6). It is known that mutation of this gene in mice causes 
inflammatory lesions in multiple organs that become lethal at 3-5 weeks of age. 
Furthermore, dysfunction of human PTPN6, also known as SHP1, has been linked to 
auto-immune and auto-inflammatory disorders. PTPN6 is a hematopoietic phosphatase. 
In one day old zebrafish embryos, we found ptpn6 to be specifically expressed in 
macrophages and at later stages of development we also observed expression in 
neutrophils and developing T-cells. We used a morpholino knockdown approach to 
study the role of ptpn6 in the innate immune system of zebrafish embryos. Knockdown 
of ptpn6 did not affect the early stages of development, but a late pleiotropic phenotype 
was observed with different morpholinos against this gene. At 5-6 days post 
fertilization (dpf), ptpn6 morphant embryos showed more proliferation in the brain, 
contained more apoptotic cells, and they developed oedema and inflammatory lesions. 
An increased induction of the pro-inflammatory genes coding for interleukin 1b (il1b) 
and matrix metalloproteinase 9 (mmp9) was found in the ptpn6 morphants. The 
induction of these genes was concomitant with the occurrence of inflammatory lesions 
that were highly infiltrated by leukocytes. This late phenotype was found to be 
independent of the presence of microbes, showing that an external trigger is not 
necessary for the development of inflammation in ptpn6 morphants and the absence of 
this gene is sufficient to cause the inflammation-associated phenotype. The 
administration of anti-inflammatory glucocorticoids could not block the development of 
inflammation in ptpn6 morphants. On the contrary, glucocorticoid treatment of ptpn6 
morphants intensified the development of inflammatory lesions as well as the induction 
of pro-inflammatory genes. These effects might be due to synergistic actions between 
the glucocortocoid receptor and several transcription factors which have been activated 
by ptpn6 knockdown. 
To analyze the function of ptpn6 during infection we focused on the first days of 
embryonic development, prior to the manifestation of the spontaneous inflammatory 
lesions and the induction of pro-inflammatory genes. We challenged the ptpn6 
morphants at 1 dpf with S. typhimurium and M. marinum infections. A more rapid 
proliferation of S. typhimurium was observed in ptpn6 morphants compared with 
control embryos. Furthermore, ptpn6 morphants showed impaired control of the 
growth of an attenuated S. typhimurium strain, which could be more efficiently cleared 
by the immune system of control embryos. Infection with M. marinum also led to 
heavier bacterial loads and increased granuloma formation in ptpn6 morphants 
compared with the controls. The infection-dependent induction of pro-inflammatory 
il1b and mmp9 genes was higher in S. typhimurium-challenged ptpn6 morphants than in 
the control embryos. Increased induction of mmp9 was also observed in M. marinum-
infected ptpn6 morphants. Thus, hyperinduction of these genes proved to be 
disadvantageous for zebrafish embryos in combating infections. 
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We chose the S. typhimurium infection model to further investigate the specific 
effects of ptpn6 knockdown on the innate immune response by microarray analysis. 
This analysis was performed 8 hours after challenge with S. typhimurium at 1 dpf, when 
no visible phenotypic effect of ptpn6 knockdown was present. The total number of 
probes with a significant responsive to infection was approximately 2-fold larger in 
ptpn6 morphants than in control embryos. Analysis of a group of 258 genes with higher 
up-regulation in infected ptpn6 morphants showed significant overrepresentation of 
TLR, NLR, RIG-I, p53, MAPK, JAK-STAT and other immune-related KEGG pathways. 
More specifically, genes showing higher up-regulation in ptpn6 morphants included 
cytokine/chemokine/interferon genes such as il1b, il8, tnfa, tnfb, and ifnphi1, matrix 
metalloproteinases such as mmp9 and mmp13, and many transcriptional regulators of 
the ATF, CEBP, AP1, NFκB, and STAT families. Similar to the increased induction of pro-
inflammatory genes, infected ptpn6 morphants also showed increased induction levels 
of several negative regulators, such as irak3, socs3a and socs3b, and NFκB inhibitor 
genes (nfkbiaa, nfkbiab, nfkbib, nfkbiz). In contrast, the anti-inflammatory cytokine gene 
il10 did not show increased induction in ptpn6 morphants. The microarray results were 
confirmed by using an RT-MLPA assay that allows the simultaneous semi-quantitative 
PCR analysis of 34 innate immune genes. Thus, under ptpn6 knockdown conditions, 
embryos responded to S. typhimurium infection by an enhanced gene induction profile 
of the innate immune response. Therefore, we could conclude that ptpn6 functions as a 
key player regulating the inflammatory response to infection through a negative 
feedback mechanism. This function of ptpn6 is crucial for preventing host-detrimental 
effects of inflammation and is essential for a successful defense mechanism against 
invading microbes. 
In Chapter 3 we used Illumina RNA deep sequencing (RNA-Seq) technology to 
determine transcriptome profiles of different immune cell types and to further analyze 
the effects of ptpn6 knockdown at a cellular level. Transgenic zebrafish lines with 
fluorescently marked macrophages (mpeg1:egfp), neutrophils (mpx:egfp), and early T-
cells (lck:egfp) were used for this study. Zebrafish larvae were dissociated at 5 dpf and 
the fluorescent cells were isolated by fluorescence activated cell sorting (FACS). First, to 
develop a protocol for RNA-Seq analysis from FACS-sorted cells, we used the 
mpeg1:egfp macrophage marker line. From pools of approximately 250 dissociated 
larvae we could obtain 4000-10,000 GFP-labeled cells. Using the Ambion RNAqueous-
Micro Kit for RNA isolation in combination with the Clontech SMARTer Ultra Low RNA 
Kit for Illumina Sequencing, we succeeded in obtaining good RNA-Seq libraries, even 
from samples with an estimated RNA input below 100 pg. We used the DEseq program 
for statistical analysis of libraries from the GFP-positive and GFP-negative cell fractions 
of four biological replicates with approximately 10 million paired-end reads per library. 
The GFP-positive cell fractions of all biological replicates showed specific enrichment of 
KEGG pathways and GO-terms related to the immune system and approximately 50% of 
significant genes were common between each pair of replicates. These results 





Having established a reproducible procedure for RNA-Seq analysis from FACS-
sorted cells, we compared the macrophage signature genes obtained from mpeg:egfp-
positive cells with FACS-sorted neutrophils from an mpx:egfp transgenic line and early 
T-cells from an lck:egfp transgenic line. As expected, known macrophage markers were 
specifically enriched in mpeg1:egfp-positive cells, including csf1r, cxcr3.2, irf8, marco, 
mfap4, mhc2dab, and mpeg1 itself. Neutrophils showed a higher expression of mpx, lyz, 
mmp9 and mmp13a than macrophages. Furthermore, the expression profile of lck:egfp-
positive cells showed very specific expression of T-cell markers including cd2, cd28, cd4, 
ikzf1 (ikaros), rag1, and rag2 along with lck. There was more overlap between the 
expression signatures of mpx:egfp-positive and mpeg1:egfp-positive cell fractions than 
there was between these myeloid cell fractions and lck:egfp-positive lymphoid cells. The 
RNA-Seq libraries gave us the opportunity to look for other specific and more abundant 
genes that may prove to be valuable markers for developing new transgenic lines and 
antibodies for distinguishing leukocyte lineages in the zebrafish model. Genes that 
showed higher abundance than mpeg1 in macrophages were members of the families of 
chemokines, immunoglobulins, olfactomedins, granulins, cathepsins, fibrinogens, 
lectins, transmembrane receptors, complement factors, and MHC II class proteins. 
Among these, granulin 2 (grn2) had a more than 10-fold higher expression level than 
mpeg1 and was highly specific for macrophages. Several other genes, for example the 
MHC class II genes cd74 and mhc2dab, were also detected almost exclusively in 
macrophages. In neutrophils, lyz and npsn showed higher abundance than mpx, and il34 
was identified as another good marker. Highly specific T-cell markers included lck, rag1, 
ccr9b, il17r, p2rx1, rorc, foxp3a, and several genes for T-cell specific immunoglobulins.  
We also used the RNA-Seq technology to investigate the immune response-
related gene expression pattern of zebrafish challenged with M. marinum. Following its 
uptake by macrophages, this pathogen causes a chronic infection in zebrafish with the 
formation of granuloma-like aggregates resembling the hallmark of tuberculosis in 
human. Infected cells carrying mCherry-labeled fluorescent M. marinum were isolated 
by FACS sorting from larvae at 4 days post infection (dpi). We compared the expression 
signature of the M. marinum-infected cells with that of uninfected mpeg1:egfp-positive 
macrophages. A set of 40 distinctive macrophage markers was detectable in the M. 
marinum-infected cells, but most of these genes were strongly down-regulated 
compared with uninfected macrophages. Furthermore, many genes that were 
expressed in uninfected macrophages, including mpeg1, were not detected in the 
infected cells.  In addition to down-regulation of macrophage markers, the infected cells 
showed specific enrichment of genes that could be grouped into five main clusters of 
gene ontology terms: ribosome, oxidative phosphorylation, proteolysis, ion transport, 
and chromatin assembly. The induction of these gene groups may reflect activation of 
protein translation and defense mechanisms in the infected cells. Examples of these 
genes include the anti-microbial hepcidin gene (hamp1) and a ribosomal protein gene 
(rps3) for which an extra-ribosomal regulator function in innate immunity has been 
reported. It is an interesting possibility that the increased expression of chromatin 
assembly genes in infected cells may be associated with the M. marinum-induced 
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morphological changes that macrophages undergo during granuloma formation. In 
addition to the five main clusters of enriched genes, we found that M. marinum-infected 
cells also showed increased expression of lipid metabolism and transport genes, lectin 
genes, and genes with immunosuppressive functions. Some of these genes have also 
been implicated in human tuberculosis. Based on these results, we concluded that M. 
marinum infection has a major impact on the gene expression signature of 
macrophages, resulting in a general down-regulation of macrophage markers and an 
up-regulation of genes proposed to be involved in both host defense and 
immunosuppression.  
Next, we decided to use the RNA-Seq profiling technology to gain further insight 
into the molecular processes responsible for increased granuloma formation in ptpn6 
morphants infected by M. marinum. Furthermore, by RNA-Seq analysis of different 
leukocyte populations we aimed at better understanding of the underlying causes of the 
inflammatory conditions that ptpn6 morphants develop around 5 dpf. Notably, matrix 
metalloproteinase genes, including mmp2, mmp9, and mmp13a, and the mmp inhibitor 
gene timp2b were significantly up-regulated in M. marinum-infected cells from ptpn6 
morphants compared with infected cells from control embryos. Along with the mmp 
genes, serum amyloid A (saa) was up-regulated. Since this gene has previously been 
implicated in regulating mmp genes expression, we propose that increased levels of saa 
play a role in triggering increased mmp gene expression during M. marinum infection of 
ptpn6 morphants. Some genes with possible functions in anti-microbial defense were 
also up-regulated, including hamp1, lepb, gcga, and steap4. These genes are connected 
with responses to nutrients and therefore may form links between the innate immune 
system and metabolic responses. However, the up-regulation of these possible anti-
microbial genes was not sufficient to prevent the strong increase in bacterial burden of 
M. marinum infection in ptpn6 morphants..  
In contrast to what was observed during S. typhimurium infection of ptpn6 
morphants (chapter 2), there was no general up-regulation of pro-inflammatory genes 
in M. marinum infected ptpn6 morphants. Therefore, we concluded that the increased 
bacterial burden in ptpn6 morphants during M. marinum infection is mainly due to a 
specific hyperinduction of mmp genes, while in S. typhimurium infection a general 
hyperinduction of pro-inflammatory genes is the cause of the increased bacterial 
burden. A model summarizing our conclusions about the effect of ptpn6 deficiency on 
the molecular processes involved in S. typhimurium and M. marinum infections is 
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Figure 1. Schematic representation of the negative regulatory mechanisms of ptpn6 
during S. typhimurium and M. marinum infections in zebrafish embryos. Intravenous 
infection of wild type embryos at 1 day post fertilization (dpf) with S. typhimurium causes a 
general induction of pro-inflammatory genes (among others il1b, tnfa, mmp9, mmp13a) at 8 
hours post injection (hpi), while this is not observed upon infection with  M. marinum (Chapter 
2, van der Vaart et al., 2012). In contrast, M. marinum infection is associated with the formation 
of granuloma-like aggregates of infected and uninfected macrophages. Infected macrophages in 
these granulomas show a down-regulation of macrophage marker genes (Chapter 3), indicated 
by a lighter color of green in the figure. The knockdown of ptpn6 results in a hyperinduction of 
pro-inflammatory genes upon S. typhimurium infection. This increased inflammatory response, 
instead of helping the host controlling the infection, makes it more susceptible to disease 
progression. As a result, the host is no longer able to clear infections with the attenuated S. 
typhimurium Ra strain (Chapter 2). M. marinum infection with the Mma20 strain does not 
induce a strong pro-inflammatory response at 8 hpi in ptpn6 knockdown embryos nor in 
control embryos. At later stages of infection, the morphants did not display a general 
hyperinduction of pro-inflammatory genes, but a specific hyperinduction of matrix 
metalloproteinase (mmp) genes was observed. This induction of mmp genes occurred 
specifically in infected and uninfected macrophages and was associated with an accelerated 
granuloma formation and increased bacterial burden (Chapters 2 and 3). These observations 
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show the importance of ptpn6 for a balanced and productive immune response in zebrafish 
embryos against bacterial pathogens.  
 
 Interestingly, the mmp9 and mmp13a genes were also up-regulated in 
macrophages of uninfected ptpn6 morphants. These macrophages also showed up-
regulation of actin, myosin and parvalbumin genes, of several immune-related 
proteases (e.g., cpa5, npsn, cpn1, mmp9 and mmp13a), and of typical neutrophil markers 
like lyz and mpx. In contrast, several typical macrophage-expressed genes (e.g. cxcr4b, 
tnfa, tnfrsf1a, mbp, grn2, mhc2dab, cd74, cd74a, and the chemokine gene si:ch211-
149o7.4) were down-regulated in macrophages of ptpn6 morphants. These data suggest 
a complex role of ptpn6 in regulating the activation status of the macrophages. The 
effects of ptpn6 knockdown on different cell populations were very specific. The up-
regulation of mmp9, mmp13a and several other protease genes was observed in 
macrophages but not in neutrophils, T-cells, or in the GFP-negative background of 
ptpn6 morphants. Up-regulation of mmp2 was detected in neutrophils in GFP-negative 
background cells. An up-regulation of genes involved in p53 signaling (tp53, mdm2, 
ccng1) was only observed in neutrophils. Furthermore, neutrophils showed specific 
down-regulation of apolipoprotein and protease genes under ptpn6 knockdown 
conditions, while down-regulation of ribosomal protein genes was specific for T-cells. 
There was no effect on p53 signaling genes in the GFP-negative background cells of 
ptpn6 morphants and no indication of a general toxicity effect in the RNA-Seq data. 
Based on these results, we suggest that enhanced mmp genes secretion by macrophages 
might be a major cause of the inflammation-associated phenotype that ptpn6 
morphants develop around 5 dpf.  
In Chapter 4 we studied the function of microRNAs (miRNAs) as another 
potential level of regulation of innate immune responses during infection of zebrafish 
embryos. MiRNAs are evolutionary conserved, genome-encoded small RNAs (~22 
nucleotides) involved in post-transcriptional gene repression. We focused on the role of 
microRNA-146a and microRNA-146b (miR-146a/b), which are two closely related 
members of the miRNA-146 family that is well conserved between human and 
zebrafish. Dysregulation of miR-146a/b has been frequently linked to inflammatory 
diseases and malignant tumors, and therefore modulating its function might have a 
therapeutic potential. Previous studies in human cells and mouse models suggested that 
miR-146a/b function in a negative feedback pathway of TLR and cytokine signaling by 
targeting IRAK1 and TRAF6 mRNAs for down-regulation. The IRAK1 and TRAF6 
homologs of both zebrafish and human contain putative target sites for miR-146a/b in 
their 3’UTRs, suggesting that miR-146 feedback control of TLR signaling is evolutionary 
conserved (Ordas et al., 2010). Using quantitative PCR (qPCR) analysis we found that 
the expression of miR-146a/b in zebrafish is inducible by infection with S. typhimurium 
and M. marinum, which was in line with previous microarray data from our group. 
Furthermore, we showed that infection-inducible expression of miR146a/b was 
partially dependent on the TLR pathway genes traf6 and myd88. The induction of miR-





embryos and in myd88 knockout mutant embryos compared with the induction levels 
in control embryos. This demonstrated the requirement of a Myd88/Traf6 pathway for 
full-scale induction of miR-146a/b during infection in zebrafish. However, it is likely 
that a parallel Myd88/Traf6-independent induction route also exists, as neither traf6 
knockdown nor myd88 knockout was sufficient to block the infection-induced 
expression of miR-146a/b completely.  
We took advantage of the morpholino knockdown technology for functional 
analysis of miR-146a/b in zebrafish embryos by. designing two different morpholinos 
for each of the miR-146 family members. The efficiency of each knockdown was 
confirmed by Taqman qPCR analysis. We did not observe any effects of the loss of miR-
146a/b on the development or differentiation of leukocytes in zebrafish embryos. 
Hypothesizing that miR-146a/b might be involved in negative regulation of the innate 
immune response, we were interested to test whether miR-146a/b knockdown leads to 
hyperinduction of pro-inflammatory genes following S. typhimurium infection, similar 
as was observed in our knockdown analysis of the negative regulator ptpn6. RNA-Seq 
analysis was performed for this purpose. First, we checked if miR-146a/b knockdown 
had an effect on gene expression in the absence of infection. We found that only 78 
genes were affected by miR-146a/b knockdown, among which 5 genes in p53 signaling. 
This might reflect a non-specific effect of the miR-146 knockdown, since morpholino 
effects on the p53 pathway are relatively common. However, considering that miR-146 
has been frequently linked with cancer, a direct effect on the p53 pathway is also 
conceivable. S. typhimurium infection led to slightly higher numbers of up- and 
downregulated genes in miR-146 morphants than in control embryos, but there was no 
general hyperinduction of pro-inflammatory genes in miR-146 morphants. The only 
pro-inflammatory marker that was induced at higher levels in miR-146 morphants was 
the mmp9 gene. Consistent with this observation, human MMP9 was down-regulated 
following overexpression of miR-146a/b in cultured cancer cells and macrophages. 
Given that there are no predicted target sites for miR-146a/b in mmp9, miR-146-
mediated regulation of this gene may occur via the Myd88/Traf6 pathway that acts 
upstream of mmp9 induction. The fact that mmp9 is the most strongly induced pro-
inflammatory marker in S. typhimurium infection may explain why differences in 
induction of other Myd88/Traf6-dependent pro-inflammatory markers were not seen 
in our RNA-Seq analysis of miR-146a/b morphants and control embryos. 
Although the overall effect of miR-146a/b knockdown observed in our RNA-Seq 
analysis was relatively minor, KEGG pathway analysis revealed a possible effect on 
apolipoprotein-mediated lipid transport in S. typhimurium-infected miR-146 
morphants. This is an interesting observation considering that many studies have 
linked apolipoproteins to immunoregulation and host defense and that several 
inflammatory disorders are associated with uncontrolled lipid accumulation. MiR-146a 
has been suggested to be involved in negative regulation of oxidized low-density 
lipoprotein accumulation in human macrophages. In future work, zebrafish infection 
models may prove useful to further explore the role of miR-146 family members in 
lipid-mediated inflammatory responses. 
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Knockdown of miR-146a/b did not affect bacterial burdens during infection with 
S. typhimurium, but infection with M. marinum under miR-146a/b knockdown 
conditions resulted in accelerated granuloma formation and led to significantly 
increased bacterial burdenscompared to control infected embryos. Knockdown 
experiments with morpholinos targeting each of the miR-146 family members 
separately, showed that loss of miR-146b rather than loss of miR-146a caused the 
increased bacterial burden during M. marinum infection. It remains to be further 
investigated if accelerated granuloma formation under miR-146b knockdown 
conditions is linked with increased mmp gene expression, similar as in the ptpn6 
knockdown situation. 
Conclusion: The work presented in this thesis has provided new insights into 
the mechanisms involved in the regulation of innate immune responses to infection in 
zebrafish embryos. Furthermore, cell-specific transcriptome profiling studies in this 
thesis have identified novel marker genes for distinguishing immune cell types, which is 
highly useful information to fulfill the demand for new fluorescent reporter lines and 
lineage-specific antibodies in the zebrafish model. Our functional studies of Ptpn6 show 
that the role of this protein-tyrosine phosphatase as a negative regulator is of critical 
importance to a properly balanced innate immune response and for the control of 
infections with S. typhimurium and M. marinum. We found that Ptpn6 has a specific 
regulatory function in responses to each of these bacterial pathogens. In S. typhimurium 
infection, ptpn6 deficiency caused a general hyperinduction of pro-inflammatory genes, 
which was contra-productive as it impaired the control of infection. In M. marinum 
infection, a more specific effect of ptpn6 deficiency on matrix metalloproteinase gene 
expression is likely to be a major underlying cause of accelerated granuloma formation 
and increased bacterial burden. We further concluded that Ptpn6 functions as a much 
stronger negative regulator than infection-inducible miRNAs of the miR-146 family, 
which may be involved in more subtle fine-tuning of the innate immune response. 
Knowledge about the distinct roles of Ptpn6 and miR-146 miRNAs has practical 
applicability in regard to their potential as therapeutic targets for inflammatory 
diseases and cancer. Our zebrafish knockdown models for these negative regulators 
may contribute to anti-inflammatory and anti-microbial drug discovery, for which high-













Infectieziekten vormen een serieuze bedreiging voor de gezondheid, niet alleen in 
ontwikkelingslanden maar ook in de westerse wereld. Een goed functionerend 
immuunsysteem is onmisbaar voor de afweer tegen ziekteverwekkende micro-
organismen. In reactie op een infectie produceren de cellen van het immuunsysteem 
signaalmoleculen die een ontstekingsbevorderende werking hebben. Een toename van 
de bloedtoevoer en  aantrekking van immuuncellen tijdens een ontstekingreactie helpt 
om verdere verspreiding van de infectie te beperken. Dit proces moet echter zeer 
precies gereguleerd worden, omdat een ontsteking ook schadelijk is voor de eigen 
lichaamscellen. Een verstoorde regulatie van dit proces kan leiden tot auto-
immuunziekten en chronische ontstekingsziekten.  
Hoofdstuk 1 geeft een overzicht van de signaalmoleculen die een belangrijke rol 
spelen bij de regulatie van het immuunsysteem. Deze signaalmoleculen zijn sterk 
evolutionair geconserveerd tussen de mens en de zebravis, het modelsysteem dat wij 
gebruikt hebben voor het onderzoek in dit proefschrift. De transparante embryo’s van 
de zebravis zijn zeer geschikt om de functie te bestuderen van macrofagen en 
neutrofielen, de eerste celtypen van het immuunsysteem die reageren op een infectie. 
In ons onderzoek werden zebravisembryo’s geïnfecteerd met Salmonella typhimurium 
and Mycobacterium marinum, als model voor respectievelijk acute and chronische 
bacteriële infecties. Met behulp van deze infectiemodellen hebben wij verschillende 
regulerende factoren van het immuunsysteem onderzocht. 
In hoofdstuk 2 hebben wij het belang aangetoond van een negatieve regulator 
van het immuunsysteem: Ptpn6, een eiwit dat behoort tot de familie van fosfatases. Het 
was al bekend dat functionele defecten van dit fosfatase in de muis gepaard gaan met 
hevige ontstekingen en dat er in de mens een verband is met auto-immuunziekten en 
ontstekingsziekten. Net als bij de mens, komt het gen voor Ptpn6 in de zebravis 
specifiek tot expressie in de cellen van het immuunsysteem (leukocyten). Uitschakeling 
van dit gen in zebravisembryo’s (door knockdown met morpholino’s) had geen 
zichtbaar effect tijdens de vroege ontwikkeling, maar leidde tot een laat fenotype in 
larven van vijf tot zes dagen oud. Deze larven ontwikkelden oedeem en huidlaesies met 
een sterke infiltratie door leukocyten. Bovendien vertoonden ze een sterk verhoogde 
expressie van ontstekingbevorderende (pro-inflammatoire) genen, zoals interleukine 1b 
(il1b) en matrix metalloproteinase 9 (mmp9). Dit fenotype was onafhankelijk van de 
aanwezigheid van micro-organismen en kon niet onderdrukt worden door behandeling 
met glucocorticoïde ontstekingsremmers. Om de functie van Ptpn6 tijdens infecties te 
onderzoeken hebben wij ons gericht op de eerste dagen van de embryo-ontwikkeling, 
voorafgaand aan het optreden van het latere fenotype in de larven. In deze periode 
vertoonden Ptpn6-deficiënte embryo’s een grotere vatbaarheid voor experimentele 
infecties met S. typhimurium en M. marinum. Tijdens S. typhimurium-infectie trad er in 
de Ptpn6-deficiënte embryo’s een sterkere inductie op van de pro-inflammatoire genen 
il1b en mmp9 dan bij geïnfecteerde controle-embryo’s. Tijdens M. marinum-infectie 
werd eenzelfde effect van Ptpn6-deficiëntie op expressie van mmp9 waargenomen. De 
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hyperinductie van deze genen had dus een negatief effect op de capaciteit van de 
embryo’s om zich te verdedigen tegen de bacteriële infecties. Vervolgens hebben wij het 
S. typhimurium-infectiemodel gebruikt om het effect van Ptpn6-deficiëntie verder te 
onderzoek met behulp van een microarray-analyse en een multiplex PCR-methode (RT-
MLPA). Dit liet zien dat er bij infectie van Ptnp6-deficiënte embryo’s een hyperinductie 
is van een grote groep van pro-inflammatoire genen en activerende transcriptiefactoren 
van de immuunrespons. Deze resultaten leidden tot de conclusie dat Ptpn6 functioneert 
als een negatieve feedback-regulator van de immuunrespons van zebravisembryo’s 
tegen infecties. Deze functie van Ptpn6 blijkt cruciaal te zijn voor het 
afweermechanisme van de embryo’s. 
In hoofdstuk 3 hebben wij RNA-Seq-technologie (Illumina RNA sequencing) 
toegepast om de expressieprofielen te bepalen van verschillende celtypen van het 
immuunsysteem en om de effecten van Ptpn6-deficiëntie verder te analyseren op 
cellulair niveau. Hiervoor hebben wij gebruik gemaakt van transgene zebravislijnen 
met fluorescent-gemarkeerde macrofagen (mpeg1:egfp), neutrofielen (mpx:egfp), en 
vroege T-cellen (lck:egfp). De fluorescerende cellen werden geïsoleerd uit vijf dagen 
oude larven met behulp van FACS-sortering (fluorescence activated cell sorting). Eerst 
hebben wij een robuust protocol opgezet voor RNA-isolatie, cDNA-amplificatie en RNA-
Seq-analyse van zeer kleine hoeveelheden uitgangsmateriaal (4000-10000 cellen en 
RNA-hoeveelheden rond 100 pg). Hiermee konden wij vervolgens sets van specifieke 
merkers bepalen voor macrofagen, neutrofielen, en T-cellen. Hierbij hebben wij nieuwe 
merkers ontdekt die een hoger expressieniveau hebben dan tot nu toe bekende 
merkers en die daarom zeer geschikt zijn voor de ontwikkeling van nieuwe transgene 
lijnen of antilichamen voor de onderscheiding van verschillende typen immuuncellen in 
de zebravis. We hebben de RNA-Seq-technologie tevens toegepast om de reactie van het 
immuunsysteem op een infectie met M. marinum te onderzoeken. Na opname door 
macrofagen, veroorzaakt deze pathogeen een chronische infectie in zebravisembryo’s, 
waarbij de geïnfecteerde macrofagen opeenhopen in granulomen. De vorming van 
granulomen is ook karakteristiek voor tuberculose bij de mens, veroorzaakt door de 
nauw verwante pathogeen Mycobacterium tuberculosis. Wij vonden dat de infectie met 
M. marinum een groot effect had op het expressieprofiel van macrofagen, waarbij er een 
sterke verlaging was van de expressieniveau’s van macrofaag-specfieke merkergenen 
en er tegelijkertijd verhoogde expressie was van genen die een mogelijke rol spelen bij 
de afweerreactie van de gastheer of juist bij immuunsuppressie. Onder condities van 
Ptpn6-deficiëntie vertoonden de geïnfecteerde cellen een extra verhoging van de 
expressie van genen voor matrix metalloproteinases, waaronder mmp9 en mmp13a. 
Bovendien was er een verhoogde expressive van serum amyloid A (saa), een gen dat 
mogelijk de expressie van mmp genen reguleert. Er was ook verhoogde expressie van 
genen met een mogelijke anti-microbiële functie, maar dat kon niet verkomen dat 
Ptpn6-deficiënte embryos vatbaarder waren voor infectie met M. marinum. In 
tegenstelling tot wat we zagen bij S. typhimurium-infectie (hoofdstuk 2), was er geen 
algemeen verhoogde expressie van pro-inflammatoire genen. Daarom concludeerden 





met name wordt veroorzaakt door een specifieke hyperinductie van mmp-genen, terwijl 
dit bij S. typhimurium-infectie komt door een algemene hyperinductie van pro-
inflammatoire genen. De expressie van mmp-genen was ook verhoogd in macrofagen 
van ongeïnfecteerde zebravislarven met Ptpn6-deficiëntie. Dit zou een belangrijke 
oorzaak kunnen zijn van de spontane onstekingsreacties die optreden in deze larven 
(hoofdstuk 2).   
In hoofdstuk 4 hebben we de functie van microRNAs (miRNAs) onderzocht die 
een moeglijke rol spelen bij post-transcriptionele regulatie van het immuunsysteem 
tijdens infecties. Het onderzoek was gericht op microRNA-146a and microRNA-146b 
(miR-146a/b), twee nauw verwante leden van de miRNA-146-familie, die sterk 
geconserveerd is tussen de mens en de zebravis.  Een veranderde expressie van miR-
146a en b is vaak in verband gebracht met ontstekingsziekten en kwaadaardige 
tumoren. Op grond van eerder onderzoek in humane cellen en muizen was 
gepostuleerd dat miR-146a en b functioneren als negatieve feedback-regulatoren van 
het immuunsysteem via afbraak van de mRNA’s van twee centrale signaalmoleculen, 
IRAK1 and TRAF6. Overeenkomstig met eerder microarraydata van onze groep vonden 
wij met behulp van kwantitatieve PCR dat de expressie van miR-146a en b in zebravis 
induceerbaar is door infectie met S. typhimurium en M. marinum. Bovendien konden wij 
aantonen dat deze infectie-inductie grotendeels afhankelijk is van een Myd88/Traf6-
signaalroute. Net als bij het onderzoek naar Ptpn6 hebben wij gebruik gemaakt van 
morpholino-knockdown om de functie van miR-146a/b in zebravisembryo’s te 
onderzoeken. Deficiëntie van miR-146a/b had geen effect op de ontwikkeling of 
differentiatie van leukocyten in de zebravisembryo’s. Ook bleek uit RNA-Seq-analyse 
dat er weinig effect was van miR-146a/b-deficiëntie op genexpressie, zowel in 
ongeïnfecteerde embryos als tijdens S. typhimurium-infectie. Een opvallend verschil met 
deficiëntie van Ptpn6 was dat er bij miR-146a/b-deficiëntie geen algemene 
hyperinductie van pro-inflammatoire genen optrad tijdens S. typhimurium-infectie. Het 
enige pro-inflammatoire gen met een enigszins verhoogde inductie bij miR-146a/b-
deficiëntie was mmp9. Wel vonden we aanwijzingen in de RNA-Seq-analyse voor een 
effect van miR-146a/b-deficiëntie op lipidetransporters (apolipoproteïnen) tijdens S. 
typhimurium-infectie. Dit is een interessante observatie, aangezien veel studies een 
verband hebben gelegd tussen lipidetransport en immuniteit en aangezien 
verschillende onstekingsziekten zijn geassocieerd met een ongecontroleerde ophoping 
van lipiden. Toekomstig onderzoek in zebravis-infectiemodellen zou kunnen bijdragen 
om de functie van de miR-146-familie in lipide-afhankelijke ontstekingsprocessen 
verder op te helderen. Deficiëntie van miR-146a/b had geen meetbaar effect op de 
vatbaarheid van zebravisembryo’s voor infectie met S. typhimurium, maar injectie van 
M. marinum-bacteriën resulteerde in een versnelde vorming van granulomen en een 
progressiever verloop van de infectie. Met gebruik van specifieke morpholino’s voor 
miR-146a en voor miR-146b bleek dat de versnelde granuloomvorming vooral werd 
veroorzaakt door deficiëntie van miR-146b. Verder onderzoek zal moeten uitwijzen of 
de versnelde granuloomvorming onder condities van miR-146b-deficiëntie ook gepaard 
gaat met verhoogde mmp9 expressie, net zoals bij Ptpn6-deficiëntie. 
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Conclusies: Het onderzoek in dit proefschrift heeft nieuwe inzichten opgeleverd 
in de mechanismen die betrokken zijn bij de regulatie van de immuunreactie tegen 
infecties in zebravisembryo’s. Met cel-specifieke expressieprofileringen hebben wij 
bovendien nieuwe merkergenen ontdekt waarmee verschillende celtypen van het 
immuunsysteem onderscheiden kunnen worden. Dit is zeer nuttige informatie omdat er 
een grote behoefte is aan merkers voor de ontwikkeling van nieuwe transgene lijnen 
(fluorescente reporters) en antilichamen voor detectie van immuuncellen. Onze 
functionele analyses van Ptpn6 hebben laten zien dat dit leukocyt-specifieke fosfatase 
betrokken is bij negatieve regulatie van het immuunsysteem en dat deze rol cruciaal is 
voor een gebalanceerde reactie van het immuunsysteem op infecties met S. 
typhimurium and M. marinum. Het bleek dat Ptpn6-deficiëntie speficieke effecten heeft 
op deze verschillende infecties. Bij S. typhimurium-infectie veroorzaakte Ptpn6-
deficiëntie een algemene hyperinductie van pro-inflammatoire genen, wat 
contraproductief was omdat het de afweer tegen de infectie verslechterde. Bij M. 
marinum-infectie was een specifiek effect van Ptpn6-deficiëntie op de expressie van 
genen voor matrix metalloproteinases de meest waarschijnlijke oorzaak van versnelde 
granuloomvorming en progressie van de infectie. Verder hebben we geconcludeerd dat 
Ptpn6 functioneert als een veel sterkere negatieve regulator dan infectie-induceerbare 
miRNAs van de miR-146-familie, die mogelijke betrokken zijn bij een subtielere “fine-
tuning” van de immuunrespons. Kennis over de functies van Ptpn6 en miR-146-miRNAs 
heeft praktische toepasbaarheid gezien hun potentieel als therapeutische doelwitten 
vooor ontstekingsziekten en kanker. Onze knockdown-modellen van deze negatieve 
regulatoren kunnen bijdragen aan grootschalige screeningen voor nieuwe anti-
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